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Abstract
Chapter 1. Investigating the Biological Roles of Nitric Oxide and Other Reactive
Nitrogen Species Using Fluorescent Probes
This chapter presents an overview of recent progress in the field of reactive nitrogen
species (RNS) sensing. Reactive nitrogen species, such as nitric oxide (NO) and its
higher oxides, play important roles in cell signaling during many physiological and
pathological events. Elucidation of the exact functions of these important biomolecules
has been hampered by the inability to detect RNS reliably under biological conditions. A
surge of research into RNS chemistry has resulted in the design of a new generation of
fluorescent probes that are specific and sensitive for their respective RNS analytes.
Progress in the field of nitric oxide, peroxynitrite, and nitroxyl sensing promises to
advance our knowledge of important signaling events involving these species and should
lead to a better understanding of oxidative biochemistry crucial to health and disease.
Chapter 2. Mechanism of Nitric Oxide Reactivity and Fluorescence Enhancement of
the NO-Specific Probe, CuFLI
The mechanism of the reaction of CuFLI (FLI = 2-{2-chloro-6-hydroxy-5-[(2-
methylquinolin-8-ylamino)-methyl]-3-oxo-3H-xanthen-9-yl}benzoic acid) with NO to
form FL1-NO in aqueous, buffered solutions was investigated. The reaction is first order
in concentration of CuFL1, NO, and hydroxide ion. Rate saturation at high base
concentrations is consistent with the fact that the protonation state of the secondary amine
of the complex is crucial for reactivity. Based on this information, faster-reacting probes
can be obtained by lowering the pKa of the secondary amine. The activation parameters
for the reaction indicate that the mechanism is associative (ASI = -29 ± 3 cal/K-mol) and
occurs with a modest thermal barrier (AHI = 9.7 ± 0.5 kcal/mol; Ea = 10.3 ± 0.5
kcal/mol). Variable pH EPR experiments indicate that as the secondary amine of CuFLI
is deprotonated, the electron density shifts yielding new spin-active species that has
electron density localized on the deprotonated nitrogen atom. This result suggests that
FL1-NO formation occurs when NO attacks the deprotonated secondary amine of the
coordinated ligand, causing inner-sphere electron transfer to Cu(II) to form Cu(I) and
subsequent FL 1-NO release from the metal.
Chapter 3. Fluorescence-Based Nitric Oxide Sensing by Cu(II) Complexes that Can
Be Trapped in Living Cells
A series of symmetrical, fluorescein-derived ligands appended with two derivatized 2-
methyl-8-aminoquinolines were prepared and spectroscopically characterized. The
ligands 2-{6-hydroxy-4,5-bis[(2-methylquinolin-8-ylamino)methyl]-3-oxo-3H-xanthen-
59-yl}benzoic acid (FL2), 2-{4,5-bis[(6-(2-ethoxy-2-oxoethoxy)-2-methylquinolin-8-
ylamino)methyl]-6-hydroxy-3-oxo-3H-xanthen-9-yl}benzoic acid (FL2E), and 2,2'-{8,8'-
[9-(2-Carboxyphenyl)-6-hydroxy-3-oxo-3H-xanthene-4,5-diyl]bis(methylene)bis(azane-
diyl)bis(2-methylquinolin-8,6-diyl)}bis(oxy)diacetic acid (FL2A) were designed to
improve the dynamic range of previously described asymmetric systems, and the copper
complex Cu2FL2E was constructed as a trappable NO probe that is hydrolyzed
intracellularly to form Cu2FL2A. The ligands themselves are only weakly emissive and
completely quenched in their Cu(II) complexes, which were generated in situ by
combining each ligand with two equivalents of CuCl2 . The resulting complexes were
investigated as fluorescent probes for nitric oxide. Upon introduction of excess NO under
anaerobic conditions to buffered solutions of Cu2(FL2), Cu 2(FL2E), and Cu2(FL2A), the
fluorescence increased by factors of 23 ± 3, 17 ± 2, and 27 ± 3, respectively. The
corresponding rate constants for fluorescence turn-on were determined to be 0.006 ±
0.003 s-, 0.0058 ± 0.0009 s-4 and 0.010 ± 0.002 s4. The probes are highly specific for
NO over other biologically relevant reactive oxygen and nitrogen species, as well as
Zn(II), the metal ion for which structurally similar probes were designed to detect.
Chapter 4. Visualization of Nitric Oxide Production in the Mouse Main Olfactory
Bulb by a Cell-Trappable Copper(II) Fluorescent Probe
The visualization of NO production using fluorescence in tissue slices of the mouse main
olfactory bulb is reported. This discovery was possible through the use of a novel, cell-
trappable probe for intracellular nitric oxide detection based on a symmetric scaffold with
two NO-reactive sites. Ester moieties installed onto the fluorescent probe are cleaved by
intracellular esterases to yield the corresponding negatively charged, cell-impermeable
acids. The trappable ester probe Cu2(FL2E) and the membrane-impermeable acid
derivative Cu 2(FL2A) respond rapidly and selectively to NO in buffers that simulate
biological conditions. Application of Cu2(FL2E) leads to detection of endogenously
produced NO in cell cultures and olfactory bulb brain slices.
Chapter 5. Dextran-Based Cell-Trappable Fluorescent Probes for Nitric Oxide
Visualization in Living Cells
Two new cell-trappable fluorescent probes for nitric oxide are reported based on either
incorporation of hydrolyzable esters or conjugation to aminodextran polymers. Both
probes are highly selective for NO over other reactive oxygen and nitrogen species
(RONS). The ability of these probes to image nitric oxide produced endogenously in Raw
264.7 cells by fluorescence is demonstrated.
Chapter 6. A Cell-Trappable Fluorescent Probe for Detecting Biological Zinc
The synthesis and spectroscopic characterization of a new, cell-trappable fluorescent
probe for Zn(II) is presented. This probe, 2-(4,5-bis((6-(2-ethoxy-2-oxoethoxy)quinolin-
8-yl)amino)methyl)-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid (QZ2E) is poorly
emissive in the off-state, but exhibits a dramatic, 120 ± 10-fold increase in fluorescence
upon Zn(II) binding. This binding is selective for Zn(II) over other biologically relevant
metal cations, toxic heavy metals, and most first-row transition metals, and is of
appropriate affinity (Kdl = 150 ± 100 [tM, Kd2 = 3.5 ± 0.1 mM) to bind Zn(II) at
physiological levels reversibly. In live cells, QZ2E localizes to the Gogli apparatus where
it can detect Zn(II). It is cell membrane permeable until cleavage of its ester groups by
intracellular esterases produces QZ2A, a negatively-charged acid that cannot cross the
cell membrane.
Appendix 1. Screening for bNOS Inhibitors in Bacillus anthracis
The incidence of anthrax infection by the Gram-positive bacterium Bacillus anthracis
and the challenges of its treatment are presented. B. anthracis pathogenesis is critically
dependent on NO production by the enzyme bacterial nitric oxide synthase (bNOS), a
variant of the eukaryotic NOSes that does not contain a reductase domain required for
catalysis. Using non-committed reductases in the cell, B. anthracis produced NO to
neutralize the oxidative environment produced in macrophages as a host defense system.
The fact that NO production is crucial for bacterial survival suggests that a selective
bNOS inhibitor would make a good antibacterial agent against Bacillus anthracis and
related pathogens. A high-throughput screen of a small-molecule library to identify
potential bNOS inhibitors by fluorescence of an NO-specific probe is proposed.
Optimization of fluorescence imaging in 384-well plates is presented as a first step
toward this goal. Future directions to improve the screening protocol and steps for
ensuring bNOS selectivity and efficacy in mice are discussed.
Appendix 2. NMR Spectra
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Chapter 1.
Investigating the Biological Roles of Nitric Oxide and Other Reactive Nitrogen
Species Using Fluorescent Probes
This chapter is based on the following published work:
1. Reproduced in part from McQuade, L. E.; Lippard, S. J. Curr. Opin. Chem. Biol.,
2010, 14, 43-49, Copyright (2010), with permission from Elsevier.
2. Reproduced in part from Tonzetich, Z. J.; McQuade, L. E.; Lippard, S. J. Inorg.
Chem., 2010, in press. Copyright 2010 American Chemical Society.
3. Reproduced in part from McQuade, L. E.; Ma, J.; Lowe, G.; Ghatpande, A.;
Gelperin, A.; Lippard, S. J. Proc. NatL. Acad. Sci. U.S.A., 2010, 107, 8525-8530.
Introduction
Biological transmission of a signal from an input stimulus to the appropriate
physiological target is accomplished by invoking a signal transduction pathway, in which
secondary messengers activate proteins to propagate information. The signal is amplified
as it is transmitted, with each wave of activation resulting in a greater number of proteins
and messengers involved in the process. Secondary messengers critical to the signaling
cascade come in a variety of forms, including oxidative compounds such as reactive
oxygen (ROS) and nitrogen (RNS) species.' The prototypical RNS is nitric oxide (NO),
which was identified decades ago as the endothelium derived relaxation factor that
promotes vascular smooth muscle relaxation when it binds and activates soluble guanylyl
cyclase.2 Since then, NO has been implicated in a wide array of biological functions,
from normal physiological events such as neurotransmission5 and host immune system
defense 6 to pathologies such as ischemia, inflammation, cancer, and neurodegeneration. 1
Moreover, as biological nitric oxide research expands it has become increasingly clear
that products of NO oxidation such as nitrogen dioxide (NO 2), dinitrogen trioxide (N20 3),
peroxynitrite (ONOO), nitrite (NO2~), nitrate (NO3~), and nitroxyl (HNO) also play
important roles in both physio- and pathological processes.1'7~9
Because of the significance of these secondary messengers to human health and
disease, investigating the roles of RNS continues to be an important area of research. One
of the major limitations in studying these essential molecules is the lack of appropriate
tools to monitor their production in vivo. Fluorescence, especially in combination with
microscopy, is amenable to in vivo analyte sensing. A fluorescent probe must have
certain characteristics to be useful for biological imaging. First, in order to be suitable
for use under biological conditions it should be water soluble, cell-membrane permeable,
non-toxic, and excitable at low-energy wavelengths that do not induce interfering
autofluorescence or cause harm to the cell. Second, it should display good photophysical
properties such as a large difference in the product of molar absorptivity and quantum
yield (E x $) between the on and off states. Finally, it should have excellent sensing
characteristics such as selectivity, cell-trappability, reversibility, and diffusability;
moreover, it should respond rapidly and directly to the analyte of interest at its biological
concentrations. Many useful fluorescent probes lack one or more of these properties, but
as each new probe generation emerges it is usually improved in one or more of the
requisite features.
This chapter summarizes recent progress in small-molecule probe design and
utilization in the areas of nitric oxide, peroxynitrite, and nitroxyl sensing. Although nitrite
and nitrate sensing by fluorescence quenching is an active research area, the field is
replete with electrochemical and colorimetric detection methods that will not be covered
here. For a more comprehensive background of RNS sensing, the interested reader is
referred elsewhere. 10-15
Small Molecule Fluorescent Probes for Nitric Oxide
Because of the various biological roles of nitric oxide, investigating the
generation, translocation, and utilization of NO continues to be an active area of research.
Detection of nitric oxide presents many challenges. NO reacts rapidly in vivo with
dioxygen, amines, thiols, metal centers, and oxygen-centered radicals such as superoxide
ion. 16'17 It also diffuses readily from its point of generation,18 making rapid detection
desirable for uncovering both its production site and function. Moreover, NO is produced
at concentrations as low as ~ 100 picomolar, so it is essential to have an NO probe with a
low detection limit.19 Fluorescent sensors should be designed to target the distribution
and trafficking of NO under physiological conditions in order to allow for in vivo nitric
oxide imaging.
Many design strategies for in vivo NO detection have been explored, and small
molecule, nanotube, 20 cellular-21 22 and protein-based2 3 assays have been employed with
great success. There are two main classes that have emerged for NO-specific small
molecule fluorescent probes: organic and metal-based sensors. In both instances, the goal
is to alter the fluorescent properties of the probe by specific reaction with NO. Organic
probes employ fluorophores with pendant functional groups that serve to quench their
fluorescence until restored by NO treatment. Metal-based probes take advantage of the
reactivity of NO directly at the metal site itself, or they alter NO reactivity at a site near
the metal.
Organic NO Probes
o-Phenylenediamines
The most prevalent organic-based NO probes are the o-phenylenediamine
constructs.24 The electron-rich vicinal amines are thought to alter the energy of the
aromatic group to facilitate photoinduced electron transfer (PET) and quench
fluorescence. In the presence of an oxidized form of NO, an electron-poor aryl triazole is
formed, which abolishes the PET pathway and restores fluorescence (Fig. 1.1 a). Based on
this reactivity, these probes can also be considered detectors of nitrosonium ion (NO*),
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Figure 1.1. a) Proposed sensing mechanism of o-phenylenediamine NO probes. The
diamine molecule is quenched by a photo-induced electron transfer mechanism that is
abolished upon reaction with oxidized NO and formation of a triazole species. b)
Examples of o-phenylenediamines using rhodamine (DAR-4M), BODIPY (DAMBOO),
cyanine (DAC-P), and calcein (DCl-DA Cal) fluorophores.
which is generated in the cell as NO 2 or N2O3. Probes incorporating fluorescein24 were
the first fluorescent sensors designed, but due to their pH sensitivity and problems with
b) N.
DAR-4M
photobleaching, rhodamine-based2 5 probes were developed. Subsequently, 4,4-difluoro-
4-bora-3a,4a-diaza-s-indacene (BODIPY) 26,2 7 fluorophores were employed in sensing
agents, and recent studies exploring cyanine-based near-IR probes provide a promising
option for live-tissue imaging (Fig. 1. lb).28
Very recent work describes a strategy to enhance the cellular retention of sensors
to increase sensitivity.29 Increased cellular retention is speculated to increase NO
sensitivity by making more intracellular sensor available for reaction and by reducing the
background fluorescence such that small changes in fluorescence induced by low NO
concentrations will be visible. When calcein is used as the parent fluorophore of such a
probe, for example in DCl-DA Cal (Fig. 1. lb), the negative charge of its two
iminodiacetate groups greatly increases cellular retention in HeLa and bovine aortic
endothelial (BAEC) cells. The background fluorescence is also lowered owing to reduced
leakage of the triazole product out of the cell.
Probes based on the o-phenylenediamine scaffold have been utilized for ex vivo
NO visualization. 3,4-Diamino BODIPYs are competent for cellular imaging.30 Similarly,
previously reported vicinal diaminobenzoacridine molecules react with NO and are useful
for imaging purposes in Raw 264.7 macrophages. 31 A variation of the o-
phenylenediamine system was reported recently in which the quenched probe is a
rhodamine B spirolactam (Fig. 1.2).2 The closed ring conformation of the fluorophore
abolishes aromaticity and thus eliminates fluorescence. Oxidized NO reacts with the
adjacent diamines to produce the ring-opened, and therefore fluorescent, rhodamine B
acylbenzotriazole, which quickly decomposes to yield rhodamine B.
Et2N 0 NEt 2  Et2N 0 NEt2+ Et2N 0 NEt 2+INO H20N P
02 COOH
H2N O
(non-fluorescent) (fluorescent) Rhodamine B(fluorescent)
Figure 1.2. The sensing mechanism of the ring-opening type probes. The spirolactam is
quenched because of a lack of aromaticity that is restored upon ring opening with
reaction with oxidized NO.
Fluorescent Nitric Oxide Cheletropic Traps
A second class of organic NO probes are the fluorescent nitric oxide cheletropic
traps (FNOCTs).33 ,3 4 NOCTs are o-quinodimethane derivatives that react directly with
NO in a cheletropic reaction to form persistent nitroxides, which can be detected by
electron paramagnetic resonance (EPR) or other spectroscopic methods (Fig 1.3a).
NOCTs suffer from reductive conversion to hydroxylamines under physiological
conditions, rendering their lifetimes too short for EPR detection in many biological
applications. FNOCTs utilize conversion to the hydroxylamine to generate non-radical,
fluorescent species that are much more emissive than the parent FNOCT. A series of
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Figure 1.3. a) The sensing mechanism of the NOCT probes. Cheletropic reaction of a
NOCT with NO generates a nitroxyl species, which is reduced to a hydroxylamine in
physiological environments. b) Examples of FNOCTs.
FNOCTs with different solubilities, excitation wavelengths, and trappability have been
produced (Fig. 1.3b).34'35 More recently, one of the better FNOCTs (FNOCT-5) has been
converted to a pH-insensitive version (FNOCT-14) that can detect NO in alveolar
macrophages. 36
Metal-based NO Probes
Organic probes have been useful as cellular NO-detection agents. One limitation,
however, is that none of the organic probes discussed are reversible, and the o-
phenylenediamines cannot detect NO directly. Because metals can form direct and
reversible bonds with nitric oxide,37 many researchers have focused on metal-ligand
constructs where the ligand contains a fluorophore. There are three main strategies used
to quench the intrinsic fluorescence of the fluorophore, outlined below.
Fluorophore Displacement
The simplest strategy to regain fluorophore emission is to remove it from the
quenching site (Scheme 1.1a). This task can be accomplished either by releasing the
ligand entirely or by removing a chelating arm to a sufficient distance from the metal. In
both cases, ligand displacement is concomitant with formation of a metal nitrosyl. Many
a. Fluorophore displacement, no metal reduction
NO
FL-M+L N NO-M"+L + FL E
b. No fluorophore displacement, metal reduction
NO, ROH "
FL-M"+L -R -- M("-i+L + RONO + H+
c. Fluorophore displacement and metal reduction
NO
FL-M"+L N M("v-l)+L + FL -- NO
Scheme 1.1. Metal-based NO sensing strategies.
.................................. .
metal-based NO-probes utilize this approach, including those containing Co(II), 8
Fe(II),3 s,39 Ru(II)4" or Rh(II).
Metal Reduction
Reduction of the metal to form a diamagnetic species can alleviate quenching
caused by paramagnetic metal ions (Scheme 1.1b). 43 Typically, this mechanism operates
in protic solvents (ROH) and results in transfer of NO to the solvent to form an alkyl
nitrite (RONO). This strategy has been employed primarily with Cu(II) probes, which are
readily reduced by NO but do not form stable Cu(I)-NO species.4 4'45
Fluorophore Displacement and Metal Reduction.
A third mechanism for restoring fluorescence emission is both to displace the
fluorophore and to reduce the paramagnetic metal center by reductive nitrosylation
(Scheme 1.1c). In this process, NO can either coordinate to the metal46-48 or nitrosate
either the ligand or solvent, when the latter is protic.49-s3 The first example of this
approach involved a paramagnetic Co(II) aminotroponiminate complex incorporating a
dansyl fluorophore as part of the ligand." Upon reaction with NO in dichloromethane,
one of the chelating arms was displaced and a diamagnetic cobalt-dinitrosyl complex
formed. This reaction was accompanied by an ~ 8-fold emission enhancement over the
course of 6 h.
Cu(II)-based NO Probes
The most promising metal-based sensor for direct, cellular detection of NO is
CuFLI (Fig. 1.4).0,51 Upon exposure of the Cu(II)-FLl complex to excess nitric oxide an
immediate 11-fold fluorescence enhancement occurs, which is selective for NO over
NO2, NO3, H202, HNO, ONOO-, 02, and C10-. During the reaction with NO, Cu(II) is
reduced to Cu(I) and the ligand is N-nitrosated to produce the fluorescent species, FL 1-
NO, which dissociates from the metal center. CuFL1 can detect endogenously produced
NO in cell culture; 51,54-59 however, it freely diffuses in and out of cells. To address this
shortcoming, second-generation cell-trappable probes of the CuFLI family have been
proposed. Their design and properties are described and will be explored in detail in
Chapters 3, 4, and 5 of this thesis.
N N
H N N
CO NO , -O
Cl Cl
C02 Cu(l) C I
CuFL1 (non-fluorescent) FL1 -NO (fluorescent)
Figure 1.4. The sensing mechanism of CuFL1. CuFLI reacts with NO, reducing the
Cu(II) to Cu(I) and nitrosating FL 1 to form a brightly fluorescent species.
The sensing strategy employed by CuFL1 is widely applicable and has been
incorporated into new NO-specific probes. A sensor was reported in which Cu(II)
binding to the blue fluorophore 4-methoxy-2-(1H-naphtho[2,3-d]imidazol-2-yl)phenol
(MNIP) quenches the fluorescence (Fig. 1.5).60 Like CuFL1, exposure of MNIP-Cu(II) to
excess NO results in rapid N-nitrosation of the ligand with concomitant reduction of
Cu(II) to Cu(I). In addition to nitric oxide detection in cultured Raw 264.7 macrophages,
MNIP-Cu(II) was used to visualize inflammation-induced NO production in liver slices
of ASHI mice, which are models for severe liver disease, versus normal Balb/c mice.
Thus, CuFLI and MNIP-Cu(II) type probes are valuable for biological imaging of NO
production.
NOHI
NNO -Q _N
MeO \ NO , MeO \
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MNIP-Cu (non-fluorescent) (fluorescent)
Figure 1.5. The sensing mechanism of MNIP-Cu(II). MNIP-Cu(I) reacts with NO,
causing reduction of the Cu(II) to Cu(I) and nitrosation MNIP, as with CuFLI.
Copper(II) is a versatile metal for NO-sensing and can be used in a wide array of
platforms. Conducting metallopolymers (CMPs) are fluorescent films that can be turned
into probes by incorporation of an appropriate sensor unit. Nitrogen-containing aromatics
such as bipyridine and terpyridine groups that bind Cu(II) have been integrated into
CMPs as NO-sensitive reaction sites.61-63 The paramagnetic Cu(II) quenches the intrinsic
film fluorescence, but reaction of NO with Cu(II) to produce the Cu(I)-polymer film
results in restoration of the film emission. The most recent report of these type of sensors
utilizes a cationic poly(fluorene) polymer containing 10% bis(imidazole) incorporation
into its backbone as the Cu(II) chelate.64 Addition of Cu(II) caused an ~ 80% reduction of
polymer fluorescence that was restored upon reaction with NO.
Non-Cu() Metal-based NO Probes
There are a few new sensor designs of note that do not contain Cu(II) or result in
N-nitrosation of a ligand. One example is a dual-platform system that utilizes the rapid
reaction of NO with deoxymyoglobin (Mb(Fe 2 )) to modulate the fluorescence of an
appended stilbene fluorophore, 4-acetamido-4'-isothiocyanoatostilbene-2,2'-disulfonic
acid) (STIS).65 The heme quenches the stilbene by an energy transfer mechanism that is
relieved upon formation of the Mb(Fe 2 )-STIS-NO complex. The authors used this
system to measure NO production in rabbit trachea.
Another design utilizes dimeric Ru(Il) complexes ligated by the fluorescent
ligands dmpzn and dmpza (Fig. 1.6).66 The heavy ruthenium atoms quench the ligand
fluorescence, but bubbling NO through a methanolic solution of the sensor results in a 2-
to 3-fold increase in fluorescence. The fluorophore remains ligated to the metal, and
fluorescence induction probably results from the change in energy of the d-d states of
Ru(II) caused by switching the ligand from a a donor (H2 0) to a n acceptor (NO).
OH2  NO -03S
H20,. R OH2  Cl Ru I / / dmpzn
N C N ,,N-Ar NO IN N-ArCl J\ 2 1OH, N\ 1
OH2  N N NO N Ar
Ar-N Ru Ar-N Ru N
H2 0v I '*OH2  COi C
Ul OH 2  dmpza
(non-fluorescent) (fluorescent)
Figure 1.6. The sensing mechanism of the dimeric Ru(II) probe and its Ru-NO product.
Small Molecule Fluorescent Probes for Peroxynitrite
Global Oxidation Probes
Increased understanding of the role of peroxynitrite as a mediator of the immune
response against pathogens and as a player in many pathogenic processes has spurred an
interest in developing probes for its detection in vivo. 9 Peroxynitrite sensors are typically
organic molecules, usually a quenched fluorescent dye, that react with ONOO~ to
produce a highly fluorescent oxidized species. Examples such as 2,7-dichlorodihydro-
fluorescein diacetate (DCFH2) and dihydrorhodamine 123 (RhH 2) have reduced xanthene
rings that are oxidized in the presence of peroxynitrite to form fully conjugated, and
therefore fluorescent, dichlorofluorescein (DCF) and rhodamine 123 (Rh), respectively
(Fig. 1.7). These oxidations are not specific to peroxynitrite, however, and can be
accomplished by hydroxyl radicals, NO2 , CO 3'~, Fe(II), Fe(IIl)/ascorbate, Fe(II)/EDTA,
cytochrome c, HOC1, and H202 in the presence of peroxidases in the case of RhH2.10' 13 ,14
Oxidation of biomolecules specifically by peroxynitrite has been accomplished in the
case of folic acid, where ONOO- oxidizes the hydroxyl group of the pterin moiety to
produce a brightly fluorescent oxidized species. 67
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Figure 1.7. a) Structures of DCFH 2, DCF, RhH 2 and Rh. b) The sensing mechanism of
DCFH 2. Two electron oxidation of the reduced fluorophore by ONOO- results in the fully
oxidized, and therefore fluorescent, DCF.
Peroxynitrite-Specific Small Molecule Probes
The trend in newer generation ONOO- probes has been to incorporate a reactive
moiety into the fluorophore that undergoes a specific reaction with peroxynitrite. These
sensors elicit turn-on fluorescence, so the reactive moiety quenches the fluorophore by a
PET mechanism until it is oxidized by ONOO-, much like the organic NO sensors based
on the o-phenylenediamine scaffold. In this manner, fluorescein-68 , rhodamine- 69, and
calcein-based 29 probes were designed to detect highly reactive oxygen species (hROS)
such as hydroxyl radicals (*OH), hypochlorite (C10-), and peroxynitrite using aryloxy-
phenols or -amines as the hROS responsive moiety (Fig. 1.8). Upon reaction with hROS
the fluorescent species is recovered and 1,4-benzoquinone or p-benzoquinoneimine is
produced. This design, however, is not specific for peroxynitrite. For example, the
calcein derivative APC exhibits a 33-fold fluorescence enhancement when exposed to
'OH, a 19-fold enhancement with ONOO-, and a 640-fold enhancement with C10~. The
fluorescein- and rhodamine-based probes also follow this pattern of selectivity.
COOH COOH
NH2 hROS
0 0 O O 0 0 OH
HOOC N N COOH HOOC N N "COOH
HOOC )COOH O NH HOOC COOH
APC (non-fluorescent) Calcein (fluorescent)
Figure 1.8. The sensing mechanism of the aryloxy-amine type probes. The aryloxy-
amine molecule quenches the fluorophore by a PET mechanism that is abolished upon
reaction with oxidized NO and liberation ofp-benzoquinoneimine.
To achieve specificity, probes were designed with an activated ketone appended
70to one of the phenolic oxygens of the fluorescein xanthene ring. Peroxynitrite
selectively reacts with the ketone to form a dioxirane intermediate, which rapidly
oxidizes the phenyl group to produce a new ketone and release the fluorophore to restore
fluorescence. Recently, a similar BODIPY probe, HKGreen-2, was prepared that does not
require cleavage of the oxidized phenyl group to restore fluorescence, a feature of the
first generation probe that limited its effectiveness (Fig. 1.9).71 The dieneone product is
sufficiently different in energy from the initial ketone to abolish the PET pathway and
restore fluorescence. HKGreen-2 is selective for ONOO~ over other biologically relevant
ROS and RNS and produces a 69-fold fluorescent enhancement in the presence of excess
peroxynitrite. Ex vivo experiments using J774.1 murine macrophages co-incubated with
the RNS/ROS producing combination of lypopolysaccharide/interferon-y (LPS/IFN-y)
and phorbol myristate acetate (PMA) as well as HKGreen-2 indicate that the probe can
selectively detect iNOS-induced ONOO~ formation in live cells.
O HO CF3O
CF3
HO ONOO- 0
-N'N- / --N,BN
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HKGreen-2 (non-fluorescent) (fluorescent)
Figure 1.9. The sensing mechanism of activated ketone type probes. The activated ketone
reacts specifically with ONOO~ to form an unquenched dieneone product that does not
require cleavage of an aryl-oxy bond for fluorescence restoration.
Small Molecule Fluorescent Probes for Nitroxyl
Nitroxyl remains less well studied in comparison to other RNS, although it has
been implicated in many (patho)physiologies such as increasing cardiac output,
protecting or exacerbating ischemia-reperfusion toxicity, and modifying thiol activity.7
One of the major challenges in nitroxyl probe design is discriminating nitroxyl from
nitric oxide, and as such very few HNO-specific optical probes exist. The most effective
strategy thus far is to use metal-based sensing platforms to distinguish the reactivity of
HNO from NO at the metal center.
Porphyrin-based Probes
Manganese(III) meso-(tetrakis(4-sulfonato-phenyl)) porphyrinate (Mni"TPPS)
selectively undergoes reductive nitrosylation with HNO-donors but not NO-donors to
form Mn(II)-NO complexes.7 2 Formation of a Mn(IL)-NO from the Mn(III) species
caused a large change in absorbance; however, the complex is unstable in the presence of
02 and is quickly oxidized to the initial Mn(IIl) species. This instability makes metal
porphyrins inadequate for quantitative biological HNO sensing. Recently, Mni'TPPS was
incorporated into an aminoalkoxysilane-derived xerogel decorated with trimethoxysilyl-
terminated poly(amidoamine-organosilicon) dendrimers that is NO-permeable but poorly
02-permeable to produce quantitative, HNO-responsive films.73 Unfortunately, HNO
dimerization at high nitroxyl concentrations and slow HNO complex formation within the
film limit this probe in its current state.
Conducting Metallopolymer Probes
Fluorescence-based nitroxyl sensing has been accomplished using conducting
metallopolymers. Previous work produced NO-sensing CMPs containing Cu(II)-binding
oligopyridyl units incorporated into poly(p-phenyleneethynylene), poly(p-
phenylenevinylene), poly(thiophene), and poly(fluorene) derivatives.61-63 The CMP
complexes are quenched by the paramagnetic Cu(II) ion, and the Cu(II)-CMP complexes
formed react with NO to reduce Cu(II) to Cu(I), thereby producing a fluorescent Cu(I)-
CMP species. These polymers competitively bind Cu(II) between the intended metal-
chelating bipyridyl units and the water-solubilizing side chains. When the bipyridyl units
are replaced with bithiophene units, the binding of Cu(II) to the CMP main chain is
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Figure 1.10. Structure of CPI.
reduced. 74 The quenched Cu(II)-polymer (CP1, Fig. 1.10) becomes fluorescent upon
exposure to excess NO in unbuffered solutions, but under simulated biological conditions
results in a decrease in emission due to precipitation of the probe. When the same CMP is
exposed to excess Angeli's salt (Na2N2O3, a nitroxyl donor) the fluorescence increases by
2.1-fold, revealing the polymer to be a selective HNO probe under simulated biological
conditions.
Cu(II)-based BODIPY Probe
Very recently, a Cu(II)-based HNO sensor that can detect nitroxyl in live cells
was reported (Fig 1.11)."5 Cu(II)[BOT1] contains a dipicolylamine Cu(II) binding pocket
appended to a BODIPY fluorophore by a triazole, a rigid linker that minimizes the
distance between the paramagnetic Cu(II) and the BODIPY, thereby maximizing
fluorescence quenching in the off state. Cu(Il)[BOT1] displays a 4.3 ± 0.6-fold
enhancement in fluorescence upon exposure to excess Angeli's salt under simulated
biological conditions, caused by reduction of Cu(II) to Cu(I). This reaction is specific for
nitroxyl over other biologically relevant RNS and RONS, however, many reductants can
cause fluorescent enhancement by forming [Cu(I)BOT1]*. Cu(II)[BOT1] can detect
externally applied Angeli's salt and thiols such as cysteine in live HeLa cells. Its
Cl CIno
N - NNNCu'C.N HNO,N - N
F'E N -NF3 N F N-cul r
F N F/,
Cu(II)[BOT1] (non-fluorescent) [Cu(I)BOT1]+ (non-fluorescent)
Figure 1.11. The sensing mechanism of Cu(II)[BOT1]. Cu(II)[BOT1] reacts with
NO to produce [Cu(I)BOT1]*, which is no longer quenched quenching due to
reduction of the paramagnetic Cu(II) to the diamagnetic Cu(I).
biological utility is limited by the fact that the fluorophore emits in both the red and the
green channels, making it difficult to perform co-staining experiments.
Conclusions and Future Directions
The field of reactive nitrogen species sensing is an active and exciting area of
research fueled by increased interest in the roles of RNS as signaling agents in biology.
The NO-sensing domain has been improved by increasing the biocompatibility of probes.
The newest NO probes reported in this thesis are cell-trappable, such that tissue and
animal experiments can now be considered. Peroxynitrite detection has been made
possible by designing probes that react specifically with ONOO~, instead of the standard
"global-oxidation" responsive sensors. A few metal-based systems that can discriminate
HNO from NO have been described, allowing the field of nitroxyl detection to emerge.
The major design feature that needs to be addressed in the field of RNS sensing is
reversibility, which is required to get true spatiotemporal resolution. In addition, sub-
cellular localization and ratiometric RNS detection, both of which have been achieved in
cation sensing, would be valuable for determining signal localization and quantification,
respectively.
In the forthcoming chapters, progress towards improving the biocompatibility of
the CuFL 1 NO probe is presented. In order to improve the sensing capabilities of CuFLI,
it is imperative that the mechanism of fluorescence enhancement upon NO exposure is
well understood. Consequently, the next chapter (Ch. 2) will focus on a kinetic and
mechanistic study of the reaction of the complex with NO, and subsequent chapters (Ch.
3 - 5) will detail progress in probe improvements and biological applications. Finally, the
I --- K*a4YVW -.-- -__
last chapter (Ch. 6) will present work on a structurally similar Zn(II)-selective sensor,
drawing on design features discovered during the NO-sensing work.
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Chapter 2.
Mechanism of Nitric Oxide Reactivity and Fluorescent Enhancement of the NO-
Specific Probe, CuFL1
Introduction
Nitric oxide (NO), once thought to be just an environmental pollutant, is now
recognized as an important biological signaling molecule that is responsible for cardiac
function,1-3 neurotransmission, 4 and fighting invading pathogens during an immune
response.' Because of the radical character of NO its lifetime in solution under
physiological conditions is limited,'' and nitrosated species such as S-nitrosothiols and
N-nitrosamines are proposed to act as vehicles for nitric oxide storage and transport in
biology."' Transition metals are also major targets of NO attack, with the classic example
being nitrosation of the heme iron of soluble guanylyl cyclase (sGC) to effect
downstream vascular smooth muscle dilation.1 Nitric oxide can reductively nitrosylate
metals, which causes one-electron reduction of the metal and nitros(yl)ation of a
nucleophile by the resulting NO* to form an E-NO species, where E is 0, N or S." This
chemistry provides a mechanism by which small molecule metal complexes react with
NO, 1 -14 and it has also been employed as a strategy for nitric oxide sensing by transition
metal-based sensors. 15-25
In 2006, one such NO-specific probe, CuFL1, was reported (Fig. 2.1). 1'19 The
FLI ligand is non-fluorescent, and DFT calculations revealed that quenching is due to
photo-induced electron transfer from lone pair electrons delocalized throughout the
aminoquinaldine unit into the half-filled fluorescein molecular orbital in the excited
state." The fluorescence is further quenched by coordination to a paramagnetic Cu(II)
ion. Exposure of a 1:1 mixture of FLI and CuCl 2 in anaerobic buffered solutions to
excess NO results in formation of a fluorescent species. Under similar anaerobic
conditions, neither treatment of FL1 with NO or with Cu(I) results in fluorescence
H N
HN CCuN NNO
Cu"C 2 + -O O O Kd= 1.5 pM O O NO -O 0 0 + Cu'
C1 - Cr CC C1
COg COj C02
FLI CuFL1 FLI-NO
NON-FLUORESCENT NON-FLUORESCENT FLUORESCENT
Figure 2.1. CuFLI and its NO detection scheme.
enhancement. Upon treatment of CuFLI with NO, the Cu(II) is reduced to Cu(I), as
evidenced by the decrease in intensity of the axial EPR signal."1'.1 UV-vis spectroscopy
revealed a new species with X.mx = 504 nm (k.(FL 1) = 505 nm, X.(CuFL1) = 498 nm),
and LC-MS analysis confirmed that one major species is formed, with m/z ratios of
564.7, 600.5, and 1128.9. These ions can be assigned to [FLI + NO - 2H]-, [FLI + NO -
H + Cl]-, and [2(FL1 + NO) - 3H]-, suggesting that FLI is nitrosated during the reaction.
The independently synthesized nitrosated ligand, FL1-NO, displays UV-vis and LC-MS
signatures identical to those obtained by reaction of CuFLI with NO. An 15N NMR
experiment confirmed that FLI-NO is nitrosated at its secondary amine, and quantum
yield measurements indicated that FLI-NO is emissive ($(FL1-NO) = 0.58 ± 0.02 versus
$(FL1) = 0.077 ± 0.002 and $(CuFL1) = 0.063 ± 0.002). Therefore, it was concluded that
formation of FL1 -NO with concomitant reduction of Cu(II) to Cu(I) is responsible for the
fluorescence enhancement observed when the non-emissive CuFLI reacts with NO (Fig.
2.1). This emission-enhancement mechanism is consistent with prior work reported by
Ford et al.2" with a Cu(II) dianthracenyl cyclam complex (1,8-bis(anthracen-9-ylmethyl)-
1,4,8,1 1-tetraazacyclo-tetradecane, Cu(DAC) 2+). Recently, a more detailed mechanistic
examination of Cu(DAC) 2* suggested that NO reacts with Cu(DAC) 2+ at a deprotonated
secondary amine of DAC, with concomitant inner-sphere electron transfer to Cu(II) to
produce Cu(I) and the nitrosated DAC-NO ligand as the products. (Scheme 2. 1).21
R R R R
IN 7OH +) 7O N7
+ C H N + H20 ONO D N'NO + Cu+
R R R R
Cu(DAC) 2+ Cu(DAC)+ Cu(DAC-NO)* DAC-NO
Scheme 2.1. Proposed mechanism for the reaction of Cu(DAC)2* with NO. Adapted
from Ref. 24.
This chapter presents a mechanistic investigation of the reaction of CuFLI with
NO. The two most likely intimate mechanisms are discussed and examined. The first,
mechanism 1, is analogous to the Ford mechanism and involves initial deprotonation of
the secondary amine of the complexed ligand, followed by direct attack of NO at that site
to form FLi-NO (Scheme 2.2). Note that the nomenclature assigned to the species in the
reaction will be used throughout this chapter. Deprotonation of the secondary amine is
concomitant with an inner sphere electron transfer event, resulting in reduction of Cu(II)
to Cu(I). The last step is release of the metal from FLI -NO, which is a poor ligand for the
soft Cu(I) center owing to its hard oxygen and nitrogen donor atoms, inability to conform
to tetrahedral geometry, and lowered electron density on the nitrosamine. The second,
mechanism 2, invokes initial formation of a Cu(I)-NO complex (Scheme 2.3).
H NO NO
Cu k C FIun-N C u- N'OW \ kOKC \ K
OO 
0  
0 H O O ,0 0 NO 0 0  0 0+Cui
C i C k C C1
C + H+CsCsCs2 1C +~ 02 C 02 C 02
CuFL1 CuFL1- CuFL1-NO FL1 -NO
Scheme 2.2. Proposed mechanism 1 for the reaction of CuFLI with NO.
Deprotonation of the secondary amine ligated to Cu(I)-NO would facilitate NO transfer
from the metal to the ligand, again followed by release of Cu(I) from FLI-NO. This
mechanism was also considered for the reaction of Cu(DAC)2 , with NO.2 ' Herein kinetic
analyses of the nitrosation of CuFLI under varying conditions, along with pH-dependent
studies, Eyring analysis, and spectroscopic analysis of the electronic structure of CuFLI
are presented. These mechanistic tools have revealed the most likely preferred reaction
pathway, mechanism 1.
HCUIN k, C H k C
0 0  0 +ONO NOO 0 - H* NO0 0  0
C-- C-
. CO N CO2 + COj
CuFL1 Cu(NO)FL1 Cu(NO)FL1-
NO NO
CV \
0 O 0o + Cu'
C1 C1
CO9p, COi
CuFLI-NO FL -NO
Scheme 2.3. Proposed mechanism 2 for the reaction of CuFLI with NO.
Experimental Section
Materials. 2-{2-Chloro-6-hydroxy-5-[(2-methylquinolin-8-ylamino)-methyl]-3-oxo-
3H-xanthen-9-yl}benzoic acid (FLI) was prepared by a previously reported procedure.'9
All other chemicals were used as received. Piperazine-N,N'-bis(2-ethanesulfonic acid)
(PIPES) was purchased from Calbiochem and potassium chloride (99.999%) was
purchased from Aldrich. Buffer solutions (50 mM PIPES, 100 mM KCl, pH 6.0, 6.5, 7.0,
7.5, 8.0 and 8.7) were prepared in Millipore water and used for all spectroscopy except
for pKa titrations and solvent isotope effect determinations. pKa titrations were performed
in a solution of 20 mM KOH, 100 mM KCI, pH 12 in Millipore water. The pH of the
solutions was adjusted using 6, 1, or 0.1 N HCl and 0.1 N KOH. Potassium carbonate
(Mallinckrodt) was used as a buffer for solvent isotope effect determinations. Buffer
solutions (20 mM K2CO 3, 100 mM KCl) were prepared at pH/D 7.0 in Millipore water or
D20 (Cambridge Isotope Laboratories), using a correction of 0.4 pH meter units to
account for the differential readings of glass electrodes in D20.26 For EPR experiments,
solutions at pH 12.7 (50 mM KOH, 100 mM KCl), pH 10.1 (20 mM K2CO 3, 100 mM
KCl), pH 7.0 (50 mM PIPES, 100 mM KCl) and pH 4.0 (20 mM NaOAc, 100 mM KCI,
sodium acetate purchased from Aldrich) were prepared in Millipore water. Copper
chloride dihydrate (99+%) was purchased from Alfa Aesar and stock solutions of 10 mM
and 1 mM were prepared in Millipore water. Stock solutions of 1 mM FLI were prepared
in DMSO and stored in aliquots at -80 C.
Kinetic Studies of the Reaction of CuFL1 with Nitric Oxide. Absorbance
measurements were made under anaerobic conditions, with cuvette solutions prepared in
an inert atmosphere glove box. Buffer and CuCl 2 solutions were deoxygenated following
standard procedures prior to use and stored under an inert atmosphere. Aliquots of FLI
were thawed immediately prior to use, deoxygenated using standard procedures, and
brought under inert atmosphere for sample preparation. Cuvette solutions were prepared
by combining CuC12-2H 20 and FLI in a 1:1 ratio in buffer and sealing the cuvette with a
septum-equipped, gas-tight cap. Nitric oxide was purchased from Airgas and purified as
previously described to minimize contamination by higher nitrogen oxides.2" Nitric oxide
gas was introduced into buffered solutions via gas-tight syringes. Samples were stirred
throughout acquisitions to ensure equal distribution of NO throughout the sample
solution. Acquisitions were made at 25.00 ± 0.05 0C unless otherwise noted. UV-vis
spectra were acquired on a Cary 50-Bio spectrometer using spectrosil quartz cuvettes
with gas-tight septa caps from Starna cells Inc. (3.5 mL volume, 1 cm path length).
Measurements were recorded over 45 min using the scanning kinetics program in Cary
WinUV v. 3.00, and changes in the intensity of the n-+n* transition of fluorescein at
either 498 nm (decrease of CuFLi) or 504 nm (increase of FL1-NO) were monitored.
The data were fit using OriginPro 8 software, and regression analysis was performed
using Microsoft Excel 2004, v. 11.5.6. All absorbance experiments were repeated in
triplicate. Fluorescence spectra for pKa titrations were obtained on a Quanta Master 4 L-
format scanning spectrofluorimeter (Photon Technology International) at 25.0 ± 0.1 *C.
Electron Paramagnetic Resonance Measurements. EPR measurements were
performed on a Briker EMX EPR instrument at 9.33 GHz (X-band) frequency. EPR
samples were prepared under anaerobic conditions in an inert atmosphere glove box.
Stock solutions of 10 mM CuCl2 and solutions of pH 12.7, 10.1, 7.0 and 4.0 were
deoxygenated following standard procedures prior to use and stored under an inert
atmosphere. Stock solutions of 5 mM FL1 were prepared in DMSO and stored in aliquots
at -80 *C. Aliquots were thawed immediately prior to use, deoxygenated using standard
procedures, and brought under an inert atmosphere for sample preparation. Samples were
prepared by combining CuC12 and FLI to a final concentration of 400 [M and 500 [LM,
respectively, such that 98.6% of Cu(II) was bound (determined from Kd(CuFL1) = 1.5
[tM).'" 9 Spectra were recorded as a frozen glass (8-10% DMSO in water). Spectra were
reported from 4 scans with a time constant of 2.56 ms, modulation amplitude of 10 G,
and microwave power of 2.01 mW. Samples were thawed, brought back under an inert
atmosphere, and 500 [L NO (g) were introduced to the samples via a gas-tight syringe.
The samples were shaken to distribute NO throughout the solutions and then allowed to
react at room temperature overnight (- 13 h) in the dark. Samples were re-frozen into a
glass prior to recording their post-NO treatment EPR spectra. Spectra were analyzed
using the WINEPR System 2.1 lb.
Results and Discussion
Kinetic Studies of the Reaction of CuFL1 with NO. When anaerobic buffered
solutions of CuFLI were exposed to excess NO under pseudo-first-order conditions, the
electronic spectra changed temporally in accord with what was expected from previous
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Figure 2.2. Plots of the absorbance vs. time for the reaction of 4 ptM CuFLi with 650
.M NO in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 25 *C. Inset: Absorbance at 504
nm vs. time (black dots) and the residuals from the exponential fit (red line).
work. " The CuFLI band at 498 nm (n-nt* fluorescein transition) decreased slowly with
concomitant growth of a new band at 504 nm corresponding to FLI-NO (Fig. 2.2). Well-
anchored isosbestic points at 500 nm and 524 nm were observed, suggesting the
formation of one spectroscopically observable product. A plot of the absorbance at 504
nm versus time revealed a rise in product formation (Fig. 2.2 inset) that fit well to a first-
order exponential equation (Fig. 2.2, inset), and such fittings were used to determine the
observed rate constants (kobs) for the reactions.
Determining the Rate Equation for the Reaction of CuFL1 with NO. The rate of
product formation varied under different reaction conditions. Increases in [CuFLI ],2
[NO], and pH all accelerated the rate of FLI-NO formation. To determine the reaction
order in [CuFL1], kinetic data were collected at constant pH, NO concentration, and
temperature, varying the concentration of CuFLI from 2 - 6 RM. A greater than 100-fold
excess of NO (650 tM) was used to maintain pseudo-first-order conditions. The observed
pseudo-first-order rate constants are summarized in Table 2.1, left-hand column. A plot
Table 2.1. Kinetic Parameters for the Reaction of CuFLI with NO.
[CuFLI] (iM)a kabS (s1)b [NO] (IiM)c kab, (s1 ) pHd kobs (S 1 )e
2 0.0022(5) 650 0.0040(3) 6.0 0.00068(6)
3 0.00324(9) 975 0.0046(6) 6.5 0.0017(2)
4 0.0040(3) 1300 0.008(2) 7.0 0.0039(3)
5 0.006(1) 1950 0.012(3) 7.5 0.008(2)
6 0.0072(9) 2600 0.014(4) 8.0 0.011(4)
_ 1_ 8.7 0.014(6)
" Measurements were performed in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 25 0C,
[NO] = 650 [M. b kOb, values were determined by fitting the absorbance at 504 nm
versus time to a single exponential equation, y = Ae(x/t) + yo C Measurements were
performed in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 25 *C, [CuFLi] = 4 [tM.
d Measurements were performed in 50 mM PIPES, 100 mM KCl, T = 25 C, [CuFLI] =
4jiM, [NO] = 650 [M. ' keb values were determined by fitting the absorbance at 498 nm
for pH 6.0 and 6.5.
of the kOb values versus the concentration of CuFLI revealed a linear relationship (Fig.
2.3, inset) and the corresponding log/log plot of kob, versus [CuFLI] revealed a CuFLI
reaction order of unity (1.09 t 0.09 after linear regression analysis, Fig. 2.3). Although
every effort was made to exclude dioxygen from the reaction, there is inadvertent 02
leakage into the cuvettes over time, which differentially affects the reactions based on
their rate. Therefore, the most likely source of error in the measurements is the NO
concentration, which varies if oxygen is present due to the formation of higher nitrogen
oxides. Despite this systematic error, the slope of the log-log plot clearly indicates a first-
order dependence on the concentration of CuFL 1.
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Figure 2.3. Plot of the log(k.,s) vs. the log([CuFL1I]) for the reactions of 2 - 6 [LM
CuFL1 with 650 stM NO in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 25 *C. Inset: Plot
of kob, vs. [CuFL1].
To determine the reaction order in NO concentration, kinetic data were collected
at constant pH, CuFL1 concentration, and temperature (Table 2.1, middle column). To
maintain pseudo-first-order conditions, a greater than 100-fold excess of NO was used
(650 pM NO vs. 4 [M CuFLI for the lowest [NO]). Consequently the highest NO
concentrations used were at the limit of solubility of NO in deoxygenated water (1.9
mM),2 9 with the highest NO concentration (2.6 mM) at the supersaturation point.
Therefore, the error for the kObS values increased with the NO concentration; however, the
plot of ko,, values versus NO concentration still revealed a linear relationship (Fig. 2.4,
inset), as did the corresponding log/log plot of kObs versus [NO] (Fig. 2.4). The slope of
the latter revealed a first-order dependence of the reaction on the concentration of NO
(1.0 t 0.1 after linear regression analysis).
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Figure 2.4. Plot of the log(kobs) vs. the log([NO]) for the reactions of 4 [M CuFLI with
650 - 2600 tM NO in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 25 *C. Inset: Plot of kob,
vs. [NO].
To determine the order of the reaction in OH- concentration, kinetic data were
collected at constant NO and CuFLI concentrations and constant temperature (Table 2.1,
right-hand column). Again, a greater than 100-fold excess of NO (650 [M) was used to
maintain pseudo-first-order conditions. The obtained kOb values revealed a more complex
pH dependence of the reaction than that for the NO or CuFL1 concentrations. The
observed rate constants increased with increasing pH, which is consistent with the
hypothesis that deprotonation of the secondary amine of FLI is required for reaction of
CuFLI with NO. A plot of the ko,, values versus [OH~] revealed saturation behavior at
high [OH-] (Fig. 2.5a). The plot of the kos values versus pH (Fig. 2.5b) illustrates that,
below pH 7, the observed rate constants also begin to plateau, again consistent with the
hypothesis that protonation state of the complex is crucial to progress of the reaction and
formation of the N-nitrosated product. These data also reveal important information
regarding the design of new NO-specific probes, namely, that lowering the pKa of the
complexed secondary amine would result in a faster reaction with NO. This feature is
important for biological NO sensing, because NO is highly reactive with many
physiological components such as amines, thiols, oxygen and metal centers owing to its
radical character. Increasing the rate of reaction between CuFL1 and NO would greatly
improve the probe's utility for biological experimentation.
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pH Titrations of FLI and CuFLi. Because of the importance of deprotonation of the
secondary amine in the reaction of CuFLI with NO, the pKa values of the both FLI and
the CuFLI complex were determined. Spectral changes of FL1 at different pH values
were monitored by UV-vis and fluorescence spectroscopy and displayed behavior that is
typical for fluorescein-based ligands (Fig. 2.6). The absorbance data (Fig. 2.6a) could be
fit to obtain a pKa(uv) value of 5.6. The fluorescence data (Fig. 2.6b) revealed three pKa
values of 4.7 (pKa(HuorI), Fig. 2.6c), 5.6 (pKauo2)), and 6.5 (pKatuor3), Fig. 2.6d). The
PKa uor3) value agrees well with the pKa value determined by fluorescence for a similar
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Figure 2.6. a) Absorbance dependence on pH, with fit, for 5 sLM FL1 in 20 mM KOH,
100 mM KC, PH ~ 12, T = 25 *. pH adjusted with 6 N, 1 N and 0.1 N HCl and 0.1 N
KOH. b) Fluorescence emission dependence on pH. c) Fluorescence emission, with fit,
from pH 2 - 6. d) Fluorescence emission, with fit, from pH 5.5 - 8.5. pKa values were
determined by fitting the plots of absorbance or integrated fluorescence emission at k.
vs. pH to the equation, y = (A, - A2)/(1 + e (x-pKa)/dx ) + A2-
Zn(1) sensor, QZl (pKa = 6. 1),30 which was assigned to the secondary amine nitrogen
atom. The PKatsuorl) value of 4.7 probably corresponds to a combination of fluorescein
carboxylic acid protonation (pKa = 4.4 for fluorescein, 3.5 for dichlorofluorescein)"'" and
lactonization of the fluorescein. The intermediate pKaFluor2) value of 5.6 can be assigned to
the quinaldine nitrogen atom (5.08 t 0.5 for N,2-dimethyl-8-quinolinamine)."3 The UV-
vis data are not resolved sufficiently to observe all three pKa values, and thus allows only
the computation of an apparent pKa (pKa(uv)). The average of all three fluorescence pKa
values is 5.6, in accord with the pKa(uv) value and, coincidentally, the same as pKatuo>2).
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0.1 N KOH. b) Fluorescence emission, with fit, from pH 2.5 - 6.5. c) Fluorescence
emission, with fit, from pH 6 - 9. pKa values were determined by fitting the plot of
integrated fluorescence emission at max vs. pH to the equation, y = (A1 - A2)/(l +
e(x-pKa)/dx) + A2.
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Figure 2.8. a) Absorbance dependence on pH for 5 sM CuFL1 in 20 mM KOH, 100
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KOH. b) Absorbance dependence, with fit, from pH 2.5 - 5.5. c) Absorbance
dependence, with fit, from pH 6 - 11. pKa values were determined by fitting the plot of
absorbance at aX, vs. pH to the equation, y = (A, - A2)/(1 + elx-pKa)/dx) + A2-
When the same experiment was repeated for CuFL1, the fluorescence data again
revealed three pKa values in the region of pH 2.5 - 9, and a fourth value above 9 that
could not be adequately resolved (Fig. 2.7a). The fluorescence data from pH 2.5 - 6.5
were fit to obtain the first value (pKats~uon>) of 4.9 (Fig. 2.7b), the maximum revealed the
second value (pKats~uor2) of 6.4, and the third value (pKats~uor>) of 7.7 was obtained by
fitting the fluorescence data from pH 6.5 - 9 (Fig. 2.7c). The UV-vis data for CuFL1,
however, differed from those of FL1 in that two pKa, values were obtained (Fig. 2.8a).
Fits of the data from pH 2.5 - 5.5 (Fig. 2.8b) and 6 - 11 (Fig. 2.8c) revealed values of 4.7
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and 7.5 for pKauvl) and pKa(Uv 2>, respectively. These results are in good agreement with
those obtained from the fluorescence data and most likely correspond to the pKa value for
deprotonation of the secondary amine ligated to Cu(II) (7.7 and 7.5) and the pKa value of
the fluorescein bottom-ring carboxylic acid/lactonization of the fluorescein (4.9 and 4.7).
The absence of a third, intermediate pKa value in the absorbance data confirms the
assignment that it belongs to the quinoline nitrogen atom, which would be bound to
Cu(II) in the complex and therefore unlikely to be protonated.
Activation Parameters of the Reaction of CuFL1 with NO. An Eyring analysis was
performed to determine the activation parameters associated with the reaction of CuFLI
with NO. Kinetic runs were performed over a temperature range of 5 - 40 *C, and the kOb,
values obtained were plotted as the natural logarithm of kabs/T versus 1/T to obtain the
enthalpy and entropy of activation (AHi and ASI, respectively) (Fig. 2.9 and Table 2.2).
The activation energy (Ea) was determined from a plot of the natural logarithm of kob,
versus 1/T. The enthalpy of activation (AHi = 9.7 ± 0.5 kcal/mol) and activation energy
(Ea = 10.3 ± 0.5 kcal/mol) indicate a relatively low activation barrier for the reaction and
are consistent with values obtained from other experimental and theoretical examinations
Table 2.2. Activation Parameters for the Reaction of CuFLI with NO.
T (K) kos (s-I)"''b Ea (kcal/mol)'
278.15 0.0011(2) 10.3(5)
288.15 0.0019(8) AH* (kcal/mol)d
298.15 0.0041(2) 9.7(5)
308.15 0.0061(6) AS* (cal/mol-K)d
313.15 0.008(2) 1 -29(3)
a Measurements were performed in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 278.15 -
313.15 K, [CuFL 1] = 4 [tM, [NO] = 650 [tM. b kob, values were determined by fitting the
plot of absorbance at 504 nm versus time to a single exponential equation, y = Ae-xt) +
yo. c kb, = Ae-(Ea/RT). d kobs= (kBT/h)exp(AS*R)exp(-AH*/RT).
of nitrosation of secondary amines.3 4 -3 6 The negative entropy of activation (AS, = -29 3
cal/mol-K) is consistent with an associative nitrosation mechanism.
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Figure 2.9. Eyring plot for the reaction of 4 [tM CuFLI with 650 RM NO in 50 mM
PIPES, 100 mM KCl, pH 7.0, T = 278.15 - 313.15 K.
pH Dependent EPR Spectroscopy of CuFL1. EPR spectra were recorded at four pH
values in order to determine whether the protonation state of the secondary amine affects
the distribution of the unpaired electron density (Fig. 2.10). At pH 4.0 the secondary
amine (pKa ~ 7.5) should be fully protonated, and the observed EPR spectrum is typical
of that for a rhombically distorted axial Cu(II) species with g,, = 2.36, g,= 2.08, and
A,,(Cu) = 463 MHz (140 G, Fig 2.1Oa). The perpendicular hyperfine coupling constant is
smaller than the peak width of the perpendicular signal component, and therefore cannot
be determined. When the pH is increased to 7.0, the spectrum loses resolution, but still
retains axial Cu(II) character with hyperfine features. The approximate g values are g1 =
2.39 and g,= 2.08 and the Cu(II) hyperfine coupling constant of A,,(Cu) ~ 529 MHz (160
G, Fig. 2.10b). It is possible that the broadening at pH 7.0 is observed because there is a
Figure 2.10.
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EPR spectra of CuFL1 at a) pH 4.0, b) pH 7.0, c) pH 10.1, and d) pH 12.7.
mixture of CuFL1 and CuFL1, where CuFL1- is complex after deprotonation of the
secondary amine (see Scheme 2.2). At pH 10.1, however, two distinct Cu(II)-based spin
active species are observed (Fig. 2.10c). It is difficult to assign the EPR parameters of
these species, not only because their spectra are overlapping, but also because the
resolution between gj, and g, is poor. At this pH the Cu(II)-amido species, CuFL1-,
should be fully populated, that is, the ligand should be fully deprotonated (pKa ~ 7.5), and
the two observed species could be water- and hydroxide-bound Cu(II) complexes. The
APO 0 W -W
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Cu(II)-amido species probably has both Cu(II)-radical and nitrogen-centered radical
character. The latter component may result in the decreased separation of g,, and g1,
because N-centered radicals tend to be more isotropic than metal complexes, with g
values that lie closer to that of the free electron (g = 2.0023). Finally, at pH 12.7, 14N
hyperfine coupling from the N-centered radical appears to be present in the spectrum, and
only one Cu(II)-based species is observed, with g,, = 2.27, g1= 2.05, and A,,(Cu) = 595
MHz (180 G, Fig. 2.10d). Although a definitive assignment of the multi-line splitting
pattern resulting from significant A( 14N) contribution is difficult, the spectrum displays
features similar to those reported for a Cu(I)-aminyl radical species. 7 A nitrogen-
centered radical would be an excellent target for attack by NO. "N-labeling experiments
to confirm the assignment of N-centered radical were not performed due to the complex
synthesis of the "N FLI ligand.
If a copper-nitrosyl adduct were formed during the reaction of CuFL1 with NO
via mechanism 2 (vide supra), it is possible that its presence could be detected by EPR
spectroscopy under conditions where the secondary amine nitrogen remains protonated.
To test this possibility, nitric oxide was introduced anaerobically to a solution of CuFLI
in pH 4.0 buffer in an EPR tube, shaken, and allowed to stand at room temperature for 13
h. The sample was then frozen and the EPR spectrum was recorded using conditions
identical to those employed to record the pre-NO spectrum. If a CuFLI-NO adduct were
formed it would be diamagnetic, and consequently reduction of the Cu(II)-based signal
intensity would be expected. The corresponding spectra, depicted in Fig. 2.11, show no
changes in the EPR signal before or after NO addition, suggesting that no copper-nitrosyl
is formed under these conditions.
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Figure 2.11. EPR spectra of CuFL1 and CuFLI + NO at pH 4.0.
Effects of Isotopic Substitution on kobS. Given the pH dependence of the spectral
properties of FLI and CuFLI and the observation that deprotonation of the secondary
amine facilitates reaction with NO, the effect of isotopic substitution (D for H) at the
secondary amine nitrogen atom was investigated to determine if the rate limiting step
involves deprotonation at this site. Kinetic runs were performed under pseudo-first-order
conditions (650 tM NO, > 100-fold excess) at a fixed concentration of 4 [tM CuFLI at
25.0 *C in either H20 or D20 at pH/D 7.0, using a correction of 0.4 pH meter units to
account for the differential readings of glass electrodes in D20.26 Plots of the absorbance
at 500 nm versus time were fit to first-order exponential equations in order to determine
the observed rate constants (kobS), which were then compared in order to ascertain the
solvent isotope effect (SIE = kcs,(H)/kes,(D)). The average k,,b(H) of 0.23 ± 0.2 min-' over
kOb,(D) of 0.11 ± 0.01 min-' gave an SIE of 2.0 ± 0.3, consistent with the hypothesis that
deprotonation of the secondary amine nitrogen atom is an important mechanistic step.
Although typically an SIE of 2 might suggest that proton-transfer occurs in the rate-
limiting step, the case of CuFLI is more complicated because the pKa of the complexed
amine (pKa ~ 7.5) will change with D substitution, i.e. moving from N-H to N-D alters
the acid-base equilibrium of the initial complex. Therefore, in addition to the decreased
rate that might be expected because of isotopic substitution based on N-H/D bond
breaking, the reaction rate might also be reduced because the deuterated secondary amine
is at a different point in its acid-base equilibrium at pH 7.0 than the undeuterated
secondary amine. Because CuFL1 is only reactive with NO in protic solvents, the kinetic
and solvent isotope effects could not be separated by using an aprotic solvent such as
acetonitrile. Therefore, although the SIE suggests that proton-transfer occurs in the rate-
limiting step, the complicating factor of the acid-base equilibrium makes it difficult to
draw a definitive conclusion about the rate-limiting step based on this experiment alone.
Mechanistic Insights. Based on the kinetic data and activation parameters obtained,
the hypotheses for the mechanism of the reaction of CuFLI with NO can now be
examined. The first mechanism invoked an initial deprotonation step, followed by
reaction of NO at the deprotonated secondary amine with concomitant reduction of Cu(II)
to Cu(I) via an inner-sphere electron transfer (Scheme 2.2). If deprotonation is rate-
limiting, then the rate law would be given by equation 2.1. Because the kinetic data
rate = ki [CuFL 1] [OH-] (2.1)
revealed the reaction to be first order in [NO], mechanism 1, in the case of rate-limiting
deprotonation, can be excluded. If, however, reaction of the deprotonated complex with
NO is rate-limiting, i.e. there is a fast pre-equilibrium between the protonated and
deprotonated CuFLI, then the rate law becomes that given by equation 2.2. The [CuFLI-]
rate = k2[CuFL1-][NO] (2.2)
can be determined from the acid-base equilibrium as defined in equation 2.3. Rearranging
equation 2.3 and substituting into equation 2.2 yields the rate law shown in equation 2.4
[CuFL1I-] [H+]
Keq = [CuFL ] (2.3)L CuFL1]
rate = k2Keq[CuFL1][NO] (2.4)[H+]
when reaction with NO is rate-limiting. This rate law is consistent with the concentration
dependence results. At high pH, rate saturation was observed, i.e. under these
circumstances the rate law should not be dependent on [H*]. If mechanism 1 were
operative at high pH, then Scheme 2.4 would describe the reaction. The rate would be
limited by reaction with NO, and would be described by that given in equation 2.5, which
is consistent with the results of the concentration dependence experiments. Therefore,
mechanism 1 is viable if reaction with NO is rate limiting and it also applies at high pH.
rate = k2[CuFL1-][NO] = k2[CuFL1][NO] (2.5)
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Scheme 2.4. Proposed mechanism 1 for the reaction of CuFLI with NO at high pH.
The second mechanism considered involves an initial, reversible reaction of CuFL 1 with
NO to form a Cu(I)-NO* species, followed by deprotonation of the secondary amine and
subsequent fast translocation of NO' to form the N-nitrosated ligand with release of Cu(I)
(Scheme 2.3). If reaction with NO is rate limiting, that yields the rate law given by
equation 2.6. Because the reaction is pH dependent, mechanism 2 cannot be operative in
rate = ki[CuFL1][NO] (2.6)
the case of rate-limiting reaction with NO. If instead deprotonation of Cu(NO)FL 1 is
rate-limiting, then the rate law is given by that shown in equation 2.7, which cannot be
solved analytically, but is dependent on all the reactants. If mechanism 2 were operative
rate = k2[OH-] (ki[CuFLI][NO]+k-2[Cu(NO)FL-][H+]) (2.7)
k1+k2[OH-])
at high pH, then Scheme 2.5 would describe the reaction. The rate law would again be
described by equation 2.5, consistent with the experimental data. Therefore, mechanism 2
is a viable mechanism if deprotonation is rate-limiting, and at high pH.
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Scheme 2.5. Proposed mechanism 2 for the reaction of CuFLI with NO at high pH.
One can also envision alternative mechanisms involving an outer sphere electron
transfer between the Cu(II) center and NO to form Cu(I)FL1 and NO' followed by steps
from either mechanism 1 or 2. In either of these cases, however, the reaction order in NO
concentration would most likely be greater than one owing to scavenging of NO* by H20,
which can be ruled out by the data.
The pH titrations support the hypothesis that at high pH the reaction with NO is
rate-limiting and the rate ceases to depend on [OH-]. Saturation kinetics would be
expected at pH values higher than the pKa value of the Cu(II)-bound secondary amine
(pKa ~ 7.5), which is consistent with the observed data. The rates begin to plateau at pH ~
8, but do not fully saturate until after at least pH 8.7, more than 1 pH unit above the pKa.
The activation parameters are also consistent with both mechanisms 1 and 2. The
activation entropy indicates an associative rate-limiting step, which can be envisioned for
either mechanism, with NO and CuFL 1 coming together in the transition state.
The two hypothesized mechanisms - either an initial deprotonation followed by
attack of NO at the secondary amine (mechanism 1) or formation of a Cu-NO species
followed by deprotonation and NO* migration to the ligand (mechanism 2) - are
indistinguishable at neutral pH or below, except for one factor, the rate-limiting step. For
mechanism 1 to be valid, reaction with NO must be rate-limiting, and for mechanism 2 to
be valid, deprotonation must be rate-limiting. The solvent isotope effect experiments
indicate that deprotonation of the secondary amine of the complexed ligand is important
in the reaction mechanism; however, because the magnitude of the SIE cannot be
determined accurately under these conditions (vide supra), no insights into the rate-
limiting step of the reaction can be made from these data.
Taken together, the data presented thus far cannot rule out either mechanism 1 or
2 definitively. According to DFT calculations performed by Ford et al. on their
Cu(DAC) 2' complex, formation of a Cu(II)-NO complex is entropically disfavored, and
the binding is predicted to be weak.24 On the basis of this finding and the fact that no Cu-
NO stretch could be observed from an IR experiment in which [Cu(DAC)]Br 2 was
allowed to react with NO under conditions where deprotonation of Cu(DAC)2+ would not
be expected, Ford et al. concluded that mechanism 1 seemed more plausible for their
reaction. Because of the limited solubility of CuFLI in acetonitrile, the same IR
experiment could not be attempted in the current system; however, the EPR data from the
reaction of CuFLI and NO at pH 4.0 (vide supra) indicate that no Cu-NO adduct is
observed at low pH. The lack of evidence for a Cu(I)-NO under conditions favoring
proton retention of the secondary amine of FLI does not exclude the possibility either
that a Cu(I)-NO adduct can be formed at higher pH, or that a Cu(I)-NO species is too
short-lived to amass an appreciable steady-state concentration under these conditions.
Therefore, formation of a Cu(I)-NO adduct cannot be discounted as a mechanistic
intermediate. The fact that the EPR spectrum changes from that of an axial Cu(II) signal
at pH 4.0 to what appears to be a mixed Cu(II)-based/N-based signal at pH 12.7 suggests
that, as CuFLI is deprotonated, an N-centered radical species is formed. This formally
Cu(I)-aminyl species could provide a site on the ligand for NO attack. Because Cu(I)-
nitrosyls are generally considered to be unstable,38 -0 it was hypothesized that the reaction
of CuFLI with NO probably invokes a mechanism that does not require formation of
such an unstable species. Instead, mechanism 1 is favored as the preferred route.
Summary
The reaction of CuFL 1 with NO in aqueous, buffered solutions is first order in
CuFL 1 and NO concentrations and also depends on the hydroxide concentration.
Saturation kinetics occur at high base concentrations, which is consistent with
deprotonation of the secondary amine of CuFL I being a key mechanistic step. These data
reveal that a CuFL1-type probe with a lower secondary amine pKa would result in a
superior NO detector in vivo. The activation parameters indicate an associative reaction.
EPR experiments at various pH values suggest that, as CuFL1 is deprotonated, the
unpaired electron density shifts from copper to nitrogen, yielding new spin-active
species. Two mechanistic interpretations fit the data, with the one that invokes initial
deprotonation of bound FL 1 at its secondary amine followed by direct attack of NO at the
deprotonated ligand being most likely.
With a more thorough understanding of the mechanism of the reaction of CuFLI
with NO available, the next chapter describes two improvements to the probe. The first
redesign of FLI was to make it symmetrical, i.e. to contain two Cu(II)-binding pockets.
Symmetrical sensors tend to have lower quantum yields, and therefore this modification
reduced the background fluorescence of the probe in the off-state. The second design
adaptation was to install ester moieties onto the quinoline rings of the symmetrical FL1.
Esters maintain the cell-membrane permeability of the probe and provide a site for
intracellular esterases to cleave, yielding negatively-charged carboxylates that render the
sensor trapped within cells.
............
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Chapter 3.
Fluorescence-Based Nitric Oxide Sensing by Cu(II) Complexes that Can Be
Trapped in Living Cells
This chapter is based on the following published work:
1. Reproduced in part with permission from McQuade, L. E.; Lippard, S. J. Inorg.
Chem., 2010, submitted. Unpublished work Copyright 2010 American Chemical
Society .
2. Reproduced in part with permission from McQuade, L. E.; Ma, J.; Lowe, G.;
Ghatpande, A.; Gelperin, A.; Lippard, S. J. Proc. Nati. Acad Sci.. U.S.A., 2010,
107, 8581-8586.
Introduction
Since the discovery that nitric oxide (NO) is the endothelium derived relaxation
factor (EDRF) responsible for vascular smooth muscle dilation," NO has been
implicated as a biological signaling agent in a wide variety of physiological processes,
ranging from roles in the immune system' to neurotransmission' to cardiovascular
function.6 Like any secondary messenger, regulation is key to maintaining homeostasis,
and failure to regulate NO production is associated with pathologies including cancer,
neurodegeneration, sepsis, and stroke.6
Previously, the synthesis and application of a derivatized fluorescein, FLI, which
forms a 1:1 complex with Cu(II) was described. This complex reacts with nitric oxide to
evolve chemistry leading to fluorescence enhancement through nitrosation of the
secondary amine on the ligand.' CuFLI responds directly and selectively to NO,
exhibiting a dramatic fluorescence enhancement upon reaction. Details of the intimate
mechanism are discussed in Ch 2. The overall product of the reaction of CuFLi with NO
is the N-nitrosated ligand, FL1-NO, the species responsible for fluorescence turn-on. In
addition to being an excellent NO sensor in vitro, CuFLI can detect endogenously
produced NO in cell culture."' 4 The probe has excellent biocompatibility, being water
soluble, non-toxic, and cell membrane permeable. Because fluorescein is the fluorophore,
CuFL1 is excited by relatively low energy light, and the emissive final product after
reaction with NO is green.
For CuFL1 be useful for experiments in biological tissues and animals, for which
continual fluid perfusion is required, it must be retained within cells. Unfortunately,
under perfusion conditions CuFLI diffuses out of cells. The inability to retain the probe
within cells under such conditions inspired the present work to create a trappable version.
Several synthetic strategies were explored, and the most successful derivative was that in
which two Cu(II) binding units, incorporating esters as the trappable moieties, were
installed onto a xanthenone ring. The esters maintain the cell membrane permeability of
the probes until inside the cell, at which point intracellular esterases hydrolyze the esters
to produce negatively charged carboxylate functionalities." The negative charge prevents
the probe from re-crossing cell membranes, rendering it trapped within the cell.
This chapter summarizes the synthesis and photophysical characterization of three
new ligands, FL2, FL2E, and FL2A (Fig. 3.1). These symmetrical, second-generation
ligands are based on FLI, and FL2E employs the ester/acid strategy for cell-trappability.
Their corresponding copper(II) complexes, generated in situ, respond quickly and
selectively to nitric oxide over other biologically relevant reactive oxygen and nitrogen
species (RONS). As described in the next chapter, the probes have detected NO
production in stimulated mouse brain olfactory bulb tissue slices.16
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Figure 3.1. Chemical structures of FL2, FL2E, and FL2A.
Experimental Section
Synthetic Materials and Methods. 8-Aminoquinaldine,17  ethyl[(8-amino-2-
methylquinolin-6-yloxy)acetate]" and 4',5'-fluorescein-dicarboxaldehyde, 9  were
prepared by previously reported procedures. Anhydrous methanol (Aldrich), sodium
borohydride (Sigma), sodium hydroxide (Mallinckrodt Chemicals), and all deuterated
solvents (Cambridge Isotope Laboratories) were used as received. Silica gel (SiliaFlash
F60, Silicycle, 230-400 mesh) was used for column chromatography. Thin-layer
chromatography (TLC) was performed on EMD Chemicals F254 silica gel-60 plates (1
mm thickness) and viewed by either UV light or ninhydrin staining. 'H and 13C{ 1H}
NMR spectra were obtained on either a Varian 300 MHz or 500 MHz spectrometer and
referenced to the residual proton or carbon resonance of the deuterated solvent. Chemical
shifts are reported in parts per million (8) and are referenced to residual protic solvent
resonances. The following abbreviations are used in describing NMR couplings: (s)
singlet, (d) doublet, (t) triplet, (q) quartet, (m) multiplet. High-resolution mass spectra
were measured by staff at the MIT Department of Chemistry Instrumentation Facility
(DCIF).
2-{6-Hydroxy-4,5-bis[(2-methylquinolin-8-ylamino)methyl]-3-oxo-3H-xanthen-9-
yl}benzoic acid (1, FL2). 4',5'-Fluoresceindicarboxaldehyde (115 mg, 296 Rmol) and 8-
aminoquinaldine (107 mg, 676 gmol) were suspended in methanol (12 mL) and stirred at
room temperature for 1 h. The dark red-purple suspension was cooled to 0 "C and sodium
borohydride (86.3 mg, 2.28 mmol) was added. The reaction clarified to a dark red
solution and was stirred for 1 h as it warmed to room temperature. The solvent was
removed under reduced pressure and the resulting residue was purified by column
chromatography on silica (gradient from 100% CH2Cl2 to 19:1 CH2Cl2:CH 30H) to afford
a dark red solid (100 mg, 50%). TLC Rf = 0.71 (silica, 9:1 CH2Cl2:CH30H); mp: 164 -
165 *C (dec); 'H NMR (CD30D + drops of CD 2Cl 2, 300 MHz): 6: 2.56 (6H, s), 4.78 (4H,
s), 6.56 (2H, d, J = 8.7 Hz), 6.63 (2H, d, J = 8.7 Hz), 6.82 (2H, dd, J = 7.7 Hz, 1.1 Hz),
6.93 (2H, dd, J = 8.3, 1.1 Hz), 7.09 - 7.18 (5H, in), 7.61 - 7.71 (2H, m), 7.88 (2H, d, J =
8.4 Hz), 7.98 (1H, dd, J = 6.3, 1.3 Hz); 13C{'H} NMR (DMSO-d6 , 125 MHz): 8: 25.90,
37.20, 106.04, 111.05, 113.43, 114.79, 123.21, 123.46, 125.34, 125.86, 127.43, 127.52,
127.67, 127.85, 128.81, 131.32, 136.71, 137.39, 138.09, 144.83, 151.62, 153.15, 156.50,
158.88, 169.70; HRMS (m/z): [M - H]- calcd 671.2300, found 671.2283; Anal. Calcd
for C42H32N405-H20: C, 73.03; H, 4.96; N: 8.11; Found: C, 72.91; H, 5.17; N, 8.09.
2-{4,5-Bis[(6-(2-ethoxy-2-oxoethoxy)-2-methylquinolin-8-ylamino)methyl]-6-
hydroxy-3-oxo-3H-xanthen-9-yl}benzoic acid (2, FL2E). 4',5'-Fluoresceindicarbox-
aldehyde (95.3 mg, 245 gmol) and ethyl[(2-methyl-8-aminoquinolin-6-yloxy)acetate]
(141 mg, 542 pmol) were suspended in methanol (13 mL) and stirred at room
temperature for 1 h. The dark red reaction suspension was cooled to 0 "C and sodium
borohydride (67.4 mg, 1.78 mmol) was added. The reaction clarified to form a dark red
solution which was stirred for 1 h as it warmed to room temperature. The solvent was
removed under pressure and the crude product was purified by column chromatography
on silica (gradient from 100% CH2C12 to 19:1 CH2Cl2:CH 30H) to afford a dark red solid
(99.9 mg, 46%). TLC Rf = 0.74 (silica, 9:1 CH2Cl2:CH 30H); mp: 174 - 175 *C (dec); 'H
NMR (DMSO-d6, 300 MHz) 8: 1.19 (6H, t, J= 7.2 Hz), 2.56 (6H, s), 4.15 (4H, q, J= 7.2
Hz), 4.74 (4H, s), 4.89 (4H, d, J = 5.7 Hz), 6.37 (2H, d, J = 2.4 Hz), 6.51 (2H, d, J = 8.7
Hz), 6.70-6.73 (4H, m), 6.88 (2H, t, J = 6.3 Hz), 7.27 - 7.30 (3H, m), 7.67 - 7.76 (2H,
m), 7.94 (2H, d, J = 8.4 Hz), 7.97 (1H, d, J = 7.2 Hz), 10.62 (1H, broad s); 13C{ 1H} NMR
(DMSO-d, 125 MHz) 5: 15.19, 25.56, 37.04, 49.77, 52.95, 61.74, 65.59, 65.73, 94.44,
97.61, 111.00, 113.22, 113.44, 123.94, 125.36, 125.80, 127.48, 128.23, 128.78, 131.29,
135.07, 136.51, 136.69, 145.76, 151.76, 153.15, 154.21, 157.66, 158.61, 169.65, 169.81,
170.33; HRMS (m/z): [M - H]- calcd 875.2934, found 875.2919; Anal. Calcd for
C5OH44N4011-H20: C, 67.10; H, 5.18; N: 6.26; Found: C, 67.26; H, 4.94; N, 6.21.
2,2'-{8,8'-[9-(2-Carboxyphenyl)-6-hydroxy-3-oxo-3H-xanthene-4,5-diyl]bis(methyl-
ene)bis(azanediyl)bis(2-methylquinolin-8,6-diyl)}bis(oxy)diacetic acid (3, FL2A).
FL2E (2, 75.5 mg, 87.0 gmol) was dissolved in aqueous sodium hydroxide (0.5 N, 9 mL)
and methanol (3 mL) and heated to 90 *C for 19 h. The solution was cooled to room
temperature and the pH was adjusted with concentrated hydrochloric acid until an orange
precipitate formed. The solid was filtered, washed with water, and dried to yield the
product (65.9 mg, 92%). TLC Rf = 0.88 (silica, 100% CH30H); mp: 183 - 184 "C (dec);
'H NMR (CD30D + drops of DMSO-d, 300 MHz) 8: 2.48 (6H, s), 4.67 (4H, s), 4.68
(4H, s), 6.32 (2H, d, J = 2.4 Hz), 6.51 (2H, s), 6.63 (2H, d, J = 8.7 Hz), 6.69 (2H, d, J = 9
Hz), 7.06 (2H, d, J = 8.7 Hz), 7.30 (1H, d, J = 7.5 Hz), 7.72 - 7.84 (4H, m), 8.03 (IH, d,
J = 7.5 Hz); 13C{1H} NMR (DMSO-d6, 125 MHz) &: 37.41, 56.09, 65.56, 84.51, 94.68,
110.91, 112.71, 113.41, 120.62, 123.89, 125.41, 125.81, 127.30, 128.60, 128.93, 129.95,
131.28, 136.74, 151.79, 153.53, 153.75, 158.06, 158.71, 169.80, 171.20, 171.30; HRMS
(m/z): [M - H]- calcd 819.2308, found 819.2297; Anal. Calcd for C46H 3 N40 1 -3HCl: C,
59.40; H, 4.23; N: 6.02; Found: C, 59.12; H, 4.29; N, 5.85.
Spectroscopic Materials and Methods. Piperazine-N,N-bis(2-ethanesulfonic acid)
(PIPES) was purchased from Calbiochem. Potassium chloride (99.999%) was purchased
from Aldrich. Buffer solutions (50 mM PIPES, 100 mM KCl, pH 7.0) were prepared in
Millipore water and used for all spectroscopic measurements except for pKa titrations,
which were performed in a solution of 10 mM KOH, 100 mM KCl, pH 12 in Millipore
water. The pH of the solutions was adjusted to the desired values using 6, 1, or 0.1 N HC
and 0.1 N KOH. Quantum yields were measured using fluorescein in 0.1 N NaOH (< =
0.95) as the standard.2 o Nitric oxide was purchased from Airgas and purified as
previously described." S-Nitroso-N-acetyl-DL-penicillamine (SNAP, Cayman
Chemical), potassium nitrate (Aldrich), sodium nitrite (Aldrich), sodium peroxynitrite
(Cayman Chemical), Angeli's salt (Na2N20 3, Cayman Chemical), hydrogen peroxide
(Mallinckrodt Chemicals), and sodium hypochlorite (J. T. Baker) were prepared as 50
mM stock solutions in Millipore water. Nitric oxide and other reactive oxygen and
nitrogen species (RONS) were introduced into buffered solutions via gas-tight syringes.
Copper chloride dihydrate (99+%) was purchased from Alfa Aesar and stock solutions of
10 mM and 1 mM were prepared in Millipore water. Zinc chloride (Aldrich, 99.999%)
stock solutions of 100 mM and 1 mM were prepared in Millipore water. Stock solutions
of 1 mM ligands were prepared in DMSO and stored in aliquots at -80 "C. UV-visible
spectra were acquired on a Cary 50-Bio spectrometer using PMMA cuvettes from
Perfector Science (3.5 mL volume, 1 cm path length). Acquisitions were made at 25.00
0.05 0C. Fluorescence spectra were obtained on a Quanta Master 4 L-format scanning
spectrofluorimeter (Photon Technology International) at 37.0 ± 0.1 *C using 1 M Cu2 (L)
(L = FL2, FL2E or FL2A) generated in situ by combining stock solutions of CuC 2 and L
in a 2:1 ratio, and then introducing either 1.3 mM NO or 167 VM RONS. Fluorescence
measurements were made under anaerobic conditions, with cuvette solutions prepared in
an inert atmosphere glove box. Replicate fluorescence measurements were taken at time
points between 40 s and 60 min.
Results and Discussion
Design Considerations. The reported probes are based on the CuFL1 scaffold, a first-
generation sensor with many beneficial features. Fluoresceins are bright, with
fluorescence quantum yields approaching unity,20 but the aminoquinoline unit of FL1
quenches emission by photoinduced electron transfer (PeT) in the excited state.? CuFL1
is also quenched owing to its paramagnetic Cu(II) center, and emission is restored upon
reduction of Cu(II) to Cu(I) and formation of FLI-NO. The tridentate N20 donor set of
the ligand coordinates Cu(II) with moderate affinity (K = 1.5 RM) but cannot retain
Cu(I), possibly due to its inability to support a tetrahedral geometry, its hard donor atoms,
and the reduced affinity of the nitrosated amine for copper.7'10 Moving from FLI to a
symmetric scaffold offers two main advantages. Firstly, it avoids the more laborious
synthesis of 7'-chloro-4'-fluorescein carboxaldehyde in favor of the simpler symmetric
22,2
variant. Secondly, symmetric ligands tend to have lower fluorescence quantum yields
than their asymmetric derivatives, probably because of the extra lone pair(s) of electrons,
one of which is delocalized over the aminoquinoline unit, available for PeT quenching of
the excited fluorophore." Moreover, Cu(II) chelation on both ligand arms should force
lactonization of the bottom ring benzoic acid to produce two phenolic oxygen atoms for
superior metal binding, decreasing emission by disrupting conjugation of the fluorophore.
These features will produce a more quenched ligand, increasing the dynamic range of
emission upon exposure to NO. An acetoxyethyl ester was employed because the
negatively charged carboxylic acid product of its hydrolysis is not rapidly effluxed by the
cell unlike the commonly used fluorescein acetate esters, which yield the basic
fluorescein scaffold upon hydrolysis and are subsequently are removed from the
intracellular environment more rapidly. 21
Synthesis. The synthesis of the ligands is depicted in Scheme 3.1. Condensation of 8-
aminoquinaldine with 4',5-fluorescein dialdehyde in a 2:1 ratio in methanol followed by
reduction using sodium borohydride afforded FL2, 1, in good yield. The ligand was
purified by column chromatography on silica, a major improvement over the purification
of asymmetric FL1, 7 which required preparative TLC. FL2E, 2, was obtained in moderate
yield by a procedure analogous to that of FL2 using ethyl[(8-amino-2-methylquinolin-6-
yloxy)acetate] as the quinoline.. The acid form of the ligand was prepared by
saponification of FL2E in methanol and water to yield FL2A, 3, in excellent yield,
without the need for additional purification steps.
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Scheme 3.1. Syntheses of FL2, FL2E, and FL2A.
Spectroscopic Properties of FL2, FL2E, and FL2A. Table 3.1 summarizes the
spectroscopic properties of the FL2, FL2E, FL2A, and their corresponding dicopper
derivatives. Previously reported spectroscopic properties of the first generation ligands
and sensors are included for comparison."" The absorption spectra of the ligands are
typical of fluorescein-derived species, exhibiting maxima at 498 nm (E = 2.91 + 0.07 x
104 M'cm'), 500 nm (F = 1.79 ± 0.07 x 104 M'cm'), and 499 nm (E = 4.60 ± 0.06) x 104
M'cm') for FL2, FL2E and FL2A, respectively. Titrations of buffered solutions of the
ligands with CuCl2 revealed the binding stoichiometries of each probe (Fig. 3.2). When
one and two equivalents of Cu(II) are added to buffered solutions of FL2 and FL2E, the
absorbance at k.. decreases. Upon addition of further equivalents of Cu(H) the
absorbance at Xm remains constant. This result is expected for the binding of two copper
atoms by the two N20 donor sets. When the same experiment is performed using FL2A,
there is a decrease in absorbance at Xmax upon addition of one, two, and three equivalents
of Cu(II), with no further changes upon titrating additional equivalents of Cu(II). The
three events probably correspond to two copper binding steps at the two N20 donor sites
Table 3.1. Photophysical properties of FL2, FL2E, and FL2A.
Absorbance Emission
X (nm), F_ x 104 (M-1cm-) (nm), 5 (%)'
unbound Cu(II) unbound Cu(II) + NO DRC ref
FLI" 504,4.3(1) 499,4.0(1) 520,8.3(4) 520, n nr,nr 2.5(1) 7
FL2  503, 3.8(5) 496, 3.8(3) 520, 8.4(2) 520, nr nr, nr 8.3(9) 7
FL3  503,3.9(1) 497,3.9(5) 520,31(1) 520,nr nr,nr 3.4(1) 7
FL4  505,6.9(1) 496,5.7(1) 520,2.4(2) 520,nr nr,nr 31(1) 7
FLI 504,4.2(1) 499,4.0(1) 520,7.7(2) 520,nr 526,58(2) 16(1) 7,10
FL2 498, 2.91(7) 494, 1.14(7) 515, 0.7(1) 512,0.7(4) 526, 51(7) 23(3) this work
FL2E 500, 1.79(7) 496, 1.06(6) 522, 0.4(1) 522,0.7(1) 526,40(8) 17(2) this work, 16
FL2A 499,4.6(6) 495, 1.56(2) 516, 1.8(2) 516, 1.9(2) 526, 36(5) 27(3) this work, 16
a Measurements were performed in 50 mM PIPES, 100 mM KCl pH 7.0, T = 25 "C.
b Referenced to fluorescein ($ = 0.95 in 0.1 N NaOH). c DR is the dynamic range,
INO/lo. nr is not reported.
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and a third binding at the upper-ring acids. Upon addition of two equivalents of CuC12,
the absorbance maxima blue shift to 494 nm (, = 1.14 ± 0.07 x 10' M-lcm-l), 496 nm (E =
1.12 ± 0.06 x 104 M-'cm-') and 495 nm (E = 1.56 ± 0.02 x 104 M-Icm'), for FL2, FL2E
and FL2A, respectively. These blue shifts are presumably due to perturbation of the
xanthenone ring n-system, which occurs when Cu(II) binds to the phenolic oxygen atoms
of fluorescein.
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Figure 3.2. a) Mole ratio plot of Cu(II) binding to 7RM FL2, b) Mole ratio plot of
Cu(II) binding to 7 RM FL2E, and c) mole ratio plot of Cu(II) binding to 7 [iM FL2A
in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 25*C.
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NO Reactivity of the Copper-Ligand Complexes. The free ligands, FL2, FL2E, and
FL2A emit with maxima at 515, 522, and 516 nm, respectively, and their emission
spectra undergo minimal changes upon binding Cu(II). The quantum yields of the ligands
are 0.7 ± 0.1%, 0.4 ± 0.1% and 1.8 ± 0.2% for FL2, FL2E, and FL2A, respectively. By
comparison, the quantum yield for FLI is 7.7 ± 0.2%. Because the extinction coefficients
of the symmetric ligands are also lower than that of FL1, incorporation of a second
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Figure 3.3. Normalized fluorescence response of a) Cu2(FL2), b) Cu2(FL2E), and c)
Cu2(FL2A) in the presence of excess NO over 1 h in 50 mM PIPES, 100 mM KCl, pH
7.0, T = 37 *C. Insets: Plots of integrated fluorescence vs. time, normalized and
adjusted for the basal fluorescence of the sensor in the absence of NO.
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Figure 3.4. Plots of absorbance vs. time for the reactions of a) 1 [tM Cu2(FL2), b) 1 [tM
Cu2(FL2E), and c) 1 RM Cu2(FL2A) with NO in 50 mM PIPES, 100 mM KCl, pH 7.0,
T = 37 *C.
quenching unit brings about a striking decrease in background emission of the free ligand.
Coordination to Cu(II) does not appreciably alter the quantum yields of the ligands (Table
3.1), whereas significant (18 ± 3%) quenching occurs when FLI binds Cu(II). This result
suggests that the additional quenching provided by the second aminoquinoline unit
compensates for that provided by coordination to a paramagnetic center. Buffered
solutions of probes generated in situ by combining CuCl2 and ligand in a 2:1 ratio exhibit
significant fluorescence enhancements relative to that of the initial copper complexes
when exposed to excess NO under anaerobic conditions (Figure 3.3, Tables 3.1). In all
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cases, the fluorescence enhancement matches (Cu2(FL2E)) or greatly exceeds (Cu2(FL2)
and Cu2(FL2A)) that of CuFLI (Table 3.1). Accompanying the fluorescence enhancement
is a red-shift of the emission maxima to 526 nm for all probes, which is consistent with
formation of the free, N-nitrosated derivatives of the ligands." 0 Also consistent with N-
nitrosation are the increased quantum yields of the final solutions after complete reaction
with NO (Table 3.1). The reaction of the probes with NO can also be monitored by the
change in absorption over time. Probe solutions exposed to NO under anaerobic
conditions were monitored over the course of an hour, during which time the Xmax value
red-shifted to 504 nm for all probes (Fig. 3.4).
Kinetics of NO reactivity. The approximate rate of fluorescence enhancement upon
reaction of the probes with NO was determined using the fluorescence data from the
previous section. The reaction occurs in two kinetic phases, characterized by a pre-
equilibrium of Cu(II) binding and then an irreversible reaction of the Cu(II) complex with
NO (eq. 3.1). The reaction for each probe with NO was monitored multiple times by
fluorescence, and the plots of the fluorescence enhancement over time were fit to first-
order exponential equations to obtain kfluor (Figure 3.5). This analysis gave estimates for
the rate constants of NO reactivity of 0.006 ± 0.003 s-', 0.0058 ± 0.0009 s-' and 0.010
0.002 s4 for Cu 2(FL2), Cu2(FL2E) and Cu 2(FL2A), respectively.
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Figure 3.5. Plots of integrated fluorescence vs. time and residual plots of the
exponential fits applied to the fluorescence vs. time graphs for the reaction of a) 1 ttM
Cu2(FL2), b) 1 RM Cu2(FL2E), and c) 1 RM Cu2(FL2A) with 1.3 mM NO in 50 mM
PIPES, 100 mM KC1, pH 7.0, T = 37 "C, normalized and adjusted for the basal
fluorescence of the sensor in the absence of NO. kb values were determined by fitting
the plot of absorbance at Xma, vs. time to a single exponential equation, y = Ae-*t) + Yo.
Probe selectivity. The reaction of the probes with NO is not limited to the gaseous
form of the molecule. A fluorescence response is also observed when the probes are
exposed No donors such as S-nitroso-N-acetyl-DL-penicillamine (SNAP, Table 3.2).
Because of the diversity of NO reactions under biological conditions, it is imperative that
..........
Table 3.2. Selectivity of Cu2(FL2), Cu2(FL2E), and Cu 2(FL2A) for NO over other
RONS after 1 h.
Fluorescence Enhancement (F/F)
RONS Cu 2(FL2)" Cu2(FL2E) Cu2(FL2A)
NO 23(3) 17(2) 27(3)
SNAP 18(1) 10(1) 15(3)
N0 2  0.92(8) 1.17(6) 1.56(4)
N0 3 ~ 0.84(2) 0.92(1) 1.33(4)
H202 1.3(1) 1.8(2) 4(1)
CIO- 1.5(2) 1.26(9) 1.8(2)
ONOO- 1.40(7) 1.2(2) 4(1)
HNOb 1.4(1) 1.3(2) 1.3(2)
a Measurements were performed in 50 mM PIPES, 100 mM KCl at pH 7.0, 37 *C, 1 h,
100 equiv. RONS. 'HNO is generated from Angeli's salt, Na2N2O3.
NO probes are selective for molecule itself and not its oxidation products, including NO2
and NO;, products of NO reactions, including ONOO- and HNO, or other cellular
oxidizing species, such as H20 2 or CIO-. When these biologically relevant reactive
oxygen and nitrogen species (RONS) are introduced to buffered probe solutions, the
fluorescence enhancement over 1 h is minimal by comparison to that afforded by NO
(Figure 3.6, Table 3.2). This result is consistent with the chemistry of the first generation
probe CuFL 17,0 and indicates that modifications to the quinoline moiety do not interfere
with the selectivity of the probes to sense nitric oxide or other NO-transfer agents such as
S-nitrosothiols.
pH Dependence. The emission of the ligands depends on pH, and this dependence was
investigated by fluorescence and UV-visible spectroscopy for FL2 and FL2A only,
because FL2E hydrolyzes under the experimental conditions. Starting at pH 12, addition
of protons to either ligand results in a fluorescence enhancement that is marginal until ~
pH 8 (FL2) or pH 9 (FL2A), but then increases sharply until ~ pH 6 for both (Fig. 3.7).
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Figure 3.6. Selectivity of 1 RM Cu2(FL2), 1 RM Cu2(FL2E) and 1 RM Cu2(FL2A) for
NO over other RONS (167 [M). Normalized fluorescence response after 1 h relative
to the emission of the probe in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 37 *C.
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Figure 3.7. Absorbance (left) and fluorescence emission (right) dependence on pH for 5
[M FL2 and 5 [M FL2A in 10 mM KOH, 100 mM KCI, pH ~ 12, T = 25 *C. pH
adjusted with 6 N, 1 N and 0.1 N HCl and 0.1 N KOH.
By comparison to the fluorescence enhancement induced by reaction of Cu2(FL2)
or Cu2(FL2A) with NO, protonation of FL2 or FL2A causes only an approximate 2-fold
fluorescent enhancement. This result indicates that the ligands are fairly insensitive to pH
in the biologically relevant range of ~ 6 - 8, especially by comparison to NO-promoted
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Figure 3.8. Absorbance dependence on pH for 5 [tM FL2 and 5 [M FL2A in 10 mM
KOH, 100 mM KCl, pH ~ 12, T = 25 *C. pH adjusted with 6 N, 1 N and 0.1 N HCl
and 0.1 N KOH. Right. Residual plots of the exponential fits applied to the pH graphs
are shown. pKa values were determined by fitting the plots of absorbance at ?,, vs.
pH to the equation, y = (A, - A 2)/(1 + e(x-pKa)/dx) + A 2 -
fluorescence. Further lowering of the pH results in a steep decrease in fluorescence for
both ligands, probably due to protonation of the fluorescein, which forms non-fluorescent
species.26 The first set of pKa values were obtained by fitting the UV-vis data (Fig. 3.8),
revealing values of ~ 7.0 and ~ 5.9 for FL2 and FL2A, respectively. Because there are
multiple protonation sites on each ligand, but only one pKa value obtained from the
absorption titration, these numbers represent an average pKa for each ligand. The second
set of pKa values were revealed by fitting the fluorescence data (Fig. 3.9). Three values
were obtained for each ligand. The first, ~ 7.3 and - 7.9 for FL2 and FL2A, respectively,
is attributed to protonation of the secondary amine nitrogen atoms.2 ' Because protonation
breaks the symmetry of the ligand, there should be two pKa values in these regions. The
first fluorescence value should therefore be treated as an apparent pKa. The second
fluorescence pKa value of ~ 5.9 and ~ 6.2 for FL2 and FL2A, respectively, corresponds to
the maxima of the titration curves, and can be attributed to protonation of the quinoline
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Figure 3.9. Fluorescence emission dependence on pH for 5 mM FL2 and 5 mM FL2A
in 10 mM KOH, 100 mM KCl, pH - 12, T = 25 *C. pH adjusted with 6 N, 1 N and 0.1
N HCl and 0.1 N KOH. Right. Residual plots of the exponential fits applied to the pH
graphs are shown. pKa values were determined by fitting the plot of integrated
fluorescence emission at Xmax vs. pH to the equation, y = (A1 - A2)/(1 + e(x-pKa)/dx) + A2.
ring. The third fluorescence pKa value, which is most likely result from a combination of
fluorescein carboxylic acid protonation and lactonization, is 5.0 and 4.9, for FL2 and
FL2A, respectively. It was determined by fitting the fluorescence plots from the maxima
at ~ pH 6 to the lowest pH values.
Zn(II) Reactivity. Zinc ions are ubiquitous in biology, providing structural support and
performing catalytic roles in a variety of proteins.2" In such proteins, Zn(II) is tightly
bound and, in general, intracellular zinc concentrations are closely regulated by Zn(II)-
specific transporters, such as ZnT-3, and Zn(II)-binding proteins, such as metallothionein
(MT).2 ' Through NO reactivity it is possible for Zn(II) to be released from proteins. For
example, NO nitrosates the Zn(II)-binding cysteines in MT, which results in loss of
Zn(II) from the protein and an increase in local Zn(II) concentration. 29
The design of the CuFLI probe is similar to that of the Zn(II) probe QZ1, which
contains a similar N20 metal-binding pocket.24 QZ1 binds Zn(II) selectively over Na(I),
Ca(II), Mg(II), Mn(II), Fe(II), Co(II), Cd(II) and Hg(II); however, Ni(II) and Cu(II)
compete, a result obtained from an experiment using a 50:1 M(II):QZ1 ratio. It was
therefore considered, in the present context, whether excess Zn(II) might displace Cu(II)
from the probes, thereby causing fluorescence enhancement. To investigate this
possibility, the fluorescence of the probes was monitored before and after the addition of
ZnCl2 (Fig. 3.10). For 1 [M concentrations of all three probes, negligible fluorescence
enhancement was observed up to ~ 100 [tM Zn(II), a physiologically relevant
concentration. For Cu2(FL2) and Cu2(FL2E), the Zn(II)-induced fluorescence
enhancement remains minimal even at millimolar concentrations of ZnCl2. For
Cu2(FL2A), millimolar concentrations of Zn(II) induced a modest (- 8-fold) fluorescence
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Figure 3.10. Selectivity of 1 [M Cu2(FL2), 1 [tM Cu2(FL2E), and 1 pM Cu2(FL2A) for
NO over ZnCl2. Normalized fluorescence response after I h relative to the emission of
the sensor in 50 mM PIPES, 100 mM KCl, pH 7, T = 37 *C.
enhancement, but one that is still less than one-third of that produced by NO.
Concentrations of Zn(II) only reach near-millimolar levels under certain physiological
conditions, such as during synaptic release of zinc in the hippocampus,3, 1 and therefore
these data suggest that excess Zn(II) will not interfere with the NO-sensing properties of
the Cu(II)-FL-type probes in live cell applications except during very specific events that
result in near-millimolar Zn(H) release. Extra control experiments to prove fluorescence
turn-on is due to NO, such as using NO inhibitors, would be advised when using
Cu2(FL2E) for such experiments.
Summary
The synthesis and spectroscopic characterization of the fluorescein-based Cu(II)
binding ligands FL2, FL2E, and FL2A are reported. These symmetrical constructs exhibit
superior photophysical properties for NO sensing compared to the asymmetric FLI
probe. They are much less emissive in the off state ($ = 0.7 ± 0.1%, 0.4 0. 1%, and 1.8 ±
0.2% for FL2, FL2E, and FL2A, respectively, compared to 7.7 ± 0.2% for FLI) and
therefore have larger dynamic ranges upon reaction with NO. The probes maintain their
selectivity for NO over other biologically relevant RONS, and Zn(II) cannot displace
Cu(II) to elicit a fluorescent response. The kinetics of NO-induced fluorescence
enhancement were investigated, and approximate pseudo-first-order rate constants of
0.006 ± 0.003 s4 , 0.0058 ± 0.0009 s- and 0.010 ± 0.002 s4 were obtained for the
reactions of Cu2(FL2), Cu2(FL2E), and Cu2(FL2A) with NO, respectively, indicating that
substitution of the aminoquinaldine unit does not significantly alter the rates.
Cell-trappability is an important feature for using a probe under simulated
physiological conditions, such as when a continual perfusion of media is required. The
viability of the new cell-trappable probe, Cu 2(FL2E), in live cells is explored in the next
chapter. Because the probe is retained in cells, Cu2(FL2E) was used to monitor NO
production in live olfactory bulb tissue slices. The same experiment could not be
performed using the cell-permeable CuFL1, and therefore represents and important
advance to the field of metal-based NO sensing.
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Chapter 4.
Visualization of Nitric Oxide Production in the Mouse Main Olfactory Bulb by a
Cell-Trappable Copper(II) Fluorescent Probe
Reproduced in part with permission from McQuade, L. E.; Ma, J.; Lowe, G.; Ghatpande,
A.; Gelperin, A.; Lippard, S. J. Proc. Nati. Acad. Sci.. U.S.A., 2010, 107, 8581-8586.
Introduction
Nitric oxide (NO) is an important biological signaling agent. It activates soluble
guanylyl cyclase, initiating a signaling cascade that promotes vascular smooth muscle
dilation.1-3 Nitric oxide produced in the nervous system has been implicated in
neurotransmission, 4 and the immune system generates NO as a defense against
pathogens.' Unregulated nitric oxide production has been associated with pathological
conditions such as cancer, ischemia, septic shock, inflammation, and neurodegeneration.'
Transition metal complexes have been investigated as platforms for NO
detection.' A typical strategy is to incorporate a fluorophore into a ligand that is quenched
either by intramolecular photoinduced electron transfer and/or by coordination to a
paramagnetic or heavy metal ion. Fluorescence is restored by reduction of the metal
and/or displacement of the ligand upon reaction of the probe with NO. CuFLI is an
example of such a metal-based cellular NO imaging agent." CuFL1 satisfies many of the
requirements of an effective sensor. It is non-toxic and cell membrane permeable, has
low energy of excitation and emission, responds directly and selectively to NO, and
exhibits dramatic fluorescence enhancement upon reaction with NO. When the non-
emissive CuFL1 reacts with NO, Cu(II) is reduced to Cu(I) and the secondary amine of
the ligand is N-nitrosated to produce the fluorescent species, FL1-NO. CuFLI has been
used to monitor NO production in bacterial cell cultures with great success;10-13
nevertheless, a cell-trappable version of the ligand would lead to a wider applicability for
biological experimentation. Cell-trappability is a key feature for biological experiments
in intact tissues for which continual perfusion of tissue slices with artificial physiological
saline solution is required. Under perfusion conditions, CuFLI diffuses out of cells,
making analysis of the results difficult. Incorporating an ester moiety onto the ligand is
one way to confer trappability to a probe. 4 The probe remains cell membrane permeable
until cytosolic esterases cleave the ester group to yield a carboxylic acid, which is
negatively charged at physiological pH. This transformation traps the probe within the
cell.
One such biological application that necessitates the use of cell-trappable probes
is the imaging of brain-derived NO in live tissue slices. The mammalian olfactory bulb
(OB), the first site for synaptic evaluation of olfactory receptor input in the CNS, is an
ideal site to elucidate the functions of NO. Immunocytochemistry experiments confirm
that the OB is rich in NO-producing cells.' 5 Direct measurements of NO in OBs, both in
vivo and in vitro, using an NO-selective microprobe reveal significant resting levels of
NO and also odor-stimulated increases in NO.16 These results are of interest because of
literature linking NO levels in the OB to odor learning and memory storage.'-' To
determine the effects of NO on synaptic interactions in the OB circuit, it would be of
great value to localize NO sources and sinks on the seconds time scale with cellular
resolution in living brain slices of the OB suitable for electrophysiological analysis.20 ,
The development of the cell trappable NO probe described herein is an important
contribution not only to these analyses, but potentially to studies of the cellular and
synaptic actions of NO in many other brain regions, e.g., the hippocampus 222 4 and
cerebellum, 2 ,26 where NO has also been implicated in processes of synaptic plasticity,
learning, and memory. Ultimately, one might envision application of the new trappable
NO probe to anaesthetized mice exposed to odorants at the nose while monitoring NO
production in the OB by fluorescence optical imaging.
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In the previous chapter, the synthesis and characterization of a new set of
fluorescein-based symmetrical ligands and their Cu(II) complexes as NO-specific
fluorescent probes was described. These second-generation probes are based on CuFLI
and employ the ester/acid strategy for cell-trappability. The Cu(II) complexes, generated
in situ, respond rapidly and selectively to nitric oxide over other biologically relevant
reactive oxygen and nitrogen species (RONS). This chapter contains data illustrating
fluorescence detection by the cell-trappable probe of endogenously produced NO in
macrophage and neuroblastoma cells, together with mouse olfactory bulb slice
experiments that visually confirm and extend previous electrochemical results are
presented.
Experimental Section
Cell Culture and Imaging Materials and Methods. HeLa, Raw 264.7 murine
macrophages, and human SK-N-SH neuroblastoma cells were obtained from American
Type Cell Collection (ATCC). HeLa and Raw 264.7 cells were cultured in Dulbecco's
Modified Eagle Medium (DMEM, Cellgro, MediaTek, Inc.) supplemented with 10% fetal
bovine serum (FBS, HyClone), 1% sodium pyruvate (Cellgro, MediaTek, Inc.), and 1%
MEM non-essential amino acids (Sigma). SK-N-SH cells were cultured in Eagle's
Minimal Essential Medium (EMEM, Cellgro, MediaTek, Inc.) supplemented with 10%
FBS and 1% non-essential amino acids. For imaging studies, cells were plated into poly-
D-lysine coated plates (MatTek) containing 2 mL of complete DMEM, and incubated
overnight at 37 *C with 5% CO 2. For all cell studies, the sensors were generated in situ by
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combining stock solutions of CuCl2 (1 mM) and L (1 mM) in a 2:1 ratio (L = FL2E,
FL2A).
For nitric oxide detection studies, iNOS was induced in Raw 264.7 macrophages
with 500 ng/mL of LPS and 250 - 1000 U/mL of IFN-y for 4 h and the cells were then
incubated with either 1 [M Cu2(FL2E) or 1 RM Cu2(FL2A) for 2 - 8 h. In SK-N-SH
neuroblastoma cells, nNOS was induced with 100 nM s-estradiol (Sigma) and were co-
incubated with 1 IM Cu2(FL2E), 4.5 [M Hoechst 33258 (Sigma), and 0.2 pM
Mitotracker Red (Invitrogen) for 30 min. Cells were washed three times with 1 mL of
PBS prior to imaging and then bathed in 2 mL of PBS during imaging.
For CuFLI diffusion studies, HeLa cells were incubated with 10 tM CuFLI for
30 min. Cells were washed three times with 1 mL of phosphate buffered saline (PBS,
Cellgro, MediaTek, Inc.) prior to imaging and then bathed in 2 mL of PBS during
imaging. To mimic media flow, the PBS was removed and the cells were washed three
times with 1 mL of fresh PBS and then bathed in 2 mL of fresh PBS. This process was
repeated every 10 min during imaging. For Cu 2(FL2E) diffusion studies, Raw 264.7
macrophages were pre-incubated with 500 ng/mL of lipopolysaccharide (LPS, Sigma)
and 250 - 1000 U/mL of interferon- y (IFN-y, BD Biosciences) for 4 h and then
incubated with 1 [tM Cu2(FL2E) for 12 h. Washing and imaging were performed in the
same manner as in the CuFLI diffusion studies.
Images were acquired on a Zeiss Axiovert 200M inverted epifluorescence
microscope equipped with an EM-CCD digital camera (Hamamatsu) and a MS200 XY
Piezo Z stage (Applied Scientific Instruments), lighted by an X-Cite 120 metal-halide
lamp (EXFO). Plates were maintained on the microscope stage in an INC-2000 incubator
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kept at 37 C under 5% CO2. Differential interference contrast (DIC) and red, blue, and
green fluorescent images were obtained using an oil immersion 63x objective lens, with
2.00 s exposure times for green fluorescent images. The microscope was operated with
Volocity software (Improvision). All fluorescent images were corrected for background.
Cytotoxicity Assays. SK-N-SH cells were seeded into 96-well plates (100 JAL total
volume/well, 3000 cells/well) in complete DMEM and incubated at 37 *C with 5% CO2
for 24 h. The medium was replaced and the cells incubated with Cu 2(FL2E) (1 [LM - 1
mM, with an untreated control lane) for another 72 h. The medium was removed and
replaced with 200 [tL of a 20:1 mixture of FBS-free DMEM and (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT, 5 mg/mL stock in PBS). The cells were
incubated for 4 h and then the medium was removed and replaced with DMSO (100 [tL/
well). The absorbance of each well was recorded at 555 nm on a microplate reader
(BioTek, Synergy HT) and the percent cell survival values are reported relative to those
of untreated control cells.
Olfactory Bulb Imaging. Cells in tissue slices were visualized with differential
interference contrast (DIC) optics on an Olympus BX50-WI microscope equipped with a
60x NA 0.90 water immersion objective and viewed with a V-1070 CCD video camera
(Marshall Electronics, El Segundo, CA). For dynamic imaging of local fluorescence in
slices, Hg arc lamp illumination with 425DF45 excitation, 475DCLP02 dichroic, and
535DF55 emission filters (Omega Optical) was used. Excitation was controlled by a
Uniblitz electronic shutter (Vincent Associates) with 8 ms frame exposure to reduce
bleaching. Single frames were acquired at 30 s intervals using a NeuroCCD-SM camera
controlled by Neuroplex 6.5 software (Red Shirt Imaging, CT). Wider area static images
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of slices were acquired with a Nikon DXM1200C digital camera attached to a Nikon
Eclipse 80i microscope, using Hg arc lamp excitation and FITC filter set (EX480/40
excitation, DM495 dichroic, BA535/50 emission).
Olfactory Bulb Slice Preparation. Olfactory bulb slices were prepared from male
mice (P21-28, CD-i, Charles River Laboratories, Wilmington, MA) as described
previously. 16,20 Animals were sacrificed under halothane anesthesia, and olfactory bulbs
were removed and transferred into ice-cold slicing solution containing 240 mM sucrose,
2.5 mM KCl, 10 mM NaHEPES, 10 mM glucose, 1 mM CaCl2, 4 mM MgCl2 , and 0.2
mM ascorbic acid at pH 7.2. Horizontal slices (200 - 300 pm thickness) were cut and
incubated for 45 min (32 'C - 23 'C) in an interface chamber containing 124 mM NaCl,
2.5 mM KCI, 26 mM NaHCO 3, 1.25 mM NaH2PO 4 , 10 mM glucose, 1 mM CaCl2, 3 mM
MgCl2, and 2 mM N"-nitro-L-arginine at pH 7.3 (aerated with 95% 02, 5% C0 2).
Nitric Oxide Probe Loading. NO probe loading solution was prepared by mixing 5
mL of 2 mM FL2E in DMSO + 20% Pluronic* F-127 (Invitrogen) with an equal volume
of 4 mM CuCl2 in water to make Cu2(FL2E), including 76 pM MK-571 to block
multidrug resistant transporters." Slices were incubated in loading solution for 2 h in a
small shallow dish in the interface chamber and subsequently transferred to an open
chamber and perfused (2 mL/min) with ACSF containing 124 mM NaCl, 2.5 mM KCl,
26 mM NaHCO 3, 1.25 mM NaH2PO4, 25 mM glucose, 2 mM CaCl2, and 1.3 mM MgCl 2
at pH 7.3 (aerated with 95% 02, 5% CO2, 23 *C). N"-nitro-L-arginine (2 mM) was used
initially to inhibit NO synthesis and then replaced with 400 [M L-arginine to promote
NO synthesis. During repeated stimulation of slices by step additions of 20 mM KCl,
there was a 350 - 590 s delay between trials.
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Animal Care. All experimental procedures adhered strictly to guidelines for animal
care, handling, and euthanasia set by the U.S. Public Health Service. All protocols were
reviewed and approved by the Monell Institutional Animal Care and Use Committee.
Results
Fluorescence Microscopic Imaging of Biologically Derived NO Production. First,
the ability of the trappable probe to detect endogenously produced NO was evaluated.
Macrophage cells of the immune system produce micromolar quantities of NO when
inducible nitric oxide synthase (iNOS) is activated in response to a pathogenic attack.'
Endotoxins from pathogens, such as lipopolysaccharide (LPS), and pro-inflammatory
cytokines, such as interferon-y (IFN-y), induce expression of the iNOS gene, which
results in NO production several hours later. To determine whether Cu 2(FL2E) can detect
NO under these conditions, Raw 264.7 macrophages were stimulated with LPS (500
ng/mL) and IFN-y (250 - 1000 U/mL) for 4 h to induce a physiologically relevant
concentration of NO, and then incubated with 1 [M Cu2(FL2E) for an additional 2 - 8 h.
In a control experiment, cells were incubated for 12 h with Cu 2(FL2E) in the absence of
an iNOS inducer. The results of these experiments are shown in Fig. 4.1. An increase in
fluorescence was observed 6 - 8 h following sensor incubation (10 - 12 h after induction
of iNOS), whereas no changes were observed in the control cells or in cells visualized at
earlier times points (6 - 8 h post-induction). These results are consistent with previous
findings using CuFLI to image NO production in Raw 264.7 macrophages,' indicating
that Cu2(FL2E) can also detect endogenously produced nitric oxide.
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Time 12 h 6 h 8 h 10h 12 h
LPS/IFN-y - + + + +
Figure 4.1. Raw 264.7 macrophages co-incubated with 1 [IM Cu2(FL2E), 500 ng/mL
LPS, and 250 - 1000 U/mL IFN-y for 6 - 12 h. Top, DIC images; Bottom, emission
from the probe in the green channel. Scale bars 25 gm.
Brain-derived neuronal nitric oxide synthase (nNOS) is activated following an
increase in intracellular Ca2* levels to produce up to nanomolar concentrations of NO.
Excess intracellular calcium binds to the regulatory protein calmodulin, which undergoes
a conformational change that in turn triggers binding to, and activation of, nNOS. 29
Addition of 17-p-estradiol (p-ES) to neuronal cells activates the estrogen receptor, which
opens calcium channels to allow an increase in intracellular Ca 2* levels.30 To demonstrate
that Cu2(FL2E) can detect low levels of biological NO, human SK-N-SH neuroblastoma
cells were co-incubated with 5 M Cu2(FL2E) and 100 nM p-ES for 30 min. As shown in
Fig. 4.2, an increase in fluorescence was observed for plates stimulated with p-ES versus
controls with no p-ES, consistent with results obtained with CuFL1.9
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Figure 4.2. SK-N-SH cells co-incubated with (top) 5 [M Cu2(FL2E) and (bottom)
5 pM Cu2(FL2E) and 100 nM 17-p-estradiol. Left, DIC images; Right, emission from
the probe in the green channel. Scale bars 25 gm.
Probe Localization in SK-N-SH Cells. Many fluorescein-based probes localize to
specific sub-cellular regions, such as the mitochondria or Golgi apparatus.31 In the SK-N-
SH imaging experiments, punctate staining of the cells was observed, suggesting that
Cu2(FL2E) localizes to a sub-cellular compartment. To investigate this hypothesis, SK-N-
SH neuroblastoma cells were co-incubated with s-ES (100 nM), Cu2(FL2E) (5 pM),
Hoechst 33258 (4.5 RM, nuclear stain), and Mitotracker Red (0.2 JM, mitochondrial
stain). Fig. 4.3 illustrates the findings of this experiment. The probe did not enter the
nucleus (Fig. 4.3b, f), as expected if the ester is rapidly converted to the acid in the cell,
preventing it from traversing the nuclear membrane. Overlay of the green (Fig. 4.3c) and
red (Fig. 4.3d) detector channels indicates colocalization as demonstrated by the yellow
color in the image (Fig. 4.3e). Colocalization scatter plots of the blue vs. green (Fig 4.3f)
and red vs. green channels (Fig 4.3g) are presented as an alternate way to visualize the
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colocalization. These data clearly reveal that Cu2(FL2E) associates with the mitochondria
of SK-N-SH neuroblastoma cells.
Figure 4.3. SK-N-SH neuroblastoma cells co-incubated with 5 RM Cu2(FL2E), 100 nM
17-s-estradiol, 0.2 pM Mitotracker Red, and 4.5 [M Hoechst 33258 for 30 min. a) DIC
image, b) emission from the blue channel (nuclear stain), c) emission from the green
channel (NO probe), d) emission from the red channel (mitochondrial stain), e) overlay
of the green and red channels, f) colocalization scatter plot of the signals from the blue
and green channels, and g) colocalization scatter plot of the signals from the red and
green channels. Scale bars 25 pm.
Cell-Trappability of Cu2(FL2E). CuFLI readily diffuses into cells and responds to
NO produced by both cNOS and iNOS in vivo.9 Because CuFLI is not cell-trappable, it
can diffuse out of cells under many conditions. This attribute is an important
shortcoming; experiments in tissue slices require perfusion of media throughout the
experiment to maintain tissue health, and experiments in live animals have body fluids
continually perfusing the tissues. To demonstrate diffusibility for CuFL1, HeLa cells
were incubated with 10 pM of the probe for 30 min and then washed and bathed in
phosphate buffered saline (PBS) prior to imaging (Fig. 4.4). An initial wash did not
significantly reduce the probe signal. Subsequently, the cells were maintained in a
microscope incubator at 37 C with 5% CO2 and imaged every 10 min over the course of
108
an hour, washing between each image. To wash the cells, the PBS was carefully removed
by pipette while the plate remained on the microscope and then fresh PBS was added.
The PBS was removed and replaced three times to attempt to mimic conditions where the
cells would be perfused with fluids. After 20 min, fluorescence microscopy revealed
virtually no CuFL1 remaining in the cells (Fig. 4.4), consistent with diffusion of CuFL1
out of the cells.
A similar study was performed using the trappable NO probe. Raw 264.7
macrophages were stimulated with LPS and IFN-y for 4 h and then incubated with
Cu2(FL2E) for 12 h. The cells were washed and imaged while in the microscope
incubator under the same conditions as with the HeLa cells. Fig. 4.4 illustrates that the
fluorescence signal is not diminished over time, confirming that the sensor is indeed
trappable.
Figure 4.4. Cell imaging experiments demonstrating diffusion of CuFL1 and retention
of Cu2(FL2E). a) DIC image, b) emission from the green channel at 0 min, c) 10 min,
and d) 20 min. Top: HeLa control cells incubated with 10 [iM CuFLi for 30 min.
Bottom: Raw 264.7 macrophages incubated with 1 RM Cu2(FL2E), 500 ng/mL LPS, and
250 -1000 U/mL IFN-y for 12 h.
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As a second demonstration of trappability, macrophages were co-incubated with
Cu2 (FL2A), the biologically relevant species, and LPS and IFN-y. Upon washing the cells
and imaging, no fluorescent signal was present (Fig. 4.5). This result is consistent with
the expectation that the negative charges of the deprotonated carboxylic acids prevent the
probe from crossing the cell membrane and entering cells.
Time 12 h 6 h 8 h 10h 12 h
LPS/IFN-y - + + + +
Figure 4.5. Raw 264.7 macrophages co-incubated with 1 [M Cu2(FL2A), 500 ng/mL LPS
and 250 - 1000 U/mL IFN-y for 6-12 h. Top, DIC images; Bottom, emission from the
sensor in the green channel. Scale bars 25 pm.
Cytotoxicity Studies. An ideal probe is minimally cytotoxic. Over the course of
experiments in both Raw 264.7 and SK-N-SH cells there was no visible cell death;
however, these experiments were performed over relatively short time periods (< 24 h)
with low micromolar probe concentrations. To investigate the potential toxicity of
Cu2(FL2E) toward SK-N-SH cells, the least robust of the cell lines used for imaging, over
a longer time frame, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assays" were performed for a large range of sensor concentrations over 3 days.
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The survival of SK-N-SH cells incubated with 5 RM Cu2(FL2E) was very good, with 86
± 1% of cells still alive after 3 days. The 50% lethal concentration (LC50) of the sensor
after a 3 day incubation period was ~ 50 [tM, indicating that the probe concentration can
be increased by an order of magnitude before substantial cell death occurs. The survival
of SK-N-SH cells incubated with 1 mM Cu2(FL2E) for only 1 day was 75 ± 1%. Thus
shorter experiments can tolerate very high probe concentrations, which is sometimes
necessary for successful loading into tissue slices.
NO Detection in the Mouse Main Olfactory Bulb. Slices were incubated with probe
loading solution and, after washing excess probe from the bathing solution, widespread
fluorescence in all cell layers of the OB was observed (Fig. 4.6). Under low
magnification (Fig. 4.7a), prominently labeled glomeruli and brightly stained cell somata
in the mitral and granule cell layers were clearly highlighted against a background of
diffuse fluorescence. Under higher magnification, the characteristic laminar arrangements
of granule cell somata were revealed (Fig. 4.7b). The mitral cell layer was separated from
granule cells by the inner plexiform layer, which was sparsely labeled. In control slices,
only very weak background fluorescence was detected from all layers of the OB, and cell
somata were not clearly resolved. Compared to control slices, fluorescence measured
after a 1 h recovery period using a FITC filter set and averaged over an area of 0.663
mm2 in OB slices loaded with Cu2(FL2E) for 2 h increased by factors of 4 ± 1 in the
glomerular layer, 4 + 2 in the external plexiform layer, and 14 ± 3 in the granule cell
layer.
After loading, fluorescence from granule layer cell somata was monitored over
time, acquiring frames every 30 s using 8 ms of illumination per frame. Under control
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Figure 4.6. Mouse main (MOB) and accessory olfactory bulb (AOB) slices (300 sm)
co-incubated with 1 mM Cu 2(FL2E) and 100 tM MK-571 for 2 h.
conditions with 400 pM L-arginine and the basal level of KCl (2.5 mM) in the bath,
monotonic increases in fluorescence were measured with a steadily decreasing slope over
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Figure 4.7. Static and dynamic fluorescence imaging of Cu2(FL2E) in OB slices. a) Low
magnification fluorescence image of a mouse OB slice after 2 h incubation in loading
solution with 1 mM Cu2(FL2E) and 100 [tM MK-571, b) High magnification fluorescence
image of sensor-loaded mouse OB slice, revealing numerous granule cell somata arrayed
in densely packed laminae, and c) Time dependence of cell fluorescence after loading.
Top: Plot of CCD camera readout voltage versus time. Bath KCl was initially 2.5 mM and
was incremented by 20 mM at 330 s and 920 s after the start of recording. Bottom: Plot of
the time derivative of the upper trace to reveal the rate of NO binding. Abbreviations: GL,
glomerular layer; EPL, external plexiform layer; MCL, mitral cell layer; IPL, internal
plexiform layer; GCL, granule cell.
the time period of 330 - 760 s (Fig. 4.7c). The derivatives of the time courses of cell
fluorescence signals decayed with a time constant of 263 ± 120 s (n = 4 cells). These
observations demonstrate that the probe can be taken up and trapped by cells in brain
slice preparations.
The strong initial fluorescence and its persistent increase over time indicate tonic
production of NO in the OB slice, consistent with findings obtained by electrochemical
microprobe detection.16 To verify the physiological origin of the fluorescence, slices were
stimulated by increasing extracellular KC1 levels. Applications of 20 mM KCl to the slice
were consistently followed by transient elevations in the rate of fluorescence increase, as
expected because KC1 depolarizes neurons, causing Ca2 to enter the cells and induce NO
synthesis (Fig. 4.7c). The time derivative of the fluorescence signal increased by a factor
of 12 ± 7 (range of increase 3.9 - 26.2, n = 8 trials from 4 cells, p = 0.0003), from which
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it was estimated that NO levels in the slice were boosted from a basal value of ~ 85 nM
to ~ 1 pM for 1 - 2 min after KCl addition. 16
Discussion
Efficient synthetic procedures for generating unique ligands for preparing the NO-
specific probes FL2E and FL2A have been devised. Cu(II) complexes assembled by
combining CuCl2 with either ligand in a 2:1 ratio display photophysical characteristics
that are consistent with the asymmetric probe CuFL1.8 The resulting complexes are
excellent nitric oxide probes and are highly selective for NO and RSNO over other
biologically relevant RONS.
The trappable probe detects endogenously produced NO from cNOS and iNOS,
consistent with the capabilities of CuFLI. 9 Like CuFL 1, the new NO probe is minimally
toxic. Unlike CuFLI, however, the trappable probe is maintained within cells after
numerous changes of the extracellular medium, confirming that installing acetoxyethyl
esters confers cell-trappability. Cu2(FL2E) localizes to the mitochondria, a feature also
observed for the Zn(II) sensor ZS5.3 1 The structure of ZS5 resembles that of FL2 up to
the secondary amine of FL2E. In ZS5 the amine is tertiary and is appended to methyl
pyridyl and methyl thiophene units. The fluorescein platform alone is not responsible for
the mitochondrial localization, because fluorescein-based probes sometimes localize to
other regions of the cell.31 The upper-ring substituents are not similar in ZS5 and FL2E,
suggesting that some other, as yet unknown, factor is responsible for directing these
sensors to mitochondria.
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The ultimate purpose in devising NO-specific probes is to apply them in
experiments pertaining to the time-dependent production of NO in the mammalian brain.
Because CuFL1 diffuses out of cells under conditions of tissue perfusion, no conclusive
results were obtained from experiments using CuFL1 in mouse OB tissue slices. This
shortcoming led to the present design of the cell-trappable probe, and with it OB tissue
slices were successfully loaded and fluorescence caused by NO production visualized.
The detection of NO probe fluorescence in mouse OB slices is consistent with
results obtained using an NO-selective microprobe to monitor robust basal NO
production in the mitral and granule cell layers of slices.1 6 The NO microprobe technique
provides fast (seconds time scale), sensitive, dynamic detection of extracellular NO
signals, but is limited in spatial resolution to a single site - 10 gm in diameter sampling
the extracellular environment of only one or a few neurons. By contrast, the fluorescent
probe described herein offers slower (minutes time scale), parallel, time-integrated
detection of intracellular NO signals from dozens to hundreds of 10 - 15 ptm sized cells
in slices that can trap the fluorophore. Extensive fluorescent labeling of slices suggests
that tonic NO production is not confined to the granule cell layer, but is widespread
throughout the OB. The most intense fluorescence occurs in the glomerular and granule
cell layers, with weaker labeling of the external plexiform layer. This result mirrors the
large-scale distribution of nNOS immunoreactive cells and fibers that has been
documented in the mouse OB.15 ,33-36 The higher density of nNOS expression in the
glomerular and granule cell layers might result in elevated binding of NO by locally
trapped probe molecules. At the cellular level, however, the patterns of fluorescence and
NOS immunoreactivity should not be directly correlated, because the probe can be loaded
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into both NOS-positive and NOS-negative cells. For example, mitral cells in mouse OB
are NOS-negative, but their somata displayed strong fluorescence in the present
experiments. Probe trapped in mitral cells may be reporting NO that was synthesized in
the granule cell layer and subsequently diffused to the mitral cell layer. The basal NO
level was previously measured to be ~ 85 nM in the vicinity of mitral cell somata.16 One
potential caveat of this interpretation is that NO may be continuously generated by cells
during the loading period, and therefore some fraction of the sensor could bind NO
before entry into cells. FL2E-(NO) 2 could then reach and load cells beyond the normal
spatial signaling range of NO in living tissue. To block this effect, the competitive NOS
inhibitor N"-nitro-L-arginine was added and exogenous L-arginine was omitted during
loading. NO production was not completely suppressed, as indicated by persistent probe
fluorescence. The kinetics of post-loading fluorescence, however, should depend on
reception of NO signals by target cells because extracellular probe will be removed by
perfusion (Fig 4.7c), and thus post-loading fluorescence signal increases will accurately
report cellular patterns of NO synthesis and neurotransmission in the neural circuit.
It was expected that a fluorescent probe could provide spatial information about
the location of NO sources if extracellular NO were intercepted by an NO scavenger and
the probe did not localize subcellularly. Commonly used scavengers, including 2-phenyl-
4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO), its derivative carboxy-PTIO,
hemoglobin and myoglobin, were tested, but these were not compatible with the
fluorescent probe: PTIO is membrane permeant and competes with the probe for NO
binding, carboxy-PTIO reacts with NO to yield NO2, which reacts with the probe, and
both hemoglobin and myoglobin have strong optical absorption at the emission
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wavelengths of the probe. Initiatives for the synthesis of new scavengers that would be
compatible with the probe and enable localization of NO generating cells are important in
determining NO sources in the OB. The subcellular localization of Cu2(FL2E) hinders the
ability to get true spatial resolution, and progress towards non-localizable probes is
discussed in Ch. 5.
Summary
Optical recordings of steady state or stimulus-driven increases in fluorescence in
slices promise to yield novel insights into spatiotemporal properties and physiological
regulators of NO signaling in the central nervous system. Future improvements in probe
design to limit the fluorescence response to intracellular, rather than tonic tissue sources,
of NO should move the field toward functional imaging of neuronal signaling at the
chemical, in addition to the electrophysiological, level.
Given that Cu 2(FL2E) localizes subcellularly, it is of interest to obtain probes that
are maintained in the cytoplasm upon cellular uptake such that true spatial resolution can
be obtained. The next chapter explore the design and synthesis of such a cell-trappable
probe, FLDex, where the NO-reactivity fluorophore is appended to dextran, a high
molecular weight macromolecule that confers both cell-trappability and cytosolic
localization.
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Chapter 5.
Dextran-Based Cell-Trappable Fluorescent Probes for Nitric Oxide
Visualization in Living Cells
Reproduced in part with permission from Pluth, M. D., McQuade, L. E.; Lippard, S. J.
Org. Lett., 2010, 12, 2318-2321. Copyright 2010 American Chemical Society.
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Introduction
The selective detection of nitric oxide (NO) in living systems has attracted much
interest since the discovery that NO is the endothelium-derived relaxing factor (EDRF).1'2
Nitric oxide is an active signal-inducing molecule in the immune, cardiovascular, and
nervous systems, initiating cascades that promote smooth muscle dilation by activating
soluble guanylyl cyclase. 5 More recently, NO has been implicated in modulating
synaptic activity in the CNS, where it plays a role in signal transduction in the olfactory
6,7bulb. Numerous pathological conditions including carcinogenesis, septic shock,
inflammation, and neurodegradation have been associated with the misregulation of NO
production.8
To understand the many biological roles of NO, tools for its selective detection in
vivo are required. Strategies for monitoring NO have relied on a variety of techniques,
including the application of fluorescent probes.9~14 One of the best such probes is
CuFL 1,15,16 previously reported to detect endogenously produced nitric oxide in
mammalian and bacterial cells. 17-22 The Cu(II) fluorescein-based NO probe is formed in
situ by treating FLI with one equiv of CuCl2. When the non-emissive CuFLI reacts with
NO, Cu(II) is reduced to Cu(l) with attendant N-nitrosation of the secondary amine of the
ligand to produce the fluorescent species, FL 1-NO CuFL 1 is minimally cytotoxic, cell-
membrane permeable, and selective for NO over other biologically relevant reactive
oxygen and nitrogen species (RONS). One limitation of CuFL 1, however, is that it cannot
be trapped within a cell. Under conditions of continual media perfusion, the probe readily
diffuses out of cells after initial loading, rendering it ineffective for many biological
experiments.
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This chapter details the synthesis and photophysical characterization of two cell-
trappable fluorescent ligands and their Cu(I) complexes that react directly and
specifically with NO are presented. These probes are variants of the CuFL1 scaffold that
are cell-trappable by means of either ester functionalization or dextran conjugation.
Fluorescence microscopy of endogenously produced NO in macrophages is presented,
along with diffusion data that confirm the probes are cell-trappable.
Experimental Section
Synthetic Reagents. Ethyl[(8-amino-2-methylquinolin-6-yloxy)acetate]2 and 7'-
chloro-4'-fluorescein carboxaldehyde24 ,25 were prepared by previously reported
procedures. N-hydroxysuccinamide (NHS, Aldrich), N-(3-Dimethylaminopropyl)-N'-
ethylcarbodiimide hydrochloride (EDC-HC, Aldrich), methoxyacetic acid (Aldrich),
ethanol (Mallinckrodt), sodium borohydride (Sigma), sodium hydroxide (Mallinckrodt),
and all deuterated solvents (Cambridge Isotope Laboratories) were used as received. The
primary amine content of aminodextran (10 kDa, 2.6 primary amine / dextran, Molecular
Probes) was confirmed by ninhydrin assay prior to use.
Synthetic Materials and Methods. Silica gel (SiliaFlash F60, Silicycle, 230-400
mesh) was used for column chromatography. Thin-layer chromatography (TLC) was
performed on J. T. Baker lB-F silica gel plates and viewed by either UV illumination or
ninhydrin staining. All NMR spectra were obtained on Varian 300 MHz, Bruker 400
MHz, or Varian 500 MHz spectrometers at the indicated frequency. Chemical shifts are
reported in parts per million (8) and are referenced to residual protic solvent resonances.
The following abbreviations are used in describing NMR couplings: (s) singlet, (d)
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doublet, (t) triplet, (q) quartet, (m) multiplet. High-resolution mass spectra were
measured by the staff at the MIT Department of Chemistry Instrumentation Facility
(DCIF). Concentrations of nitric oxide in solution were measured with a Warner
Instruments inNO-T nitric oxide measuring system equipped with a calibrated amiNO-
700 probe.
2-(2-Chloro-5-(((6-(2-ethoxy-2-oxoethoxy)-2-methylquinolin-8-yl)amino)methyl)-6-
hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid (1, FL1E). 7'-Chloro-4'-
fluoresceincarboxaldehyde (103 mg, 260 pmol) and ethyl[(2-methyl-8-aminoquinolin-6-
yloxy)acetate] (76.9 mg, 295 ptmol) were suspended in ethanol (10 mL) and stirred at
room temperature for 1 h. The dark red suspension was cooled to 0 *C and sodium
borohydride (50.3 mg, 1.33 mmol) was added. The reaction mixture clarified to form a
dark red solution and was stirred for 1 h as it warmed to room temperature. The product
was purified by column chromatography on silica (gradient from 100% CH2C12 to 9:1
CH2Cl2:CH30H) to afford a dark red solid (54.3 mg, 33%). TLC Rf = 0.80 (silica, 9:1
CH2Cl2:CH30H); mp: 141 - 143 *C (dec); 'H NMR (DMSO-d, 300 MHz): 8 1.20 (3H, t,
J= 7.2 Hz), 2.57 (3H, s), 4.17 (2H, q, J= 7.2 Hz), 4.69 (2H, d, J= 6.3 Hz), 4.80 (2H, s),
6.39 (1H, d, J= 2.4 Hz), 6.50 (lH, d, J= 8.7 Hz), 6.56 - 6.70 (3H, m), 6.80 (1H, t, J=
6.6 Hz), 7.09 (1H, s), 7.29 (1H, d, J= 8.4 Hz), 7.31 (1H, d, J= 7.5 Hz), 7.69 - 7.81 (2H,
m), 7.94 (1H, d, J= 8.1 Hz), 8.00 (1H, d, J= 7.5 Hz), 10.59 (1H, broad s), 11.11 (1H,
broad s); 13C{H} NMR (DMSO-d 6, 125 MHz): 6 14.08, 24.58, 35.45, 60.65, 64.65,
82.57, 93.19, 96.56, 103.99, 109.61, 110.84, 112.30, 116.17, 122.82, 124.09, 124.93,
126.10, 127.10, 127.50, 128.08, 130.37, 134.00, 135.34, 135.76, 144.77, 150.24, 150.38,
151.76, 153.12, 155.14, 156.58, 157.69, 168.46, 169.07; HRMS (m/z): [M - H]- caled
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637.1383, found 637.1371; FTIR (KBr, cm-): 3435 (br, s), 2987 (m), 2917 (m), 1751 (sh,
w), 1652 (m), 1522 (w), 1437 (in), 1409 (m), 1385 (w), 1316 (w), 1261 (w), 1028 (s), 954
(in), 707 (w), 674 (vw), 613 (vw). Anal. Calcd for C35H27ClN20 8-H20: C, 63.98; H, 4.45;
N: 4.26; Found: C, 63.86; H, 4.55; N, 3.81.
2-(5-(((6-(Carboxymethoxy)-2-methylquinolin-8-yl)amino)methyl)-2-chloro-6-
hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid (2, FL1A). FLIE (162 mg, 253 pmol)
was dissolved in aqueous sodium hydroxide (0.5 N, 12 mL, 6.0 mmol) and methanol (4
mL) and heated to 90 *C for 19 h. The solution was cooled to room temperature and the
solution was acidified with concentrated hydrochloric acid until an orange precipitate
formed. The solid was filtered, washed with water, and dried to yield the product (155
mg, 91%). TLC Rf = 0.22 (silica, 9:1 CH2Cl2:CH 30H); mp: 177 - 179 *C (dec); 1H NMR
(DMSO-d6 , 300 MHz): 6 2.83 (3H, s), 4.61 (2H, broad m), 4.80 (2H, s) 6.41 (1H, d, J =
2.4 Hz) 6.52 (1H, d, J= 8.7 Hz), 6.68 - 6.54 (3H, in), 7.03 (1H, s), 7.27 (1H, d, J= 8.4
Hz), 7.31 (1H, d, J= 7.5 Hz), 7.69 - 7.81 (2H, m), 7.99 (1H, d, J= 7.5 Hz), 8.61 (1H, d,
J = 7.5 Hz), 10.63 (1H, broad s), 11.08 (1H, broad s); 13C{'H} NMR (DMSO-d, 125
MHz): 6 25.1, 37.1, 66.0, 84.0, 94.9, 99.4, 105.6, 111.1, 112.3, 113.4, 113.7, 117.6,
124.4, 125.5, 126.4, 127.7, 129.1, 129.5, 131.9, 137.3, 145.3, 151.8, 151.9, 153.3, 154.6,
156.6, 158.6, 159.3, 169.9, 171.6; HRMS (m/z): [M - H] calcd 609.1070, found
609.1068; FTIR (KBr, cm'): 3428 (br, s), 3138 (br, s), 3048 (br, s), 2961(w), 2922 (w),
2851 (w), 1759 (m), 1603 (s), 1579 (s), 1515 (w), 1449 (m), 1427 (m), 1370 (w), 1285
(m), 1262 (m), 1220 (w), 1161 (m), 1089 (w), 1067 (w), 1035 (w), 1014 (vw), 874 (vw),
832 (w), 802 (w), 760 (w), 702 (w), 623 (vw), 599 (vw), 552 (vw).
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FLDex (3). FLDex was prepared by M. D. Pluth. Aminodextran (20 mg, 2.0 Rmol, 5.2
[tmol primary amine) was dissolved in 1 mL of water in a 6 mL vial. In a separate vial,
NHS (1.6 mg, 14 gmol) and EDC-HCI (3.4 mg, 17 gmol) were combined in 200 pL of
water and stirred for 5 min, after which FLIA (6.3 mg, 10.4 pmol), dissolved in 2 mL
DMF, was added. The resulting solution was protected from light, stirred for 10 min at
room temperature and then added to the aminodextran to afford a homogenous solution.
After stirring for 3 h at room temperature, any unreacted primary amines were capped
with methoxybenzoic acid by adding a solution of NHS (14.8 mg, 129 pmol), EDC-HCl
(24.3 mg, 128 pmol) and methoxy acetic acid (10 pL, 130 pmol) in 200 pL H20. The
resulting solution was protected from light and stirred for 2 h at room temperature, after
which it was poured into a mixture of 30 mL EtOH and 10 mL acetone. Centrifugation at
3000 rpm, 4 *C for 30 min provided a bright orange solid. The supernatant, containing
excess ligand as confirmed by TLC, was decanted and the orange solid was taken up in 3
mL of water and dialyzed with 1000 MW cutoff dialysis tubing against Millipore water
for 18 h at 4 'C protected from light. The orange solution was collected and lyophilized
to yield an orange powder (16 mg, 65%) that showed no residual FLIA by TLC (9:1
CH2Cl2:CH30H). mp: 204 - 206 *C (dec). FTIR (KBr, cm 1): 3427 (br, s), 2922 (m),
1635 (m), 1522 (w), 1429 (w), 1353 (w), 1261 (w), 1150 (sh, m), 1021 (s), 911 (w), 760
(w), 706 (w), 668 (vw), 549 (vw), 525 (vw).
Spectroscopic Materials and Methods. Piperazine-N,N'-bis(2-ethanesulfonic acid)
(PIPES, Calbiochem) and potassium chloride (99.999%, Aldrich) were used to make
buffered solutions (50 mM PIPES, 100 mM KCl, pH 7.0) with Millipore water. Nitric
oxide was purchased from Airgas and purified as previously described.2 6 Nitrogen
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dioxide (NO2) was purchased from Aldrich and purified by condensation into a gas bulb
at -78 *C followed by removal of higher-boiling impurities under vacuum. S-Nitroso-N-
acetyl-DL-penicillamine (SNAP, Cayman Chemical), potassium nitrate (Aldrich), sodium
nitrite (Aldrich), sodium peroxynitrite (Cayman Chemical), Angeli's salt (Na2N2O3,
Cayman Chemical), hydrogen peroxide (Mallinckrodt Chemicals), and sodium
hypochlorite (J. T. Baker) were prepared as aqueous stock solutions in Millipore water.
Nitric oxide and other reactive oxygen and nitrogen species (RONS) were introduced into
buffered solutions via gas-tight syringes. Copper(II) chloride dihydrate (99+ %, Alfa
Aesar) was used to prepare 10 mM and 1 mM CuCl2 stock solutions with Millipore
water. Stock solutions of FLIA and FLIE, dissolved in DMSO, and FLD*X, prepared in
water, were assembled in Millipore water and stored in aliquots at -80 *C. UV-visible
spectra were acquired on a Cary 50-Bio spectrometer using PMMA cuvettes from
Perfector Science (3.5 mL volume, 1 cm path length). Acquisitions were made at 25.00 ±
0.05 *C. Fluorescence spectra were obtained on a Quanta Master 4 L-format scanning
spectrofluorimeter (Photon Technology International) at 37.0 ± 0.1 *C using 1 p.M Cu(L)
(L = FLIE or FLIA) generated in situ by combining stock solutions of CuCl2 and L in a
1:1 ratio (or 1.7:1 for FLDex), and then introducing either 1.3 mM NO or 100 pM RONS.
Fluorescence measurements were made under anaerobic conditions, with cuvette
solutions prepared in an inert atmosphere glove box. Replicate fluorescence
measurements were taken at time points between 40 s and 60 min. All fluorescence
experiments were repeated at least in triplicate.
Typical procedure for NO release measurements using SNAP: A 100 pL aliquot
of SNAP (4.5 mM) was frozen in liquid nitrogen and thawed immediately prior to use. A
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plastic vial containing 5.0 mL PIPES buffer (50 mM PIPES, 100 mM KCI, pH 7) was
sealed with a screw cap containing three holes for a nitrogen purge, the NO electrode,
and a syringe. The NO electrode was immersed in the solution and the vial was purged
with nitrogen, at which point a freshly thawed 100 pL aliquot of SNAP was added by
syringe. After waiting for 100 sec, 50 gL of a 1 [tM solution of FLIE, CuFLIE, or CuC12
in PIPES buffer was added.
Cell Culture and Imaging Materials and Methods. Raw 264.7 murine macrophages
were obtained from ATCC and cultured in Dulbecco's Modified Eagle Medium (DMEM,
Cellgro, MediaTek, Inc.) supplemented with 10% fetal bovine serum (FBS, HyClone),
1% sodium pyruvate (Cellgro, MediaTek, Inc.), and 1% MEM non-essential amino acids
(Sigma). For imaging studies, cells were plated into poly-D-lysine coated plates
(MatTek) containing 2 mL of complete DMEM, and incubated at 37 *C under 5% CO 2 .
For all cell studies, the fluorescent probes were generated in situ by combining stock
solutions of CuCl 2 and FLIE (1:1), FLIA (1:1), or FLDex (1.7:1) based on the
stoichiometry determined by Cu(II) titrations of the compounds.
For nitric oxide detection studies, iNOS was induced in Raw 264.7 macrophages
with 1.25 gg/mL of lipopolysaccharide (LPS, Sigma) and 625 - 6250 U/mL of
interferon-y (IFN-y, BD Biosciences), and the cells were then co-incubated with either 4
gM CuFLIE or 4 gM FLD*x and 4.5 ptM Hoechst 33258 (Sigma). For iNOS inhibition
studies, the same conditions were used but with 10 pM L-NNA (NG-nitro-L-arginine).
Prior to imaging, cells were washed three times with 1 mL of phosphate buffered saline
(PBS, Cellgro, MediaTek, Inc.) and then bathed in 2 mL of PBS during imaging.
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For diffusion studies, Raw 264.7 macrophages were pre-incubated with 1.25
pg/mL of LPS, 625 - 6250 U/mL of IFN-y and 4 pM CuFLI, 4 pM CuFLIE, or 4 pM
CuFLDex for 14 h. The cells were washed three times with 1 mL of PBS prior to imaging
and then bathed in 2 mL of PBS during imaging. To mimic media flow, the PBS was
removed, and the cells were washed three times with 2 mL of fresh PBS and then bathed
in 2 mL of fresh PBS while on the microscope. This process was repeated every 10 min
during imaging. For CuFLIA controls, Raw 264.7 macrophages were pre-incubated with
500 ng/mL of LPS, 250 - 2500 U/mL of IFN-y and 2 pM CuFLIA for 14 h. The cells
were washed three times with 1 mL of PBS prior to imaging and then bathed in 2 mL of
PBS during imaging.
For subcellular localization studies of FLIE and FLDex, Raw 264.7 macrophages
were incubated with 1.25 pg/mL LPS, 625 - 6250 U/mL IFN-y, 4 pM of CuFLIE or
CuFLDex, and 4.5 jM Hoechst 33258 for 14 h. At this point, the cells were incubated with
50 nM Mitotracker Red for 30 min after which the cells were washed three times with 1
mL PBS and then bathed in 2 mL PBS during imaging.
Images were acquired on a Zeiss Axiovert 200M inverted epifluorescence
microscope equipped with an EM-CCD digital camera (Hamamatsu) and a MS200 XY
Piezo Z stage (Applied Scientific Instruments), illuminated by an X-Cite 120 metal-
halide lamp (EXFO). Plates were maintained on the microscope stage in an INC-2000
incubator kept at 37 *C with 5% CO2. Differential interference contrast (DIC) and red,
blue, and green fluorescent images were obtained using an oil immersion 63x objective
lens, with 5.00 or 10.00 s exposure times for green fluorescent images. The microscope
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was operated with Volocity software (Improvision). All fluorescent images were
corrected for background.
Results and Discussion
Design Considerations. The probes are based on the FL 1 scaffold, because of its
proven ability to detect endogenously-produced NO in a direct and selective manner. To
impart cell-trappability to FL, two strategies were employed: esterification and dextran
conjugation. The first strategy involved incorporating an ester moiety on the quinoline
ring, resulting in the ligand FL 1 E. The esterified version of this probe is cell-membrane
permeable until cytosolic esterases cleave the ester to yield a carboxylic acid, FL1A,
which is negatively charged at physiological pH and unable to cross the cell
membrane.27 28 An acetoxyethyl ester was employed because the carboxylic acid product
of its hydrolysis is not rapidly effluxed by the cell unlike the commonly used fluorescein
acetate esters, which yield the basic fluorescein scaffold upon hydrolysis and are
subsequently are removed from the intracellular environment more rapidly.29
The second strategy employed was to append the FL1 probe to a macromolecule,
specifically aminodextran, which because of its high molecular weight can gain entry to
cells by endocytotic pathways, however, is unable to diffuse out of cells once inside.30
Dextrans are hydrophilic polysaccharides with low toxicity and low reactivity that are
used as carriers for fluorescent probes.3 134 Their a-1,6-polyglucose linkages cannot be
cleaved by most intracellular glycosidases, rendering dextran conjugates stable in cells.
Additionally, dextrans are large enough to prevent intracellular localization of the probe,
a feature observed for other fluorescein-based probes.3 s,36 FLIA was appended to amino
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dextran using the acid linker on the quinoline ring for ease of coupling as well as minimal
perturbation of the photophysical properties of the fluorophore.
Synthesis. The syntheses of FLlE, FL1A, and FLDex are outlined in Scheme 5.1. The
Schiff base formed by condensation of ethyl[(2-methyl-8-aminoquinolin-6-
yloxy)acetate], 1,2 with 7'-chloro-4'-fluoresceincarboxaldehyde, 2,24,2 in ethanol was
reduced with NaBH4 to afford FL1E. Subsequent hydrolysis under basic conditions
yielded the corresponding acid, FLIA. The dextran conjugate, FL e*, was prepared by in
situ formation of the NHS-ester of FL1A followed by EDC coupling to 10 kDa
aminodextran (2.6 amine/dextran). Optimization of the amide coupling efficiency as well
as the fluorescence turn-on with NO of the product conjugate revealed that two equiv of
FLiA per primary amine of the dextran provides optimal coupling. Although the
coupling was mainly complete, capping excess primary amines with 2-methoxyacetic
acid resulted in an enhanced fluorescence turn-on with NO by comparison to the
uncapped version. The final conjugate FLDex was purified by dialysis.
0,,0 0
HO 0 NH2
O C HN HN
O OCO2H HO O 0 1) EDC.HCI, NHS, H20 HO O 0
N Cl-2) DMF, RT, 3 h C1C 2) XS 0
NH2  1) EtOH, RT, 1 h C02H HO)YOMe C02H
2) NaBH4, 00C, 1 h EDC-HCI, NHS, RT, 2 h
R =Et, FL1E, 1 FLD*x, 3
R = H, FL1A, 2
Scheme 5.1. Syntheses of FL1E, FLIA, and FLD*X
Spectroscopic Properties of FLIE, FLIA and FLDex. The photophysical properties of
FL1E and FLIA are similar to those of FL1, as shown in Table 5.1. The absorption
spectra exhibit maxima at 506 nm (E = 2.08 ± 0.05 x 104 M~1cm-') and 504 nm (F = 6.00 ±
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0.07 x 104 M'cm'), for FLIE and FLIA, respectively. FLDex exhibits an absorbance
maximum at 507 nm. No extinction coefficient measured for FLDex because the exact
concentration of the fluorophore in the macromolecule cannot be determined. Titrations
of buffered solutions of the various ligands with CuCl2 revealed that both FLIE and
FLIA form 1:1 Cu(II):ligand complexes, with concomitant hypsochromic shifts of the
absorbance maxima to 500 nm (F = 0.77 ± 0.01 x 104 M- cm-) and 499 nm (E = 1.94 ±
0.08 x 104 M-1cm'), respectively, attributed to the disruption of the fluorescein
xanthenone ring conjugation when the phenolic oxygen atom binds Cu(II). FLDex binds
1.7 equiv of Cu(II) per FLIA unit, probably due to non-specific Cu(II)-binding to the
dextran backbone, and this binding induces a minor blue-shift to 505 nm.
Table 5.1. Photophysical properties of FL1, FLIE, and FLIA.
Absorbance Emission
X (nm), e x 104 (MACm-) k (nm), < (%)'
unbound Cu(II) unbound Cu(II) + NOd DRe ref
FLla 504, 4.2(1) 499,4.0(1) 520, 7.7(2) 520, nr' 526, 58(2) 16(1) 15, 16
FL1E 506, 2.08(5) 500, 0.77(1) 520, 2.6(1) 520, 3.4(1) 526, 22 (1)9 5.4(3) this work
FLIA 504, 6.00(7) 499, 1.94(8) 521, 2.4(1) 520, 2.8(2) 527, 37(2)_ 11.3(1) this work
a Measurements were performed in 50 mM PIPES, 100 mM KC at pH 7.0. ' Referenced
to fluorescein ($= 0.95 in 0.1 N NaOH). ' One equiv. of CuCl2 was added. d1300 equiv.
of NO, 60 min, 37 "C. ' DR is the dynamic range, INO/b. o nr is not reported. g Generated
in situ.
NO reactivity of the Copper-Ligand Complexes. The free ligands emit with emission
maxima at 520, 521 and 524 nm for FLIE, FLIA and FLDex, respectively. The quantum
yields of FLIE and FLIA are 2.6 ± 0.1% and 2.4 ± 0.1%, respectively, which increase
slightly upon Cu(II) addition. Using the copper stoichiometry determined by titration,
exposure of buffered solutions of the probes generated in situ to excess NO under
anaerobic conditions led to an immediate fluorescence enhancement with a concomitant
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bathochromic shift of the emission maxima (Fig. 5.1 and Table 5.1). These results are
consistent with formation of the N-nitrosoamine products. 15"16 Also consistent with N-
nitrosation are the increased quantum yields of the final solutions after complete reaction
with NO, 22 ± 1% and 37 ± 2% for FLIE and FLIA, respectively (Table 5.1). The
relative fluorescence enhancement of CuFLIA when exposed to excess NO was 11.3 L
0.1 fold, which is similar to that of CuFLI (16 ± 1). Although the fluorescence
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Figure 5.1. Normalized fluorescence response of a) CuFL1E, b) CuFlA, and c) CuFLD" in
the presence of excess NO over 1 h in 50 mM PIPES, 100 mM KC1, pH 7.0, T = 37 *C.
Insets: Plots of integrated fluorescence vs. time, normalized and adjusted for the basal
fluorescence of the sensor in the absence of NO.
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enhancement of CuFLIE (5.4 4 0.3) is somewhat diminished by comparison to that of
CuFL1A, it is sufficient to be visualized by fluorescence spectroscopy, and because
CuFL1E is not the biologically relevant sensing species it is not a liability that it is less
bright than CuFLIA. CuFLDex exhibited an intermediate 6.9 ± 0.8 fold fluorescence
enhancement, possibly due to self-quenching by adjacent fluorophores on the dextran
backbone. Treatment of any of the probes with NO under anaerobic conditions in the
absence of Cu(II) did not result in fluorescence turn-on.
Probe Selectivity. The reactions of CuFL1E, CuFL1A, and CuFLDex with NO are not
limited to the molecule in its gaseous state, but also occur when anaerobic buffered probe
solutions are exposed to NO donors such as S-nitroso-N-acetyl-DL-penicillamine
(SNAP). Because SNAP produces NO upon reaction with metals such as Cu(II), the
reaction of SNAP with CuFL1E was monitored by an NO-detecting electrode to
determine if the probe caused increase NO production by the S-nitrosothiol. Addition of
FL1E alone did not increase the rate of NO release from SNAP appreciably (Fig. 5.2a).
Addition of CuFLiE did, however, increase the rate of NO release from SNAP (Fig.
5.2b), but not to the level of release induced by CuCl2 (Fig. 5.2c).
500 500- 500
a b c
400 + SNAP 400- 400-
+ SNAP
300 300 - 300 + SNAP
+ FL1E S+ CuFL1E S 2
200 0 200- O 200
100* 100- * 100
0 0 00 50 100 150 200 250 300 0 50 100 150 200 250 30C 0 50 100 150 200 250 300
Time (s) Time (s) Time (s)
Figure 5.2. Influence of a) FL1E, b) CuFLIE, and c) CuCl2 on the release of NO from
S-nitroso-N-acetyl-DL-penicillamine (SNAP) in 50 mM PIPES, 100 mM KCl, pH 7.0,
room temperature, 90 M SNAP, 1 1AM FL 1 E, CuFL 1 E, or CuCl 2).
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Table 5.2. Selectivity of CuFL 1 E, CuFL 1 A and CuFLDex for NO over other RONS
after 1h.
Fluorescence Enhancement (F/Fo)
RONS CuFLla CuFLIA CuFLIE CuFL ex
NO2 1.2(2) 1.52(5) 1.41(5) 1.99(2)
N0 3~ 1.2(2) 1.5(1) 1.49(1) 2.2(1)
CIO 1.9(1) 1.7(4) 1.54(5) 2.3(1)
H20 2  1.2(2) 4(2) 2.4(4) 3.5(2)
ONOO~ 2.6(3) 2.1(5) 2(1) 2.3(6)
HNOb 1.4(2) 1.7(1) 1.7(1) 2.3(2)
NO 2  nr 5.3(8) 1.8(2) 2.5(1)
SNAP nr 10.2(4) 4.7(4) 7.8(3)
NO 16(1) 9.6(4) 4.6(3) 7.0(6)
a Measurements were performed in 50 mM PIPES, 100 mM KC1 at pH 7.0, 37 *C, 60 min,
100 equiv. RONS. b HNO is generated from Angeli's salt, Na 2N20 3.
One advantage of using the CuFL1 scaffold is that the reaction of the ligand
aniline nitrogen atom with NO is selective and does not occur with other biologically
relevant reactive oxygen and nitrogen species such NO2, NO3-, CIO-, H20 2, ONOO-,
and HNO (Fig. 5.3 and Table 5.2). There is some reactivity of CuFLIA with NO 2, a
higher nitrogen oxide that probably reacts with free ligand in solution.
12-
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CuFL"
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Figure 5.3. Selectivity of 1 [tM CuFLIE, 1 FtM CuFLIA and I [tM CuFLDex for NO
over other RONS (167 jAM). Normalized fluorescence response after 1 h relative to the
emission of the probe in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 37 *C.
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pH Dependence. Because FLDex enters cells through endocytosis, it was essential to
confirm that the FLIA platform would bind Cu(II) at a pH similar to that encountered in
the endosomes.37,38 To confirm that the CuFLDex is stable under these conditions and that
copper would not dissociate at the low pH of the endosome, FL1A and CuFLIA were
used as a model and their UV-vis (Fig. 5.4a) and fluorescence spectra (Fig. 5.4b) were
monitored as a function of pH. A fit of the absorbance data for FL1A revealed an
effective pKa of 5.65. For FLIA, as the pH decreased, the fluorescence maxima blue-
shifted; however, for CuFLIA, no shift in maxima was observed from pH 6.5 - 4.0,
indicating stability of the copper complex at the acidic pH most likely encountered in the
endosome (Fig. 5.4c).
0.0 - 1.0 -
a b 0% L*.CuFLlA'
-0.1 -- 0.8 -
* .2N
-0520 SE0.6
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Figure 5.4. a) Absorbance, b) fluorescence emission, and c) x~ (emission) dependence
on pH for 5 M FLiA and 5 4M CuFLA in 10mM KOH, 100 mM KCl, pH 12, T =
25 *C. pH adjusted with 6 N, 1 N and 0.1 N HCl and 0.1 N KOH.
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Effect of Zn(II) on Fluorescence Enhancement. Zinc ions are ubiquitous in biology,
and fall into two categories: protein-bound and "loosely" bound, otherwise known as
"mobile" Zn(II). 39 Zn(II) can be released from storage proteins such as metallothionein
by nitrosation of the Zn(II)-binding cysteines in the protein to result in a local increase
Zn(II) concentration.40 Because of the similarity of the FLI scaffold to known Zn(II)
probes, 4 1 it was a concern whether CuFLIA was susceptible to fluorescence turn-on by
Zn(II)-mediated displacement of Cu(II) after NO-mediated release of Zn(II) in cells. In
order to evaluate this possibility, CuFLlA was generated in situ and varying amounts of
ZnCl2 were added. Upon addition of up to 1000 equiv. of ZnCl 2 to CuFLIA, only a 2.5-
fold fluorescence enhancement was observed, indicating that Zn(II) is incapable of
displacing Cu(II) from the metal-binding pocket of the probe, and therefore incapable
eliciting a fluorescence response (Fig. 5.5).
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Figure 5.5. Selectivity of 5 [M CuFLlA for NO over ZnCl2. Normalized fluorescence
response after 1 h relative to the emission of the sensor in 50 mM PIPES, 100 mM KCl,
pH 7.0, T = 37*C.
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Fluorescence Microscopic Imaging of Biologically Derived NO Production. In
order to evaluate the efficacy of CuFLIE and CuFLDex in live cells, Raw 264.7 murine
macrophages were employed because they produce NO from iNOS when induced in
response to external activators.4 2 In these cells, NO production is stimulated by addition
of endotoxins, such as lipopolysaccharide (LPS), and cytokines, such as interferon-y
(INF-y). Raw 264.7 macrophages that were incubated with either CuFLIE or CuFLD*, for
14 h without LPS or INF-y did not exhibit increased fluorescence (Fig. 5.6a). Cells that
were incubated with either of the probes along with LPS and INF-y displayed an increase
in fluorescence (Fig. 5.6b), whereas cells treated with L-NG-nitroarginine (L-NNA), an
iNOS inhibitor (Ki = 4.4 jiM for murine macrophages), 43 as well as LPS and INF-y
incubation showed little fluorescence enhancement (Fig 5.6c). These experiments
confirm that CuFL1E and CuFLDex can detect NO produced in vivo.
Figure 5.6. Visualization of NO produced endogenously in Raw 264.7 cells using
CuFL1E (left) and CuFLD*, (right) after stimulation with LPS and INF-y for 14 h. Top:
DIC images, Bottom: fluorescence. a) Probe only, b) Probe, LPS, INF-y, and L-NNA
(iNOS inhibitor), and c) Probe, LPS, and INF-y. [Probe] = 4 pM, [LPS] = (1.25 pg/mL),
[INF-y] = (625 - 6250 U/mL), [L-NNA] = 10 gM. Scale bars = 25 pm.
Cell-Trappability of CuFLIE and CuFL De. Because CuFLI does not contain a
trappable element, it readily diffuses in and out of cells. To demonstrate this feature, Raw
264.7 macrophage were stimulated with LPS and IFN-y and then incubated with CuFL1
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Figure 5.7. CuFLi diffusion in Raw 264.7 cells. Top, DIC images; bottom, green
fluorescence. After each image, the cells were washed three times with 2 mL PBS.
[CuFL5] = 4 pM, [LPS] = 1.25 ptg/mL, [INF-y]= 625 - 6250 U/mL. Scale bars = 25 pm.
for 14 h. Fig 5.7 illustrates that over the course of 30 min of mimicked media flow, the
fluorescence decreases to a baseline level. In order to test the cell-trappability of CuFL lE
and CuFLDex, Raw 264.7 macrophages were stimulated with LPS and IFN-y and then
incubated with the probes for 14 h. The cells were washed and imaged in the microscope
incubator under mimicked media flow, and unlike CuFL1, minimal changes in
fluorescence intensity were observed over the course of 30 min for both CuFLIE and
CuFLDex, confirming cell-trappability in contrast to the parent FL 1 scaffold (Fig. 5.8). As
a control, Raw 264.7 macrophages were incubated with CuFLlA for 14 h under NO-
producing conditions. After washing and imaging the cells, no fluorescence was
observed, indicating the acid form of the probe is not cell permeable (Fig. 5.9).
Figure 5.8. CuFLlE (left) and CuFLDex (right) diffusion in Raw 264.7 cells. Top, DIC
images; bottom, green fluorescence. After each image, the cells were washed three times
with 2 mL PBS. [CuFLIE] = 4 pM, [FLDex] = 4 pM, [CuCl2 for FLDex] = 6.8 gM [LPS]
= 1.25 pg/mL, [INF-y] = 625 - 6250 U/mL. Scale bars = 25 pm.
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Figure 5.9. Raw 264.7 cells treated with CuFLiA, LPS, and INF-y. [CuFLiA] = 2 gM,
[LPS] = 500 ng/mL, [INF-y] = 250 - 2500 U/mL. Scale bars = 25 pm.
Probe Localization in SK-N-SH Cells. Some fluorescein-based probes subcellularly
localize to organelles such as the mitochondria or Golgi apparatus.3 ' 36 Dextran-appended
probes, however, should not localize significantly because the high molecular weight
macromolecule cannot easily enter sub-cellular compartments. To determine the
localization of the cell-trappable probes, Raw 264.7 macrophages were stimulated with
LPS and IFN-y and then co-incubated with either CuFL1E or CuFL ", the nuclear stain
Hoechst 33258 and the mitochondrial stain Mitotracker Red. The results for CuFLIE are
depicted in Figure 5.10. The probe did not enter the nucleus (Fig. 5.10b) because the
Figure 5.10. Localization studies of CuFLlE in Raw 264.7 cells. a) DIC image, b) blue
channel showing Hoechst dye, c) green channel, d) red channel showing Mitotracker dye,
e) overlay image of the blue, green, and red channels, f) blue-red correlation, g) green-
blue correlation, and h) green-red correlation. [CuFLlA] = 4 gM, [LPS] = 1.25 pg/mL,
[INF-y] = 625 - 6250 U/mL, [Hoechst 33258] = 4.5 gM, [Mitotracker] = 50 nM. Scale
bars =25 gm.
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hydrolyzed acid product would be negatively charged at physiological pH, rendering it
incapable of crossing the nuclear membrane. Overlay of the green (Fig. 5.10c) and red
(Fig. 5.10d) detector channels showed a yellow color, indicating that CuFLI localizes to
the mitochondria (Fig. 5. 1Oe). Colocalization scatter plots of the blue vs. red (Fig. 5.10f),
blue vs. green (Fig 5.10g) and red vs. green channels (Fig 5.10h) are presented as an
alternate way to visualize the colocalization. When CuFL'e was imaged in the same
manner (Fig. 5.11), the probe still did not enter the nucleus (Fig. 5.11 b), but in contrast to
CuFLIE, the overlay of the green (Fig. 5.11c) and red (Fig. 5.11d) channels did not
indicate any substantial localization of the two channels as witnessed by a absence of
yellow (Fig. 5.11 e), as expected.
Figure 5.11. Localization studies of CuFLD*x in Raw 264.7 cells. a) DIC image, b) blue
channel showing Hoechst dye, c) green channel, d) red channel showing Mitotracker
dye, e) overlay image of the blue, green, and red channels, f) blue-red correlation, g)
green-blue correlation, and h) green-red correlation. [CuFLIA] = 4 pM, [LPS] = 1.25
pg/mL, [INF-y] = 625 - 6250 U/mL, [Hoechst 33258] = 4.5 pM, [Mitotracker] = 50 nM.
Scale bars = 25 pm.
Summary
Two new cell-trappable probes of the CuFLi family, CuFLIE and CuFLD", have
been prepared and spectroscopically characterized. Both probes maintain their selectivity
for NO over other biologically relevant RONS and Zn(II) cannot displace Cu(II) to elicit
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a fluorescent response. CuFLIE and CuFLD detect endogenously produced NO in live
Raw 264.7 cell cultures, and both are maintained within cells under simulated media
flow.
Drawing on the success of the design features of CuFL1E and Cu2(FL2E), new
cell-trappable probes for other biologically relevant signaling agents were envisioned.
Because of the similarity of the FL scaffold to known Zn(II)-selective probes (QZ1 and
QZ2),'" the ester/acid strategy was employed to impart trappability to QZ2. This work is
presented in the next chapter.
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Chapter 6.
Cell Trappable Quinoline-Derivatized Fluoresceins for Selective and Reversible
Biological Zn(II) Detection
144
Introduction
Zinc is a ubiquitous and crucial metal in biology, that is both tightly associated
with proteins, where it plays structural or catalytic roles,' and loosely bound in pools of
so-called "mobile zinc".2 The latter occur in abundance in certain regions of the body,
including the brain, particularly the hippocampus3 and olfactory bulb,4 and the pancreas,'
where release of Zn(II) plays important roles in physiological signaling processes. As for
any signaling molecule, maintaining homeostasis is critical to proper function, and zinc
levels are highly regulated by transporters 2,6,7 and zinc-binding proteins, such as
metallothionein.' 9 Misregulation of Zn(II) homeostasis has been associated with several
pathologies, including ischemia,'4 Alzheimer's disease,"' 12 and prostate cancer.13' 14
To understand the biological roles of mobile Zn(1I) it is essential to have tools for
its detection in vivo.15-19 Although many methods are available for cation sensing,
fluorescence detection by microscopy has proved to be an invaluable technique for non-
invasive imaging of mobile Zn(II). Fluorescent probes can be designed to be biologically
compatible, that is, water-soluble, cell-membrane permeable, non-toxic, and excitable at
low-energy wavelengths that do not induce interfering autofluorescence or cause harm to
the cell. Their photophysical properties can be tuned such that large differences in
luminescence between the metal-free and metal-bound states, either through changes in
intensity or wavelength, are observed. Sensor characteristics such as binding affinity can
be adjusted to match the physiological concentration of the analyte of interest, and in the
case of cation sensing, the chelating group can be chosen to impart selectivity to the
probe for a given metal ion.
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Figure 6.1. Select symmetrical, fluorescein-based Zn(II) probes.
Many Zn(II)-specific probes have been designed and utilized for both ex vivo and
in vivo imaging. Fig. 6.1 illustrates a selection of symmetrical, fluorescein-based probes
developed in the Lippard lab.20-29 Fluorescein is an ideal reporter because it is biologically
compatible, very bright in the on-state ( = 0.95 in 0. 1 N NaOH),30 and compatible with
most microscope setups. The pH dependence of fluorescein can be modified such that
proton-induced fluorescence enhancement of a probe is minimized at physiological
pH. 12 ' 1 3  Symmetrical sensors tend to have lower extinction coefficients than their
asymmetrical counterparts, thereby lowering the fluorescence emission in the metal-free
state and increasing the effective dynamic range. 2 1 23
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One of the symmetrical probes illustrated in Fig. 6.1, QZ2, 23 displays particularly
interesting sensing characteristics by comparison to the first generation Zinpyr (or ZP)
family of probes.20,21,26-29 ,33-37 For example, QZ2 has a much lower affinity for Zn(II) (Kdl
~ mid-micromolar) than ZP1 (Kdl ~ picomolar), and can therefore detect higher
concentrations of mobile Zn(II) reversibly and without probe saturation. It also has a
larger dynamic range (- 150-fold turn on) than any of the ZP-type probes, which is
beneficial for in vivo imaging, where poor signal-to-noise ratios can limit data
interpretation. One limitation of QZ2 is that it is not cell-trappable. Other similar
quinoline-derivatized fluorescein probes, such as the NO sensor CuFL 1,3,39 readily
diffuse out of cells after loading when a continual perfusion of media is applied. Because
media flow is a requirement for many biological imaging experiments, a cell-trappable
version of QZ2 would render it useful for more diverse sensing applications.
This chapter summarizes the synthesis, photophysical characterization, and live-
cell imaging of a new, cell-trappable ligand for Zn(II), QZ2E, which employs the
ester/acid strategy for cell-trappability outlined in Chapters 3 - 5. QZ2E elicits a dramatic
fluorescence enhancement in the presence of excess Zn(II) that is selective for the metal
over other biologically relevant alkali and alkaline earth metals, toxic heavy metals, and
most first row transition metals. The binding of Zn(II) by QZ2E is weak and ranges from
micromolar to millimolar, making it suitable to detect mobile Zn(II) at high physiological
concentrations.
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Experimental Section
Synthetic Materials and Methods. 4',5'-Fluoresceindicarboxaldehyde2 o and
ethylenediamine tetraacetate ethyl ester (EDTA-(Et) 4)' were prepared by previously
reported procedures. All other chemicals were used as received. Silica gel (SiliaFlash
F60, Silicycle, 230-400 mesh) was used for column chromatography. Thin-layer
chromatography (TLC) was performed on EMD Chemicals F254 silica gel-60 plates (1
mm thickness), and viewed by either UV light or ninhydrin staining. 'H and 3C{'H}
NMR spectra were obtained on either a Varian 300 MHz or 500 MHz spectrometer.
Chemical shifts are reported in parts per million (8) and are referenced to residual protic
solvent resonances. The following abbreviations are used in describing NMR couplings:
(s) singlet, (d) doublet, (dd) doublet of doublets, (t) triplet, (q) quartet, (m) multiplet.
High-resolution mass spectra were measured by the staff at the MIT Department of
Chemistry Instrumentation Facility (DCIF).
6-Hydroxy-8-nitroquinoline (1). 4-Amino-3-nitrophenol (5.00 g, 32.4 mmol) was
suspended at 95 0C in 37% hydrochloric acid (35 mL) and 85% phosphoric acid (15 mL).
Acrolein (2.4 mL, 36 mmol) was added dropwise and the reaction mixture was stirred
while heating for 4 h, during which time it changed color from yellow to orange to dark
red. The reaction mixture was cooled, filtered, and washed with water. Ammonium
hydroxide (28%, 50 mL) was added to the filtrate and the resulting red precipitate was
filtered and washed with water to yield pure product (1.11 g, 18%). TLC Rf = 0.68 (silica,
9:1 CH2Cl2:CH30H); mp: 162 - 163 *C (dec); 'H NMR (DMSO-d, 300 MHz) 6: 7.45
(lH, d, J = 2.7 Hz), 7.58 (1H, dd, J = 8.4 Hz, 4.2 Hz), 7.80 (1H, d, 2.7 Hz), 8.35 (1H, dd,
J = 8.4 Hz, 1.2 Hz), 8.78 (1H, dd, J = 4.2 Hz, 1.8 Hz); "C{'H} NMR (DMSO-d, 125
148
MHz) 8: 112.34, 115.45, 123.19, 129.82, 133.50, 134.76, 148.63, 149.34, 154.42; HRMS
(m/z): [M + H]* caled 191.0451, found 191.0450.
Ethyl[(8-aminoquinolin-6-yloxy)acetate] (2). To a solution of 6-hydroxy-8-
nitroquinoline (1, 234 mg, 1.23 mmol) in ethanol (10 mL) was added ethylbromoacetate
(400 [L, 3.6 mmol) and NN-diisopropylethylamine (650 pL, 3.7 mmol) and the reaction
was heated to reflux for 24 h. The reaction was then cooled and the solvent was removed.
The resultant crude product was taken up in fresh ethanol (25 mL) with 10% palladium
on carbon (203 mg) and purged with N2 for 15 min, after which an atmosphere of H2 was
applied and the reaction was stirred at room temperature for 16 h. The resulting solution
was then purged with N2, filtered, and the solvent was removed. The dark brown solid
was purified by column chromatography on silica using 3:1 hexanes:ethyl acetate as the
eluant to afford a pure, light brown solid (227 mg, 75%). TLC Rf = 0.20 (silica, 1:1
Hex:EtOAc); mp: 92 - 94 *C; 'H NMR (CD 2Cl2, 300 MHz) 6: 1.29 (3H, t, J = 7.2 Hz),
4.26 (2H, q, J = 7.2 Hz), 4.69 (2H, s), 5.08 (2H, broad s), 6.39 (1H, d, J = 2.7 Hz), 6.61
(1H, d, J = 2.4 Hz), 7.33 (1H, dd, J = 8.4, 4.2 Hz), 7.95 (1H, dd, J = 8.4 Hz, 1.5 Hz), 8.59
(1H, dd, J = 4.2 Hz, 1.5 Hz; 13C{'H} NMR (CD 2Cl2, 125 MHz) 8: 14.51, 61.84, 65.78,
95.62, 101.40, 122.51, 130.12, 135.34, 135.97, 145.97, 146.16, 157.58, 169.22; HRMS
(m/z): [M + H]* calcd 247.1077, found 247.1079.
2-(4,5-Bis((6-(2-ethoxy-2-oxoethoxy)quinolin-8-yl)amino)methyl)-6-hydroxy-3-oxo-
3H-xanthen-9-yl)benzoic acid (QZ2E, 3). 4',5'-Fluoresceindicarboxaldehyde (43.9 mg,
113 pmol) and ethyl[(8-aminoquinolin-6-yloxy)acetate] (2, 54.8 mg, 223 Pmol) were
suspended in methanol (5 mL) and stirred at room temperature for 1 h. The dark red
suspension was cooled to 0 C and sodium borohydride (21.5 mg, 568 smol) was added.
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The reaction clarified to a dark red solution and was stirred for 1 h as it warmed to room
temperature. The reaction solution was quenched with water (5 mL) and the methanol
was removed under reduced pressure. The aqueous phase was extracted with 5 x 10 mL
of dichloromethane and the combined extracts were dried over MgSO 4, filtered and the
solvent was removed. The resulting residue was purified by column chromatography on
silica (gradient from 99:1 CH2Cl2:CH 30H to 19:1 CH2Cl2:CH 30H) to afford a dark red
solid (25.6 mg, 27%). TLC Rf = 0.67 (silica,); mp: 148 - 149 "C; 1H NMR (DMSO-d6 ,
500 MHz) 8: 1.19 (6H, t, J = 4.2 Hz), 4.16 (4H, q, J = 8.4 Hz, 4.2 Hz), 4.75 (4H, s), 4.79
(4H, d, J= 3.6 Hz), 6.40 (2H, d, J= 1.5 Hz), 6.53 (2H, d, J= 5.4 Hz), 6.66 (2H, d, J= 1.5
Hz), 6.71 (2H, d, J = 5.4 Hz), 6.77 (2H, t, J = 3.3 Hz), 7.34 (1H, d, J = 4.5 Hz), 7.37 (2H,
dd, J = 4.8 Hz, 2.4 Hz, 7.74 (2H, dt, J = 12 Hz, 4.2 Hz;), 7.98 (1H, d, J = 4.5 Hz), 8.02
(2H, d, J = 4.8 Hz), 8.48 (2H, d, J = 2.4 Hz); '3C{'H} NMR (DMSO-d, 125 MHz) 6:
13.98, 14.13, 60.62, 64.61, 77.13, 83.42, 93.18, 93.38, 96.26, 96.43, 109.90, 111.96,
122.14, 124.66, 126.31, 127.05, 127.73, 129.13, 130.14, 134.65, 134.87, 145.28, 150.49,
152.08, 157.19, 157.56, 168.55, 168.61; HRMS (m/z): [M + Na]* calcd, 871.2586, found
871.2570.
Spectroscopic Materials and Methods. Piperazine-N,N'-bis(2-ethanesulfonic acid)
(PIPES) was purchased from Calbiochem. Potassium chloride (99.999%) was purchased
from Aldrich. Buffer solutions (50 mM PIPES, 100 mM KCl, pH 7) were prepared in
Millipore water, chelexed, filtered, and used for all spectroscopic studies. Zinc chloride
(Aldrich, 99.999%) stock solutions of 1 M, 100 mM, 10 mM, and 1 mM were prepared in
Millipore water. Stock solutions of 1 mM ligands were prepared in DMSO and stored in
aliquots at -80 *C. Stock solutions of 40 mM ethylenediamine tetraacetate (EDTA) and
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40 mM NN,N',N'-tetrakis(2-pyridylmethyl)-ethylenediamine (TPEN) were prepared in
DMSO, aliquotted, and stored at -20 'C. UV-visible spectra were acquired on a Cary 50-
Bio spectrometer using spectrosil quartz cuvettes from Starna cells Inc. (3.5 mL volume,
1 cm path length). Acquisitions were made at 25.00 ± 0.05 *C. Fluorescence spectra were
obtained on a Quanta Master 4L-format scanning spectrofluorimeter (Photon Technology
International) at 25.0 ± 0.1 "C using 1 pM QZ2E unless otherwise noted. All fluorescence
experiments were repeated in triplicate.
Cell Culture and Imaging Materials and Methods. HeLa cells were obtained from
American Type Cell Collection (ATCC) and cultured in Dulbecco's Modified Eagle
Medium (DMEM, Cellgro, MediaTek, Inc.) supplemented with 10% fetal bovine serum
(FBS, PAA Laboratories), 2 mM glutamine (GIBCO, Invitrogen), 100 U/mL penicillin
(Cellgro, MediaTek, Inc.), and 100 [tg/mL streptomycin (Cellgro, MediaTek, Inc.). For
imaging studies, cells were plated in poly-D-lysine coated plates (MatTek) containing 2
mL of complete DMEM and incubated overnight at 37 "C under 5% CO 2
For Zn(II) detection studies, the HeLa cells were incubated with 5 [tM QZ2E for
18 h. Thirty minutes prior to imaging the cells were co-incubated with 4.5 [iM Hoechst
33258 (Sigma), and either 200 nM Mitotracker Red (Invitrogen) or 100 nM BOPIDY TR
Ceramide (Invitrogen) for 30 min. Cells were washed two times with 1 mL of phosphate
buffered saline (PBS, Cellgro, MediaTek, Inc.) prior to imaging and then bathed in 2 mL
of serum-free DMEM during imaging. Stock solutions of 10 mM ZnCl2, prepared in
Millipore water, and 20 mM sodium pyrithione (2-pyridinethiol-1-oxide), prepared in
DMSO, were combined in a 1:1 ratio and diluted in serum-free DMEM to a 5 mM stock
concentration. Zn(II) was added to cells directly on the microscope stage at a final
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concentration of 100 [tM and allowed to incubate with cells for 5 min prior to imaging.
Stock solutions of 40 mM ethylenediamine tetraacetate ethyl ester (EDTA-(Et)4)40 and 40
mM N,N,N',N'-tetrakis(2-pyridylmethyl)-ethylenediamine (TPEN) were prepared in
DMSO, aliquotted, and stored at -20 *C. Aliquots were thawed immediately prior to use
and diluted in serum-free DMEM to a 4 mM stock concentration. The chelators were
added to the cells on the microscope stage at a final concentration of 150 [tM for 5 min
prior to imaging.
For diffusion studies, HeLa cells were incubated with 5 [tM QZ2E for 18 h, with
4.5 [tM Hoechst 33258 added 30 min prior to imaging. Cells were washed twice with 1
mL of PBS prior to imaging and then bathed in 2 mL of serum-free DMEM during
imaging. To mimic media flow, the serum-free DMEM was removed, and the cells were
washed three times with 1 mL of fresh serum-free DMEM and then bathed in 2 mL of
fresh serum-free DMEM. This process was repeated every 10 min during imaging.
Images were acquired on a Zeiss Axiovert 200M inverted epifluorescence
microscope equipped with an EM-CCD digital camera (Hamamatsu) and a MS200 XY
Piezo Z stage (Applied Scientific Instruments), illuminated by an X-Cite 120 metal-
halide lamp (EXFO). Plates were maintained on the microscope stage in an INC-2000
incubator kept at 37 *C under 5% CO2. Differential interference contrast (DIC) and red,
blue, and green fluorescent images were obtained using an oil immersion 63x objective
lens, with 2.00 s exposure times for green fluorescent images. The microscope was
operated with Volocity software (Improvision). All fluorescent images were corrected for
background.
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Cytotoxicity Assays. HeLa cells were seeded into 96-well plates (100 RL total
volume/well, 2500 cells/well) in complete DMEM and incubated at 37 *C under 5% CO2
for 24 h. The medium was replaced and the cells incubated with QZ2E (1 [M - 50 [tM,
with an untreated control lane and a 5% DMSO in complete DMEM lane) for another 24
h. The medium was removed and replaced with 200 [tL of a 20:1 mixture of FBS-free
DMEM and (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 5
mg/mL stock in PBS). The cells were incubated for 4 h and then the medium was
removed and replaced with DMSO (100 pL/well). The absorbance of each well was
recorded at 555 nm on a microplate reader (BioTek, Synergy HT) and the percent cell
survival values are reported relative to those of untreated control cells.
Results and Discussion
Design Considerations. The new trappable Zn(II) probes were based on the QZ2
scaffold, because this ligand offers many advantages as a Zn(II) detector. 3 Firstly, it
employs fluorescein as the fluorescent reporter, which imparts good water solubility,
membrane permeability, low cytotoxicity, and visible emission and excitation profiles.
Secondly, QZ2 detects Zn(II) with a large (~ 150-fold) dynamic range, and is selective
for Zn(II) over most biologically relevant cations, toxic heavy metals, and first-row
transition metals, with the exception of Cu(II) and Ni(II), neither of which is available as
a mobile M(II) species at high concentrations in vivo. Lastly, QZ2 is capable of detecting
Zn(II) using one- and two-photon fluorescence microscopy in live cells, where it reports
variable fluorescence over a wide range of Zn(II) concentrations. Importantly, the low
binding affinity of QZ2 (dissociation constant Kdi = 41 ± 3 VM)" relative to other Zn(II)-
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specific probes such as ZP1 (Kdl = 0.04 pM, Kd2 = 1.2 nM)" make QZ-type probes
suitable for in vivo imaging under conditions of high zinc levels, such as in synaptic
clefts during neurotransmission in the hippocampus 4 2 or from the pancreatic beta cells
during insulin secretion, where it is estimated that labile Zn(II) concentrations may
approach millimolar concentrations. Because QZ2 binds Zn(II) with a micromolar
dissociation constant and its fluorescence does not saturate until millimolar
concentrations of Zn(II) are present, QZ2 Zn(II) binding and subsequent fluorescence
enhancement should be reversible under these physiological conditions, making the probe
particularly suitable for in vivo imaging.
To impart cell-trappability to QZ2, esters were incorporated onto the quinoline
rings. Esters maintain cell permeability until the probe is internalized by cells, where
intracellular esterases hydrolyze the substituents to negatively charged carboxylates. The
two negative charges on the probe scaffold make QZ2E incapable of re-crossing the cell
membrane, rendering it cell-trappable.
Synthesis. The synthesis of QZ2E is presented in Scheme 6.1. 6-Hydroxy-8-
nitroquinoline, 1, was prepared in low yield by the Skraup-Doebner-von Miller reaction
between acrolein and 4-amino-3-nitrophenol. Esterification of the quinoline using ethyl
bromoacetate and Hilnig's base, followed by reduction of the nitro group by
hydrogenation with palladium on carbon afforded ethyl [(8-aminoquinolin-6-
yloxy)acetate], 2, in moderate yield. Condensation of the aminoquinoline with 4',5'-
fluoresceindicarboxaldehyde 20 in methanol followed by reduction of the imine using
sodium borohydride resulted in product formation. Purification by column
chromatography on silica afforded the trappable ligand, QZ2E, 3, in fair yield.
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Scheme 6.1. Synthesis of QZ2E.
Spectroscopic Properties of QZ2E. QZ2E shows spectroscopic properties similar to
those of QZ2 (Table 6.1).2' The absorbance spectrum of the probe exhibits a maximum at
499 nm for QZ2E (E = 2.72 + 0.09 x 104 M-1cm 1 ), with a shoulder at 467 nm (E = 1.2 ±
0.2 x 104 M-t cm'). By comparison to QZ2 (F = 3.72 x 10' M-'cm1 ), esterification of the
top-ring quinoline decreases the molar absorptivity. Upon addition of excess ZnCl2, the
maximum absorbance shifts hypsochromically to 496 nm (E = 3.36 x 104 M-'cm- and e =
1.6 ± 0.3 x 104 M'cfI for QZ2 and QZ2E, respectively) (Fig 6.2). This blue-shift is
typical for metal coordination by fluorescein-based sensors and is presumably caused by
perturbation of the fluorescein a-system upon cation binding to the phenolic oxygen
atoms of the xanthenone ring.
Table 6.1. Photophysical properties QZ2 and QZ2E.
Absorbance Emission
k (nm), , x 104 (M em) ub (nm), <p (%)D
nbouunbound Zn(I) nbound Zn(II)" pKad DR' - ref
QZ2a 499, 3.72 489, 3.36 - 520, 0.5 518,70 7.0 -150 23
QZ2E 499, 2.72(9) 496, 1.6(3) 519, 0.4(1) 514, 73(3) nr' 120(10) this work
" Measurements were performed in 50 mM PIPES, 100 mM KCl at pH 7.0. b Referenced
to fluorescein (< = 0.95 in 0.1 N NaOH). C 20 mM ZnCl2 was added. d Apparent pKa
obtained by fluorescence. ' DR is the dynamic range, 'NO 1 o . nr is not recorded.
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Figure 6.2. Absorbance spectra for the addition of excess ZnCl2 to I [tM QZ2E in 50
mM PIPES, 100 mM KCl, pH 7.0, T = 25 *C.
Metal binding of QZ2E. The emission profile of QZ2E is almost identical to that of
QZ2. The emission maxima are at 519 nm and 520 nm for QZ2E and QZ2, respectively,
and the quantum yields of the free ligands are 0.4% and 0.5% (Table 6.1). Buffered
solutions of QZ2E exhibit significant fluorescence enhancements when treated with
excess ZnCl 2, leading to a 120 ± 10-fold increase in integrated emission upon saturation
and a quantum yield increase to 73% (Figure 6.3, Table 6.1). By comparison, addition of
excess Zn(II) to QZ2 causes an ~ 150-fold increase in integrated emission and a quantum
yield increase to 70%. The differences in fluorescent dynamic range can be accounted
for by the difference in molar absorptivities of the two ligands. Comparing the product of
the molar absoprtivity and quantum yield (E x () of QZ2E (~ 114 M'cm~' in the off-state,
~ 11680 M-cm' in the on-state) with that of QZ2 (- 186 M'cm' in the off-state, ~ 23520
M'cm1 in the on-state) yields dynamic ranges (brightness on/brightness off) of ~ 102 and
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~ 126, respectively. The dynamic ranges observed by fluorescence (- 120 and ~ 150,
respectively) are greater, but the ratio of the dynamic range of QZ2E to that of QZ2 is ~
0.8 using either the brightness or the fluorescence emission. Therefore, the difference
observed is accounted for by the differences in molar absorptivities. Despite the slight
lowering of dynamic range upon esterification of the quinoline, an ~ 120-fold change in
fluorescence intensity is still much larger than that exhibited by Zn(II) sensors of the ZP
family 7 and more than adequate for cellular imaging.
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Figure 6.3. Normalized fluorescence response of 1 [M QZ2E in the presence of excess
ZnCl2 in 50 mM PIPES, 100 mM KC1, pH 7.0, T = 25 "C. Inset: Integrated fluorescence
vs. ZnCl2 concentration, normalized and adjusted for the basal fluorescence of the sensor
in the absence of Zn(II).
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The strength of Zn(II) binding by a probe is an important feature that determines
its use under specific biological conditions. Because biological mobile Zn(II)
concentrations vary widely depending on location and physiological events, it is essential
to have fluorescent sensors with a wide array of dissociation constants for Zn(II) in order
to ensure reversible detection without probe saturation. As discussed in the design
considerations, the QZ-type probes are weak Zn(II) binders, with K values in the
micromolar range." This affinity holds true for QZ2E, which requires millimolar Zn(II)
for saturation of the fluorescence emission. The strength of QZ2E Zn(H) binding was
determined by fitting the fluorescence data to a two-site model according to equation 6.1,
F = [QZ2E]t(Ii+I 2Ka1[Zn(II)]+I 3Ka1Ka2[Zn(II)] 2) (6.1)
(1 +Kai [Zn(II)]+Ka1 Ka2[Zn(II)] 2)
where [Zn(II)] is the concentration of free Zn(II), corrected for dilution, [QZ2E], is the
total concentration of the probe, corrected for dilution, Ka, and Ka2 are the association
constants for the reactions in equations 6.2 and 6.3, respectively, and I, 12, and 13 are the
proportionality constants that account for the relative contributions of each QZ2E species
QZ2E + Zn(I) ai QZ2E(Zn(II)) , Kai = [QZ2E(Zn(II))] = 1/Kd2 2)[QZ2E] [Zn(II)]
Ka2 [QZ2E(Zn(II))2]QZ2E(Zn(Il)) + Zn(II) = QZ2E(Zn(II)) 2 , Ka2 = [QZ2E(Zn(II))=] I /Kdl[QZ2E(Zn(II))] [Zn(II)]
(6.3)
F = II[QZ2E] + 12[QZ2E(Zn(II))] + 13[QZ2E(Zn(II) 2] (6.4)
[QZ2E]t = [QZ2E] + [QZ2E(Zn(II))] + [QZ2E(Zn(II) 2] (6.5)
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to the overall fluorescence emission, according to equation 6.4 (Fig. 6.3, inset). Equation
6.1 was determined by substituting into equation 6.4 using equations 6.2, 6.3, and 6.5.
Because the binding of Zn(II) by QZ2E is weak, [Zn(II)] can be approximated by
[Zn(II)],, the total concentration of Zn(II), corrected for dilution. Applying the fit to the
normalized fluorescence data yields values of Ka = 7000 t 5000 M and Ka2 = 287 t 8 M.
Substituting into equations 6.2 and 6.3 yields dissociations constants of Kdl = 3.5 t 0.1
mM (from Ka2) and K 2 = 150 t 100 [tM (from Kai). The large error associated with the
Ka, determination is probably due to the small changes in fluorescence intensity observed
upon coordination of the first Zn(II) equivalent (Fig. 6.4, micromolar region). This
hypothesis is substantiated by the fact that the second proportionality constant, 12, is
similar to the first (I, = 1.1 0.3 x 104, 12 = 3 - 4 x 104) and that this value is subject to a
large error. On the other hand, the large fluorescence changes associated with the second
binding event (13 = 1.44 t 0.01 x 106, Fig. 6.4, millimolar region) allow for a more precise
estimation of Ka. It is useful to note that the order of magnitude of binding, ~ 100 tM, is
on the same order of magnitude as that estimated for QZ2. The KdI value for QZ2 was
determined by taking kinetic data taken from stopped-flow spectroscopy and fitting it to a
one-site binding model, assuming that the second Zn(II) binding event was of
significantly lower affinity. When the fluorescence data obtained for QZ2E were fit to a
one-site model (equation 6.6), the Kd was 2.9 mM, suggesting that the second binding
event is responsible for the major fluorescence enhancement. The poor fit of the data,
however, indicates that such a one-site model is inadequate to describe the system (data
not shown).
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Figure 6.4. Top. Integrated fluorescence vs. ZnCl2 concentration (log scale),
normalized and adjusted for the basal fluorescence of the sensor in the absence of
Zn(II). Bottom. Residual plot of the fit (Equation 6.1) applied to fluorescence data.
Finally, due to the micromolar - millimolar affinity of QZ2E for Zn(II), it was
expected that, like QZ2, the Zn(II)-induced fluorescence would be readily reversed by the
Zn(II) chelator TPEN (Kd = 10-15.6 M)." When 100 [M ZnCl2 was added to a 1 [M
solution of QZ2E, however, the resulting fluorescence was hardly reduced by addition of
(6.6)
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Figure 6.5. a) Normalized fluorescence response of 1 tM QZ2E to 100 [M TPEN after
fluorescence is elicited by addition of 100 [M ZnCl2. b) Normalized fluorescence
response of 1 [tM QZ2E to 100 [tM EDTA after fluorescence is elicited by addition of
100 [tM ZnCl2-
100 RM TPEN (Fig. 6.5a). When the same experiment was repeated using EDTA (Kd =
10-16.4 M)" as the Zn(II) chelator, the fluorescence was diminished to near baseline levels
(Fig. 6.5b). Repeating the experiment with tripicolylamine (TPA) versus
diethylenetriaminepentaacetic acid (DTPA, Kd = 10-18-7 M)" gave similar results (data not
shown). It is unlikely that TPEN and TPA are incapable of chelating Zn(II), given their
superior affinity for the metal over QZ2E. The basic, pyridyl-based chelators seemingly
interact with QZ2E to elicit a fluorescence response by a different, unknown mechanism.
Because esterification of the quinoline rings of QZ2E presumably bends the quinolines
out of plane with respect to the fluorescein to avoid a steric clash, it is possible that the
Zn(II)-binding pocket of QZ2E is different than that of QZ2. It is hypothesized that
instead of chelating Zn(II), the pyridine rings of TPEN form a complex with Zn(II)-
bound QZ2E, thus stabilizing a fluorescent species. Because an effective chelator
(EDTA) was found, the details concerning TPEN binding were not pursued.
.. ....... 
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Selectivity of QZ2E for Zn(II). In order for a probe to be useful for cellular detection
of an analyte, it must be specific for that analyte over other competing biologically
relevant species. One advantage of the QZ scaffold over the ZP scaffold is that, although
the dipicolylamine chelating unit of the ZP family binds Zn(II) very tightly, it is not as
specific for Zn(II) compared to the aminoquinoline Zn(II)-binding unit of QZ2.17 '2 1 Both
families of sensors are specific for Zn(II) over the biologically relevant Na(I), Ca(II), and
Mg(II), the first row transition element Mn(II), and the toxic heavy metals Hg(II) and
Cd(II). The QZ family, however, is also selective for Zn(II) over Fe(II) and Co(II),
demonstrating an improvement in selectivity.23 A fluorescence selectivity study was
performed to ensure that modification of the quinoline ring did not alter the metal binding
properties of QZ2E significantly enough to affect its selectivity (Fig. 6.6). Indeed, Zn(II)
can displace from QZ2E all the metals tested except for Ni(II) and Cu(II), in agreement
140 - QZ2E + 50 equiv. M"'
S+ 50 equiv. Zn 2+
120- + 500 equiv. 
Zn 2.
S+ 2500 equiv. Zn 2+
100 -
80-0
LL
LL
60-
40-
20-
Na' Ca2 Mg Mn2 Fe2* C02+ Ni2. Cu2 * Zn2 Cd2+ Hg24
Metal Cations
Figure 6.6. Selectivity of QZ2E for Zn(II) compared to Na(I), Ca(II), Mg(II), Mn(II),
Fe(II), Co(II), Ni(II), Cu(II), Cd(II), and Hg(II). Normalized fluorescence response
relative to the emission of QZ2E in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 25 *C.
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with the selectivity shown by QZ2, confirming that modification of the quinoline ring
does not disrupt metal binding selectivity.
Zn(II) Detection in Live Cells. The ability of QZ2E to detect Zn(II) in live cells was
investigated using pyrithione as an ionophore to load Zn(II) into cells. HeLa cells were
incubated with 5 [tM QZ2E for 18 h (Fig. 6.7), with 4.5 RM Hoechst 33258 added 30 min
prior to imaging to stain the cell nuclei (Fig. 6.7b). Very little background fluorescence
was observed (Fig. 6.7c) in the absence of Zn(II), but upon addition of a physiologically
relevant concentration of 100 [M Zn:pyrithione (1:1) an immediate increase in
fluorescence occurred that maximized within 5 min (Fig. 6.7d). To ensure that Zn(II)
binding of QZ2E induced this fluorescence response, EDTA-(Et) 4, a cell-permeable
variant of EDTA, was incubated with the cells. For EDTA-(Et)4-induced Zn(II) chelation,
and therefore reduction in fluorescence signal to occur, the ester moieties of the chelator
must be hydrolyzed intracellularly. Addition of 150 [tM EDTA-(Et)4 did not cause an
immediate reduction of fluorescence, but after an ~ 5 min incubation period the
fluorescence in the green channel was reduced to near background levels (Fig. 6.7e). This
result demonstrates that the observed fluorescence is Zn(II)-induced. A longer incubation
period of EDTA-(Et)4 would presumably lead to complete hydrolysis of the chelator and
Figure 6.7. HeLa cells co-incubated with 5 IM QZ2E, and 4.5 [tM Hoechst 33258 for
18 h. a) DIC image, b) emission from the blue channel (nuclear stain), c) emission from
the green channel (Zn(II) probe), d) emission from the green channel after addition of
100 [M Zn:pyrithione (1:1), and e) emission from the green channel after addition of
150 FtM EDTA-(Et) 4. Scale bars 25 tm.
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therefore complete reduction of the fluorescence signal in the green channel; however,
both the chelator and the ethanol byproduct of hydrolysis is toxic to cells, and longer
EDTA-(Et)4 incubation periods resulted in cell death.
Cell-Trappability of QZ2E. To demonstrate trappability of the probe, HeLa cells were
incubated with 5 tM QZ2E for ~ 18 h to ensure sufficient time for hydrolysis of the ester
moieties to produce the cell-impermeable acids (Fig. 6.8). Addition of 4.5 pM Hoechst
33258 30 min prior to imaging was used to stain the cell nuclei (Fig. 6.8b). Addition of
100 [tM Zn(II):pyrithione (1:1) resulted in a change in fluorescence from background
levels (Fig 6.8c) to bright green (Fig. 6.8d) within 5 min. During this time and throughout
the experiment, cells were maintained in a microscope incubator at 37 *C under 5% CO2
to preserve cell viability. Over the course of 45 min, the cells were periodically washed to
mimic conditions of media perfusion. The serum-free DMEM bath was carefully
a b cd
e f gh
Figure 6.8. Cell imaging experiments demonstrating retention of QZ2E in HeLa cells
co-incubated with 5 tM QZ2E, and 4.5 stM Hoechst 33258 for 18 h. a) DIC image,
b) emission from the blue channel (nuclear stain), c) emission from the green channel
(Zn(II) probe), d emission from the green channel after addition of 100 pAM
Zn:pyrithione (1:1) at 5 min, e) 15 min, f) 25 min, g) 35 min, and h) 45 min. Scale bars
25 pm.
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removed by pipette while the plate remained on the microscope and then fresh serum-free
DMEM was added. The serum-free DMEM was removed and replaced three times to
ensure good washing of the cells, and then removed permanently and replaced with 2 mL
of fresh serum-free DMEM. Imaging every 10 minutes over the course of the experiment
(Fig. 6.8e - h) revealed that, under these conditions, Q2E is retained in HeLa cells.
QZ2E Localization in HeLa Cells. Like many other fluorescein-based probes, QZ2E
shows localization patterns in live cells. 5'45 Punctate staining was observed that was
clustered in the region surrounding the nuclei, suggesting that QZ2E subcellularly
localizes in HeLa cells. To test this hypothesis and determine the organelle of
localization, HeLa cells were first coincubated with QZ2E (5 IM), Hoechst 33258 (4.5
tM, nuclear stain), and Mitotracker Red (200 nM, mitochondrial stain), because a probe
with a similar structure, Cu2 (FL2E), demonstrates mitochondrial localization in SK-N-SH
cells. 45 Zn(II):pyrithione (100 [tM, 1:1) was added because the green fluorescence could
not be visualized adequately without inducing fluorescence enhancement. The results are
illustrated in Fig. 6.9. QZ2E does not enter the nucleus (Fig. 6.9b, c), as expected,
because the negatively charged acids produced upon esterase cleavage of the esters
should not allow it to cross the nuclear membrane. An overlay of the green probe
fluorescence (Fig. 6.9c) and the red mitochondrial stain fluorescence (Fig. 6.9d) indicates
very little overlap (Fig. 6.9e). Most of the red fluorescence persists in the overlay except
for a small region of yellow immediately surrounding the nucleus. These data are
inconsistent with QZ2E localization to mitochondria.
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Figure 6.9. HeLa cells co-in-cubated with 5 [M QZ2E, 4.5 p.M Hoechst 33258, and 200
nM Mitotracker red for 18 h. a) DIC image, b) emission from the blue channel (nuclear
stain), c) emission from the green channel (Zn(II) probe) after addition of 100 RM
Zn:pyrithione (1:1), d) emission from the red channel (mitochondrial stain), e) overlay
of the green and red channels. Scale bars 25 pm.
The Golgi apparatus is another subcellular compartment to which fluorescein-
based probes can localize,25 and is located within close proximity to the nucleus.
Therefore, the localization experiments were repeated by incubating HeLa cells with
QZ2E (5 sM), Hoechst 33258 (4.5 [tM, nuclear stain), and BODIPY TR Ceramide (100
nM, Golgi apparatus stain), and then inducing adequate green fluorescence for
visualization with Zn(II):pyrithione (100 [tM, 1:1, Fig. 6.10). In contrast to the results of
the mitochondrial staining experiment, an overlay of the green probe fluorescence (Fig.
6.10c) and the red Golgi stain fluorescence (Fig. 6.10d) reveals excellent colocalization
(Fig. 6. 1Oe). Essentially all of the red fluorescence observed in Fig, 6. 1Od appears yellow
when overlayed with the green QZ2E fluorescence, indicating that QZ2E localizes
Figure 6.10. HeLa cells co-incubated with 5 [M QZ2E, 4.5 p.M Hoechst 33258, and
100 nM BODIPY TR Ceramide for 18 h. a) DIC image, b) emission from the blue
channel (nuclear stain), c) emission from the green channel (Zn(II) probe) after addition
of 100 [M Zn:pyrithione (1:1), d) emission from the red channel (Golgi apparatus
stain), e) overlay of the green and red channels. Scale bars 25 pm.
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subcellularly to the Golgi apparatus in HeLa cells. The small overlap of green and red
fluorescence observed in Fig. 6.9e is probably due to mitochondrial and Golgi overlap
along the z-axis of the cell and not true localization of QZ2E to mitochondria.
Cytotoxicity of QZ2E. Over the course of the cell imaging experiments, there was no
visual cell death caused by QZ2E at the concentration used (5 [M); however, the
experiments were performed at low probe concentration. To investigate the potential
cytotoxic effects of QZ2E at higher concentrations, which may be needed for certain
biological applications such as in tissue slices,45  3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assays4 6 were performed over a 24 hour period. The
results indicate that QZ2E is minimally cytotoxic to HeLa cells at concentrations under
25 pM, with ~ 85% cell survival over 24 h for 1 [tM probe loading, and ~ 70% cell
survival over 24 h for 10 [tM QZ2E. At higher concentrations, the probe becomes more
toxic. For example, at 25 [M QZ2E the cell survival over 24 h drops to ~ 50%. The
cytotoxicity assays are limited by the insolubility of QZ2E in DMSO. Incubation of HeLa
cells with 50 [M QZ2E requires a 5% loading of DMSO, which is itself toxic, and
therefore cell survival at this concentration over 24 h was only ~ 30%. A control
incubation with 5% DMSO and no QZ2E showed similar results (~ 20% cell survival
over 24 h), confirming that the addition of DMSO associated with QZ2E application is a
limiting factor in QZ2E cytotoxicity.
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Summary
The synthesis and spectroscopic characterization of the cell-trappable,
fluorescein-based Zn(II) probe QZ2E is reported. Esterification of the quinoline ring of
QZ2E does not drastically alter its Zn(II) binding capacity as compared to the first
generation probe, QZ2 (Kdl (QZ2) = 41 ± 3 pM, Kdl (QZ2E) = 3.5 +0.6 mM, Kd2 (QZ2E)
= 150 ± 100 [M), nor its emissive properties before and after ZnCl2 addition to buffered
solutions ($ (QZ2) = 0.5%, $ (QZ2 + Zn(II)) = 70%; * (QZ2E) = 0.42 ± 0.05%, * (QZ2E
+ Zn(II)) = 73 + 3%). QZ2E has a slightly reduced dynamic range with respect to QZ2 (-
120-fold enhancement versus ~ 150-fold enhancement, respectively) but maintains
selectivity for Zn(II) over other biologically relevant cations, toxic heavy metals, and
most first-row transition metals. QZ2E is a competent Zn(H) sensor in live HeLa cells,
and is retained intracellularly despite numerous washings. Unlike QZ2, QZ2E localizes to
the Golgi apparatus in HeLa cells, a difference that may reflect its greater negative charge
following intracellular hydrolysis of its ester moieties.
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Appendix 1.
Screening for bNOS Inhibitors in Bacillus anthracis
Reproduced in part from Tonzetich, Z. J.; McQuade, L. E.; Lippard, S. J. Inorg. Chem.,
2010, in press. Copyright 2010 American Chemical Society.
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Introduction
Anthrax Infection
Bacillus anthracis, or anthrax, is a rare, acute, life-threatening infectious agent.
Three forms of the infection exist: cutaneous, gastrointestinal, and inhalation (wool-
sorter's disease).1 The most common type of infection is cutaneous, which causes at least
95% of anthrax infections and results from direct skin contact with infected animals or
their byproducts.2 Anthrax is prevalent in regions where agriculture is a major industry
and good methods for controlling and preventing anthrax in animals are lacking, such as
South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean,
and the Middle East. It is usually treatable by antibiotics, with < 1% of infections
resulting in death.3 The gastrointestinal form of the infection is rare and results from the
consumption of infected meat. No cases have been reported in the United States, but in
other countries the death rate from this infection has been estimated to be 25 - 60%.3
Reports of inhalation anthrax are also scarce, and the infection results from breathing in
8,000 - 50,000 bacterial spores.3 Mortality rates for this form of infection are high, and
reported outbreaks in this century range from 86 - 97% fatality.3 According to the
Centers for Disease Control and Prevention (CDC), the incidence of anthrax infections in
the United States has dropped dramatically, from ~ 130/year in the early 1900's to zero
cases from 1993-2000;2 however, intentional distribution of anthrax spores via the US
Postal System in 2001 resulted in 11 cases of cutaneous anthrax and 11 cases of
inhalation anthrax (5 deaths).4 The World Health Organization (WHO) estimates that
releasing 50 kg of bacterial spores upwind of a city of half a million people could result
in 125,000 infections and 95,000 deaths a mere three days after distribution.' Thus,
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despite the rarity of B. anthracis infection, anthrax has great potential to cause
devastating effects if used maliciously and therefore requires more effective treatment
options than those currently available.
Challenges of Treating Anthrax Infections
The major challenge in curing inhalation anthrax infection is that, upon invasion,
the bacteria spread easily and act rapidly, making immediate, effective treatment essential
for the host to survive. In addition, B. anthracis can incubate in the lungs for days to
weeks as spores, which are untreatable by antibiotics. Typical medications, such as
doxycycline, ciprofloxacin, or penicillin are only effective against germinating bacteria,
so delayed onset of the disease sometimes occurs after cessation of initial antibiotic
3,6therapy. A vaccine for the prophylactic treatment of anthrax exists, but it has numerous
side effects and is not readily available to the public, but rather only to those at high risk.
Antibiotics may also be utilized for prophylaxis in patients who are exposed to anthrax
spores but are asymptomatic. Antibiotics work well if administered before or
immediately after the onset of illness, but if administered later than 48 h after symptoms
appear death occurs in ~ 95% of cases. 3 Additionally, there are known penicillin- and
doxycycline-resistant strains of the bacteria, making multi-drug treatment required for
best results.6 Thus, there is a dearth of fast-acting, effective antibiotics.
B. anthracis Pathogenesis
When anthrax spores enter into the human body, either through the skin,
gastrointestinal tract, or lungs, they are rapidly phagocytosed by activated
macrophages.79 Spores germinate in macrophage lysosomes and then escape, multiply in
the cytoplasm, and within several hours kill the macrophages and enter the bloodstream.
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Because they form capsules that help protect them from destruction, the bacteria can
replicate to reach extremely high titers (108 cells/mL) and then quickly kill a host by
secreting a tripartite toxin molecule.' Most anti-anthrax drug development has focused
on the major virulence factors found on two plasmids, pXO1 and pXO2, that are
responsible for exotoxin production, capsule formation, and spore germination." The
survival of B. anthracis in phagocytes immediately after germination is critical for
development of the infection. Production of reactive oxygen species (ROS) such as
hydrogen peroxide and hydroxyl radical by phagocytes plays an essential role in
damaging the bacterial DNA and proteins, resulting in pathogen death.12" Therefore,
immediate ROS neutralization is crucial for bacterial survival.
Nitric Oxide Production by Nitric Oxide Synthase in Eukaryotes vs. Bacteria
Most nitric oxide produced in vivo is generated by the enzyme nitric oxide
synthase (NOS), which converts L-arginine to L-citrulline and NO via N-hydroxy-L-
arginine.14 There are three isoforms of eukaryotic nitric oxide synthases (euNOSes),
neuronal (nNOS), inducible (iNOS), and endothelial (eNOS), which are well
characterized in mammals.1 5 In eukaryotes, the three isoforms are separated into two
major classes of the enzyme; constitutive and inducible, which produce different
concentrations of NO after induction by different stimuli. 16 Neuronal (nNOS) and
endothelial (eNOS) nitric oxide synthases represent the constitutive forms of the enzyme
(cNOS) and they require activation to produce NO. This process occurs after an increase
in the intracellular Ca 2 ion concentration activates calmodulin (CaM). Calcium binding
to CaM induces a conformational change in the protein, which primes it for subsequent
action on a variety of targets, including nNOS and eNOS.1'" 7 The NO-forming reaction
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occurs in the oxidase domain of cNOSes, which contains a heme center responsible for
L-arginine hydroxylation. A reductase domain supplies electrons required for turnover.
The electrons are shuttled from flavin moieties in the reductase to the heme center after
calmodulin binding alters the protein conformation to bring the oxidase and reductase
domains into close proximity.16 Recently, a NOS from the Gram-negative bacterium
Sorangium cellulosum has been isolated that is similar to eukaryotic NOSes.' 8 This
enzyme uses a Fe 2S2 ferrodoxin domain in the reductase instead of flavins to transfer
electrons, and it utilizes either tetrahydrobiopterin (H4B) or tetrahydrofolate (H4F) as
cofactors, rather than only H4B in the euNOSes.18
Many Gram-positive bacteria express an oxidase, bacterial nitric oxide synthase
(bNOS), that is homologous to the eukaryotic oxidase.19 The reductase domain, however,
is lacking in these proteins, and consequently it was long thought that bNOS-expressing
bacteria were incapable of producing NO in vivo. Recently, NO production has been
observed in three Gram-positive bacteria, Bacillus subtillus, Staphylococcus aureus, and
Bacillus anthracis.2 0-2 2 It is hypothesized that these bNOS-expressing bacteria recruit
non-committed reductases to provide electrons for catalysis. 2' This NO protects Bacilli
against reactive oxygen species produced when they are taken up by host immune cells
(Fig. Al. 1).20,22 There is a dual mechanism of protection at play (Fig. A1.2). Firstly, NO
helps suppress the Fenton reaction that leads to hydroxyl radical production and
subsequent DNA, protein, and lipid damage. In order for Fenton chemistry to operate
catalytically, the ferric iron generated in the reaction must be converted back to ferrous
iron, a process that is accomplished by using cysteine as the reductant in bacteria. Nitric
oxide inhibits the thioredoxin/thioredoxin reductase (Trx/TrxR) system, the only system
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for thiol reduction in many bacteria.2 2 Secondly, NO directly activates catalase, the major
enzyme that protects the cell against ROS by removing hydrogen peroxide, converting it
to water and dioxygen. 20
I s nt + NOSI Ao inhibitor
H20 2
resistance
j1A=7timm A=7±2mm
NO
production
Fig. A1.1. NO protects B. anthracis against oxidative stress. Top: bNOS-mediated
cytoprotection in B. anthracis. Anaerobically grown wildtype (wt) and Anos cells were
plated on BHI agar. Disks were saturated with 10 mM H20 2 and placed on top of the
bacterial lawns. A indicates the increase of the sterile zone observed when bNOS was
either deleted or inhibited. Bottom: bNOS-dependent NO production in vivo, imaged
using CuFLL. B. anthracis Sterne (WT) and Anos cells were grown in LB medium to
OD600 ~ 0.5 followed by CuFLI addition. Adapted from Ref. 22.
Fig. A1.2. The dual mechanism of the NO-mediated defense system against ROS toxicity
in B. anthracis. bNOS-derived NO interrupts the production of damaging hydroxyl
radicals from the Fenton reaction and directly activates catalase (Kat). Reproduced from
Ref. 22.
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NO as a Virulence Factor in B. anthracis
The NO-mediated protection is unique because it is immediate and does not rely
on the induction of defense protein synthesis, which is time and energy consuming for the
bacteria. On the contrary, it affects the target proteins directly and protects the bacterial
cells in a matter of seconds. Such immediate protection is a valuable defense weapon for
bacteria germinating inside macrophages. 20,22 B. anthracis (Sterne) pre-treated with NO
have increased viability against hydrogen peroxide exposure, and the deletion of B.
anthracis bNOS increases bacterial susceptibility to attack by cultured macrophages (Fig.
Al.3a). Moreover, the virulence of the bNOS deficient strain is reduced by three orders
of magnitude relative to that of the wild type (Steme) cells in a mouse model of systemic
infection (Fig. A1.3b). Recent findings also suggest NO production plays a role in
antibiotic resistance.23 The bNOS-produced NO is hypothesized to chemically modify
antibiotics, as well as mitigate the oxidative stress caused by said antibiotics. These
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Fig. A1.3. bNOS is essential for B. anthracis virulence in mice and survival in
macrophages. a) wt versus Anos B. anthracis survival in J774A.1 macrophages. Viable
bacteria within macrophages were recovered and colony-forming units were determined
12 h after infection. b) Lethal dose of anthrax spores as a function of bNOS activity. The
indicated amounts of B. anthracis spores (Sterne or Anos) were inoculated s.c. into A/J
mice (n = 10 for each group). Shown are the effects of LD1oo. Adapted from Ref. 22.
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findings implicate NO as an important virulence factor for B. anthracis and as a
necessary agent for bacterial survival within a mammalian host.
The observation that NO is required for bacterial survival in a host suggests that a
bNOS inhibitor would make a good antibacterial agent against Bacillus anthracis,
provided that the compound were specific for bNOS over the eukaryotic enzymes.
Bacterial NO synthase might even be a broadly applicable antibacterial target, because
NO production occurs in a number of Gram-positive bacteria and might prove to be a
general virulence factor. Because the bNOS enzyme lacks a reductase domain it is
possible that inhibition of the reduction step would prove to be useful as a strategy for
selective inhibition of bNOS. Using CuFL 1,24,25 a protocol for measuring NO production
in B. anthracis (Sterne) cells was established.2 1 This protocol revealed that the NO
production times in bacteria vs. macrophages are very different (Fig. A1.4). The latter use
inducible nitric oxide synthase (iNOS), which, unlike cNOSes, must be activated by
a) MF b) relative fluormence intensity %
21, 3MF+wt B&_.
MFAnos B.a n
16
Fig. CuF14aQanifd in J774A.1 macrophagesat2da0 h after
Ref. 22.
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immunogenic agents, such as cytokines.1 7 Inducible nitric oxide synthase is regulated at
the transcriptional level and its basal expression levels are negligible. Activation involves
upregulation of the iNOS mRNA, which after a few hours is translated into the functional
enzyme.17 The different NO-production kinetics of bNOS and iNOS offers a window of
opportunity for using CuFLI to discover selective inhibitors of the former (Fig. A1.4b).
Project Goals and Overview
The ultimate goal of this project is to use the fluorescence response of an NO-
specific probe for a high-throughput screen of a library of thousands of compounds to
search for bNOS inhibitors by monitoring the lack of fluorescence emission from cells
incubated with said compounds (Scheme A1.1). The basic protocol will involve growing
bacterial cultures in media to a sufficient optical density for the experiment and then
transferring them into multi-well plates for the screen. An E. coli strain harboring the
pBad expression vector containing the B. anthracis bNOS cloned into it (pBNOSBan)
will be used. This E. coli construct produces measurable levels of NO upon induction of
gene expression by L-arabinose (Fig. A1.5).21 Small molecules from a large (- 300,000)
screening library will be coincubated with the cells, and then the bacteria will be induced
22 h, 370C, 5% CO 2  37
0C, 5% CO 2
E. coli transfected with bNOS in LB 1) Small molecule, potential inhibitor 1) NO-specific probe
2) Arabinose, to induce NOS expression 2) Image fluorescence and absorbance
3) Incubate, 370C, 5% CO 2 3) Compare ratios
Scheme A1.L. High-throughput screening protocol.
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to produce nitric oxide. The wells will be loaded with a highly specific NO probe and,
after an incubation time sufficient for the production and detection of nitric oxide, the
plates will be screened for fluorescence and absorbance. A successful inhibitor will be
one that elicits significantly decreased fluorescence emission of the NO-specific probe
relative to a positive control. The optical density of the samples will be examined to
determine whether the small molecules are asserting deleterious effects on the bacteria.
This step is important for confirming that the lack of fluorescence observed is due to
bNOS inhibition and not cell death. Otherwise, it would be impossible to discern the
mechanism by which a compound kills the culture, and therefore selectivity for bNOS
cannot be established. This appendix presents work focused on taking the protocol from
the lab into a screening facility to optimize the conditions in 384-well plates.
pBad pNOSan
(2.5±1%) (58.9±10%)
Fig. A1.5. NO production by B. anthracis bNOS expressed in E. coli. Representative
fluorescent image of bacteria treated with CuFL1 for 15 min after arabinose and L-
arginine addition. The percent of fluorescent cells (mean E SD) is indicated for the
empty vector- (pBad) and the bNOS-containing E. coli. Adapted from Ref. 21.
Experimental Section
Cell Preparation and Imaging Methods. E. coli Top 10 [pIG] cells were obtained
from Ivan Gusarov of the Nudler lab at the New York University School of Medicine.
High-throughout screening protocol optimization was performed at the Institute of
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Chemistry and Cell Biology (ICCB) screening facility at Harvard Medical School in
collaboration with Dr. Tao Ren, Senior Assay Developer. Cultures were grown overnight
in Luria-Bertini (LB) medium supplemented with 100 pg/mL ampicillin at 37 *C. In the
morning, the cells were diluted 1:100 in LB and reincubated with aeration until OD600 ~
0.3 - 0.4 (approximately 2 h). They were then plated in 50 pL aliquots into a 384-well
plate, unless otherwise specified. The promoter of the plasmid was induced with aqueous
L-arabinose and cells were allowed to incubate for 2 h, unless otherwise specified. Cell
stocks were loaded with 0 - 20 pM CuFLI and incubated for 10 - 60 min. The cells were
imaged using a Perkin Elmer EnVision plate reader, with x = 485 nm, and Xem = 535
nm.
Results and Discussion
Design Considerations. There are two fundamental approaches for obtaining selective,
effective, and potent inhibitors for an enzyme. The first is to rationally design an inhibitor
based on the electronic properties and steric environment of the active site of the enzyme
and known substrates for the reaction it catalyzes. This approach can lead to good
inhibitors but generally requires a crystal structure and knowledge of the transition
state(s) of the enzyme mechanism. In addition, the potential inhibitor often fails to effect
the desired result due to some key interaction or mechanistic step in the reaction that is
unknown to the designer, which the inhibitor does not take into account. The second is to
use a high-throughput screen to rapidly evaluate a large library of small molecules,
peptides, and the like for their effectiveness as inhibitors of the enzyme. Although some
argue this "brute force" way of identifying lead compounds is less appealing than rational
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design, it can be a more effective way to uncover good candidates, especially when
detailed knowledge of the enzyme active site, transition state, or mechanism is lacking. In
addition, compounds may be uncovered that inhibit the enzyme by an alternative
mechanism than active site occupancy, for example by preventing association of two
subunits or by blocking electron transfer to an active site. Because of these advantages
the high-throughput screening (HTS) approach was chosen as the major method for
uncovering new bNOS-antagonists as anti-bacterial compounds active against anthrax.
Optimization of Screening Conditions: The Sensor. The initial studies monitoring
NO production in pIG cells in the Nudler lab at NYU and in the Lippard Lab at MIT were
performed in 96-well plates using 20 gM CuFL1. For high-throughput screening
purposes, the concentration of sensor should be chosen such that the signal to noise ratio
is maximized while the amount of sensor used is minimized. Therefore, the first
parameter optimized at the ICCB was the sensor concentration. Five concentrations (20
pM, 10 pM, 5 pM, 1 pM, 0.1 pM) were evaluated following the standard protocol
outlined in the experimental section. To create a positive control (i.e. one with no
fluorescence), some cells were not induced with arabinose, and therefore could not
produce NO. The ratio of the fluorescence of the induced cells (F+) over the fluorescence
of the uninduced cells (F~) was compared for the five concentrations (Table Al. 1). Three
Table A1.1. CuFLI Concentration Dependence of F*/F~.
[CuFL1] (pM) Fe/F (20 min CuFL1) Fe/F (40 min CuFL1)
20 1.1(2) 1.1(2)
10 1.0(1) 1.03(9)
5 1.01(8) 1.00(6)
1 1.1(2) 1.0(1)
0.1 1.0(1) 1.0(1)
0 0.99(9) 1.0(1)
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major observations were made. The first observation was that the fluorescence
enhancement of the induced cells was almost negligible under the standard conditions,
indicating that the 96-well plate protocol did not translate to the 384-well plates. There
are many possible reasons for this result, the most important being the decreased volume
of the wells. With smaller well volumes there is less oxygen available in each well, which
may affect both the growth of the plated cells as well as their ability to form nitric oxide,
because 02 is a substrate in the enzymatic reaction to form NO from L-arginine. The
second observation was that the sensor concentration had little affect on the F*/F ratio. It
was impossible to determine whether this result meant that the sensor concentration did
not matter or whether the results were similar due to the general lack of fluorescence
enhancement. Consequently, three concentrations were used for the remaining
optimization experiments (20 pM, 5 pM and 0.1 pM). The third observation was that the
incubation time of the sensor did not alter the results very much. Again, this result was
possibly due to the minimal turn-on observed, but further optimization experiments
indicated that longer sensor incubation times did not improve the F*/F- ratio (results not
shown). Twenty minutes was chosen as the final incubation time, sufficient to introduce
the sensor and have it react with NO, but not too long as to render the screening
procedure inefficient.
Optimization of Screening Conditions: Arabinose Induction. To investigate whether
0 2-deficiency was causing the lack of fluorescence enhancement observed in the 384-
well experiments, the fluorescence enhancement was compared for cells prepared under
the standard protocol, where induction of bNOS occurred after the cells were plated,
versus cells that were induced in the dilution flask and then plated. Cells were incubated
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for 2 h under these two conditions, loaded with 20 pM, 5 pM or 0.1 pM sensor, then
reincubated for 20 min, after which the fluorescence response was measured (Table
A1.2). For the 20 pM and 5 pM trials the fluorescence enhancement was improved by
incubating in the larger volume flask versus the wells, so this practice was adopted for the
HTS protocol.
Table A1.2. Effect of Induction Conditions on F*/F~.
[CuFLI] ( M)a Fe/F (wells)
20 1.2(1)
5 1.02(9)
0.1 1.0(1)
F*/F- (plates)
1.28(4)
1.458(9)
1.00(6)
Arabinose is used to regulate the araBAD promoter, which initiates expression of
bNOS in the pBAD vector system. For maximum expression, 2% aqueous arabinose is
used, although gene expression can be induced with lower concentrations of the sugar.
Unfortunately, cells do not grow as well under conditions of maximum bNOS expression,
possibly because much of their resources are being depleted during protein production
and are therefore unavailable for regular functions. Consequently, the fluorescence
response may be reduced due to decreased sample viability. For high-throughput
screening purposes, the concentration of arabinose used should maximize the F*/F~ ratio
while minimizing the amount of material required. The concentration of arabinose was
Table A1.3. Arabinose Concentration
[CuFL1] ([M) Fe/F-
a20
5
0.1
b20
5
0.1
Dependence F/F.
(5% arabinose) Fe/F
1.4(3)
1.24(4)
1.10(6)
1.5(1)
1.42(7)
1.3(2)
(2% arabinose)
1.44(6)
1.25(4)
1.14(7)
1.5(1)
1.41(5)
1.3(2)
a Static induction. b Shaking induction.
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reduced from 2% - 0.5% and cells were incubated overnight in a flask under two
conditions - static incubation or incubation in shaker (Table A1.3). The fluorescence
enhancement was the same within statistical significance, irrespective of arabinose
concentration, but was greater in cells that were shaken during induction. The first
observation was disappointing, because tests in 96-well plates performed in the Lippard
lab indicated that lower concentrations of arabinose produced greater fluorescence
responses. Because reducing the concentration of arabinose to 0.5% allowed less material
to be wasted per screen, this concentration was chosen. The second observation supports
the hypothesis that 0 2-deficiency may be causing decreased NO production, because
shaking helps promote oxygen dissolution in the media.
The experiment was repeated using two induction incubation times, 6 h and 22 h,
to see whether overnight incubation was necessary or if shaking for a shorter time was
sufficient to obtain the same results (Table A1.4). The fluorescence enhancement was
greatest when the cells were allowed to incubate shaking overnight during arabinose
induction. It is not clear why this procedure is necessary, because E. coli transfected with
bNOS show 20 pM or greater NO2 ~/NO3 production, based on a Griess Assay, within 2
- 4 h of induction, so there should be enough NO produced to saturate the CuFL1 by the
216 h time point.
Table A1.4. Effect of Induction Time on Ft/F~.
[CuFLI] ([tM)a F*/F- (6 h) F*/F- (22 h)
20 1.1(2) 1.38(5)
5 1.09(3) 1.32(7)
0.1 1.09(4) 1.2(2)
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Z-Test and Pilot Study. For high-throughput screening applications, the difference
between the positive signal and the negative signal should be maximized. To ensure that
the F+ was statistically significantly greater than the F- a Z-test was performed (equation
Al. 1). The standard for such a test is that if Z > 0.5 the difference between the positive
(0'+ c-)1
Z=l-3 + (A1.1)
and negative results should be large enough to differentiate hits from non-hits. The screen
was performed under the optimized conditions, using 5 gM CuFL 1. This concentration
was chosen because the results from the final optimization experiment were statistically
the same for the 20 pM and 5 pM concentrations, but using 5 pM CuFLI meant that less
sensor was consumed during a full screen. The results of the Z-test were modest but
positive, with Z = 0.52. A pilot study was run using a modified protocol. Briefly, after the
cells were grown to O.D.600 - 0.3 - 0.4 they were plated into 384-well plates, to which
100 nL of a small molecule from the ICCB library was added using an Epson robot pin
array. The cells were then induced with arabinose and allowed to incubate overnight in a
shaker. The rest of the protocol was followed as previously described. The screen was
performed in duplicate and the results from duplicate plates matched, indicating the
screen is consistent. Unfortunately, there was a wide range of fluorescence signals, such
that it was impossible to distinguish a hit from a non-hit. This result was possibly due to
the fact that the arabinose induction had to take place in the wells instead of in a flask
during the actual screen.
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Conclusions and Future Directions
The NO detection protocol was taken from 96-well plates in the lab to 384-well
plates in the ICCB screening facility. Many parameters were optimized, including sensor
concentration and incubation time, arabinose concentration, induction time and induction
conditions. A Z-test was executed to determine the statistical significance of the results of
the optimized protocol, and a pilot screen was performed using a few hundred small
molecules from the ICCB library.
The difference between positive and negative results must be increased to make
the screen viable under high-throughput conditions. One way to accomplish this goal
would be to improve the NO-specific probe. The dynamic range is greatly improved in
the symmetrical variants of CuFL1 (Chapter 3), so using these probes may increase F/F-
ratio. If probe leakage from cells is limiting the fluorescence sensitivity then performing
the screen with a trappable probe such as Cu2(FL2E) (Chapter 4) would be valuable.
An alternative strategy for increasing the difference between positive and negative
results is to optimize the bacterial NO production. Because bNOS does not have a
reductase domain, it must acquire electrons from an external source, presumably non-
specific reductases in Bacilli or E. coli.21 One way, therefore, to increase NO output is to
tether a reductase to bNOS through a flexible linker. CysJ or ykuNP from B. subtilis are
good candidates. CysJ has the highest homology to the mammalian reductase domains of
NOS, and YkuNP supports NO synthesis in vitro. 26 Each reductase can be cloned to the
pBNOSBan vector in the same frame as the bNOS gene and introduced into E. coli. As a
result, both domains would be overexpressed to a high level, and because they will be
linked their local concentration be increased dramatically, yielding a higher NO output.
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Furthermore, the composition of the media can be optimized. If there is still insufficient
NO production for the screen, B. subtilis can be used as a host for bNOS expression.
Because B. subtilis has its own bNOS and therefore naturally expresses the required
cofactors, it will be easier to increase NO output simply by overexpression of bNOS from
B. anthracis.
Once the F/F- ratio is improved, a full high-throughput screen will be performed,
and presumably some positive hits for potential bNOS inhibitors will be discovered. The
long-term directions will be, in collaboration with the Nudler Lab at NYU, to determine
whether the lead compounds from the HTS are selective for bNOS over euNOSes.
Briefly, this task will be accomplished by incubating the small molecules in mammalian
tissue that expresses either the constitutive (cNOS) or inducible (iNOS) form of NOS.
The fluorescent NO probe will be co-incubated with the lead compounds, and NO
production will be monitored to ensure that the inhibitors are not preventing NO
production from euNOSes. The inhibitors will then be examined in macrophages that
have phagocytosed B. anthracis, a system that models the early stages of host invasion.
Because of the differential timing of NO production in macrophages versus bacteria (vide
supra), the differential fluorescence emission in this system can be used to establish the
target of small molecule inhibition. Finally, the toxicity of the most selective bNOS
inhibitors will be determined in vivo. A/J susceptible mice will be inoculated with B.
anthracis (Sterne) spores to mimic a mammalian systemic infection. The mice will be
monitored over a two-week period, and toxic side effects noted. The LD50 and LD100
values will be determined for each inhibitor and the dosages and administration routes
will be optimized.
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